00001083853/312025Q3FalseP3Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purewrld:installmentwrld:acquisition00001083852024-04-012024-12-3100001083852025-01-3100001083852024-12-3100001083852024-03-3100001083852024-10-012024-12-3100001083852023-10-012023-12-3100001083852023-04-012023-12-310000108385us-gaap:CommonStockMember2024-09-300000108385us-gaap:AdditionalPaidInCapitalMember2024-09-300000108385us-gaap:RetainedEarningsMember2024-09-3000001083852024-09-300000108385us-gaap:CommonStockMember2024-10-012024-12-310000108385us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310000108385us-gaap:RetainedEarningsMember2024-10-012024-12-310000108385us-gaap:CommonStockMember2024-12-310000108385us-gaap:AdditionalPaidInCapitalMember2024-12-310000108385us-gaap:RetainedEarningsMember2024-12-310000108385us-gaap:CommonStockMember2023-09-300000108385us-gaap:AdditionalPaidInCapitalMember2023-09-300000108385us-gaap:RetainedEarningsMember2023-09-3000001083852023-09-300000108385us-gaap:CommonStockMember2023-10-012023-12-310000108385us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310000108385us-gaap:RetainedEarningsMember2023-10-012023-12-310000108385us-gaap:CommonStockMember2023-12-310000108385us-gaap:AdditionalPaidInCapitalMember2023-12-310000108385us-gaap:RetainedEarningsMember2023-12-3100001083852023-12-310000108385us-gaap:CommonStockMember2024-03-310000108385us-gaap:AdditionalPaidInCapitalMember2024-03-310000108385us-gaap:RetainedEarningsMember2024-03-310000108385us-gaap:CommonStockMember2024-04-012024-12-310000108385us-gaap:AdditionalPaidInCapitalMember2024-04-012024-12-310000108385us-gaap:RetainedEarningsMember2024-04-012024-12-310000108385us-gaap:CommonStockMember2023-03-310000108385us-gaap:AdditionalPaidInCapitalMember2023-03-310000108385us-gaap:RetainedEarningsMember2023-03-3100001083852023-03-310000108385us-gaap:CommonStockMember2023-04-012023-12-310000108385us-gaap:AdditionalPaidInCapitalMember2023-04-012023-12-310000108385us-gaap:RetainedEarningsMember2023-04-012023-12-310000108385us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310000108385us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310000108385us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000108385us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000108385us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-12-310000108385us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-12-310000108385us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-03-310000108385us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-03-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-12-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-12-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-03-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2024-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:TaxAdvanceLoanMember2024-12-310000108385wrld:TaxAdvanceLoanMember2024-03-310000108385us-gaap:PerformingFinancingReceivableMemberus-gaap:ConsumerPortfolioSegmentMember2024-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMemberus-gaap:ConsumerLoanMember2024-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2024-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2024-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2024-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2024-12-310000108385us-gaap:ConsumerLoanMemberus-gaap:ConsumerPortfolioSegmentMember2024-12-310000108385us-gaap:PerformingFinancingReceivableMemberwrld:TaxAdvanceLoanMember2024-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:TaxAdvanceLoanMember2024-12-310000108385us-gaap:PerformingFinancingReceivableMemberus-gaap:ConsumerPortfolioSegmentMember2024-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMemberus-gaap:ConsumerLoanMember2024-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2024-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2024-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2024-03-310000108385us-gaap:ConsumerPortfolioSegmentMember2024-03-310000108385us-gaap:ConsumerLoanMemberus-gaap:ConsumerPortfolioSegmentMember2024-03-310000108385us-gaap:PerformingFinancingReceivableMemberwrld:TaxAdvanceLoanMember2024-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:TaxAdvanceLoanMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMemberus-gaap:ConsumerLoanMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:PerformingFinancingReceivableMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMemberus-gaap:ConsumerLoanMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:PerformingFinancingReceivableMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMember2024-03-310000108385us-gaap:ConsumerPortfolioSegmentMember2024-10-012024-12-310000108385wrld:TaxAdvanceLoanMember2024-10-012024-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2024-04-012024-12-310000108385wrld:TaxAdvanceLoanMember2024-04-012024-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2023-10-012023-12-310000108385wrld:TaxAdvanceLoanMember2023-10-012023-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2023-04-012023-12-310000108385wrld:TaxAdvanceLoanMember2023-04-012023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:RecencyBasisMemberwrld:A60MonthsMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-12-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMember2024-12-310000108385wrld:RecencyBasisMember2024-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:RecencyBasisMemberwrld:A60MonthsMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-03-310000108385wrld:RecencyBasisMemberwrld:TotalPastDueMember2024-03-310000108385wrld:RecencyBasisMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:A0To5MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:A6To17MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:A18To35MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:A36To59MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A60MonthsMember2024-12-310000108385wrld:ContractualBasisMemberwrld:A60MonthsMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-12-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMember2024-12-310000108385wrld:ContractualBasisMember2024-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:A0To5MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:A6To17MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:A18To35MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:A36To59MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:A60MonthsMember2024-03-310000108385wrld:ContractualBasisMemberwrld:A60MonthsMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TaxAdvanceLoanMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-03-310000108385wrld:ContractualBasisMemberwrld:TotalPastDueMember2024-03-310000108385wrld:ContractualBasisMember2024-03-310000108385wrld:A0To5MonthsMember2024-10-012024-12-310000108385wrld:A0To5MonthsMember2023-10-012023-12-310000108385wrld:A0To5MonthsMember2024-04-012024-12-310000108385wrld:A0To5MonthsMember2023-04-012023-12-310000108385wrld:A6To17MonthsMember2024-10-012024-12-310000108385wrld:A6To17MonthsMember2023-10-012023-12-310000108385wrld:A6To17MonthsMember2024-04-012024-12-310000108385wrld:A6To17MonthsMember2023-04-012023-12-310000108385wrld:A18To35MonthsMember2024-10-012024-12-310000108385wrld:A18To35MonthsMember2023-10-012023-12-310000108385wrld:A18To35MonthsMember2024-04-012024-12-310000108385wrld:A18To35MonthsMember2023-04-012023-12-310000108385wrld:A36To59MonthsMember2024-10-012024-12-310000108385wrld:A36To59MonthsMember2023-10-012023-12-310000108385wrld:A36To59MonthsMember2024-04-012024-12-310000108385wrld:A36To59MonthsMember2023-04-012023-12-310000108385wrld:A60MonthsMember2024-10-012024-12-310000108385wrld:A60MonthsMember2023-10-012023-12-310000108385wrld:A60MonthsMember2024-04-012024-12-310000108385wrld:A60MonthsMember2023-04-012023-12-310000108385wrld:A0To5MonthsMember2024-12-310000108385wrld:A0To5MonthsMember2024-03-310000108385wrld:A6To17MonthsMember2024-12-310000108385wrld:A6To17MonthsMember2024-03-310000108385wrld:A18To35MonthsMember2024-12-310000108385wrld:A18To35MonthsMember2024-03-310000108385wrld:A36To59MonthsMember2024-12-310000108385wrld:A36To59MonthsMember2024-03-310000108385wrld:A60MonthsMember2024-12-310000108385wrld:A60MonthsMember2024-03-310000108385wrld:NonaccrualStatusMember2024-12-310000108385wrld:NonaccrualStatusMember2024-03-310000108385srt:MinimumMember2024-12-310000108385srt:MaximumMember2024-12-310000108385us-gaap:EmployeeStockOptionMember2024-12-310000108385us-gaap:EmployeeStockOptionMembersrt:MaximumMember2024-04-012024-12-310000108385us-gaap:EmployeeStockOptionMembersrt:MinimumMember2024-04-012024-12-310000108385wrld:Target1Member2024-04-012024-12-310000108385wrld:Target2Member2024-04-012024-12-310000108385wrld:Target2Member2024-07-012024-09-300000108385us-gaap:PerformanceSharesMember2024-07-012024-09-300000108385us-gaap:RestrictedStockMembersrt:MinimumMember2024-12-310000108385us-gaap:RestrictedStockMembersrt:MaximumMember2024-12-310000108385wrld:ServiceOptionMember2024-04-012024-12-310000108385us-gaap:PerformanceSharesMember2024-04-012024-12-310000108385wrld:Target3Member2024-04-012024-12-310000108385us-gaap:PerformanceSharesMember2023-07-012023-09-300000108385us-gaap:RestrictedStockMemberwrld:A2024LongTermIncentiveProgramAndNonEmployeeDirectorAwardsMember2024-12-182024-12-180000108385us-gaap:PerformanceSharesMemberwrld:A2024LongTermIncentiveProgramAndNonEmployeeDirectorAwardsMember2024-12-182024-12-180000108385us-gaap:EmployeeStockOptionMember2024-03-310000108385us-gaap:EmployeeStockOptionMember2024-04-012024-12-310000108385us-gaap:EmployeeStockOptionMember2024-10-012024-12-310000108385us-gaap:EmployeeStockOptionMember2023-10-012023-12-310000108385us-gaap:EmployeeStockOptionMember2023-04-012023-12-310000108385us-gaap:EmployeeStockOptionMemberwrld:Scenario1Member2024-12-310000108385us-gaap:EmployeeStockOptionMemberwrld:Scenario2Member2024-12-310000108385us-gaap:RestrictedStockMember2024-04-012024-12-310000108385us-gaap:RestrictedStockMember2023-04-012024-03-310000108385us-gaap:RestrictedStockMember2024-12-310000108385us-gaap:RestrictedStockMember2024-03-310000108385us-gaap:RestrictedStockMember2024-10-012024-12-310000108385us-gaap:RestrictedStockMember2023-10-012023-12-310000108385us-gaap:RestrictedStockMember2023-04-012023-12-310000108385us-gaap:EquitySecuritiesMember2024-10-012024-12-310000108385us-gaap:EquitySecuritiesMember2023-10-012023-12-310000108385us-gaap:EquitySecuritiesMember2024-04-012024-12-310000108385us-gaap:EquitySecuritiesMember2023-04-012023-12-310000108385us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2024-12-310000108385us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-12-310000108385us-gaap:CustomerListsMember2024-12-310000108385us-gaap:CustomerListsMember2024-03-310000108385us-gaap:NoncompeteAgreementsMember2024-12-310000108385us-gaap:NoncompeteAgreementsMember2024-03-310000108385us-gaap:RevolvingCreditFacilityMember2024-12-310000108385wrld:LetterOfCreditWorkersCompensationMember2024-12-310000108385wrld:LettersOfCreditInvestmentInCaptiveInsuranceMember2024-12-310000108385us-gaap:RevolvingCreditFacilityMember2024-04-012024-12-310000108385srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2024-12-310000108385us-gaap:RevolvingCreditFacilityMember2023-04-012023-12-310000108385us-gaap:RevolvingCreditFacilityMember2024-03-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2021-09-272021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2021-09-272021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2021-09-272021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2024-04-012024-12-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2024-12-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2023-04-012024-03-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2024-03-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2024-10-012024-12-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2023-10-012023-12-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2023-04-012023-12-310000108385wrld:Scenario1Memberus-gaap:RevolvingCreditFacilityMember2024-04-012024-12-310000108385wrld:Scenario2Memberus-gaap:RevolvingCreditFacilityMember2024-04-012024-12-310000108385wrld:HistoricTaxCreditInvestmentMember2024-12-310000108385wrld:HistoricTaxCreditInvestmentMember2024-03-310000108385wrld:HistoricTaxCreditInvestmentMember2024-10-012024-12-310000108385wrld:HistoricTaxCreditInvestmentMember2023-10-012023-12-310000108385wrld:HistoricTaxCreditInvestmentMember2024-04-012024-12-310000108385wrld:HistoricTaxCreditInvestmentMember2023-04-012023-12-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

__________________________________
 Form 10-Q
__________________________________

(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934

For the transition period from ______________ to ______________
 
Commission File Number:  000-19599

WORLD ACCEPTANCE CORPORATION
(Exact name of registrant as specified in its charter.)
South Carolina
 57-0425114
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)
104 S Main Street
Greenville,South Carolina29601
(Address of principal executive offices)
(Zip Code)
(864)298-9800
(registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, no par valueWRLD
The NASDAQ Stock Market LLC
(NASDAQ Global Select Market)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period than the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
1


Large Accelerated filerAccelerated filer
  
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No x

The number of outstanding shares of the issuer’s common stock, no par value, as of January 31, 2025 was 5,746,677.

2


 WORLD ACCEPTANCE CORPORATION
FORM 10-Q

TABLE OF CONTENTS
Item No.ContentsPage
GLOSSARY OF DEFINED TERMS
PART I - FINANCIAL INFORMATION 
1.Consolidated Financial Statements (unaudited):
 Consolidated Balance Sheets as of December 31, 2024 and March 31, 2024
 Consolidated Statements of Operations for the three and nine months ended December 31, 2024 and December 31, 2023
 Consolidated Statements of Shareholders' Equity for the three and nine months ended December 31, 2024 and December 31, 2023
 Consolidated Statements of Cash Flows for the nine months ended December 31, 2024 and December 31, 2023
 Notes to Consolidated Financial Statements
2.Management's Discussion and Analysis of Financial Condition and Results of Operations
3.Quantitative and Qualitative Disclosures about Market Risk
4.Controls and Procedures
PART II - OTHER INFORMATION
1.Legal Proceedings
1A.Risk Factors
2.Unregistered Sales of Equity Securities and Use of Proceeds
3.Defaults Upon Senior Securities
4.Mine Safety Disclosures
5.Other Information
6.Exhibits
EXHIBIT INDEX
SIGNATURES

Introductory Note: As used herein, the "Company," "we," "our," "us," or similar formulations include World Acceptance Corporation and each of its subsidiaries, unless otherwise expressly noted or the context otherwise requires that it include only World Acceptance Corporation. All references in this report to "fiscal 2025" are to the Company’s fiscal year ending March 31, 2025; all references in this report to "fiscal 2024" are to the Company's fiscal year ended March 31, 2024; and all references to "fiscal 2019" are to the Company’s fiscal year ended March 31, 2019.
3

GLOSSARY OF DEFINED TERMS

The following terms may be used throughout this Report, including consolidated financial statements and related notes.
TermDefinition
2008 PlanWorld Acceptance Corporation 2008 Stock Option Plan
2011 PlanWorld Acceptance Corporation 2011 Stock Option Plan
2017 PlanWorld Acceptance Corporation 2017 Stock Incentive Plan
2018 Performance Option Measurement Period
The 6.5 year performance period beginning on September 30, 2018 and ending on March 31, 2025 over which Performance Options are eligible to vest, following certification by the Compensation Committee of achievement
2018 Performance Share Measurement Period
The 6.5 year performance period beginning on September 30, 2018 and ending on March 31, 2025 over which Performance Shares are eligible to vest, following certification by the Compensation Committee of achievement
2024 Performance Option Measurement Period
The 1 year performance period beginning on January 01, 2025 and ending on December 31, 2025
2024 Performance Share Measurement Period
The 1 year performance period beginning on January 01, 2025 and ending on December 31, 2025 over which Performance Shares are eligible to vest, following certification by the Compensation Committee of achievement
$20.45 Performance SharesPerformance shares associated with the $20.45 trailing 4-Quarter EPS target for September 30, 2018 through March 31, 2025
ASCAccounting Standards Codification
ASUAccounting Standards Update
CECLCurrent Expected Credit Loss
CEOChief Executive Officer
CFOChief Financial Officer
CFPBU.S. Consumer Financial Protection Bureau
Compensation CommitteeCompensation and Stock Option Committee
Customer TenureThe number of months since a customer was first serviced by the Company
EPSEarnings per share
ERISAEmployee Retirement Income Security Act
Exchange ActSecurities Exchange Act of 1934, as amended
FASBFinancial Accounting Standards Board
FICOThe Fair Isaac Corporation
G&AGeneral and administrative
GAAPU.S. generally accepted accounting principles
HTCHistoric Tax Credit
IRSU.S. Internal Revenue Service
Notes$300 million in aggregate principal amount of 7.0% unsecured senior notes due November 2026 issued on September 27, 2021
PCDPurchased Assets with Credit Deterioration
Performance OptionsPerformance-based stock options
Performance SharesService- and performance-based restricted stock awards
Rehab RatePercentage of 91 days or more delinquent that do not charge off
Restricted StockService-based restricted stock awards
SECU.S. Securities and Exchange Commission
Service OptionsService-based stock options
SOFRSecured Overnight Finance Rate
TALTax Advance Loan
4

PART I.  FINANCIAL INFORMATION

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
 December 31, 2024March 31, 2024
ASSETS  
Cash and cash equivalents$15,582,553 $11,839,460 
Gross loans receivable1,381,461,902 1,277,149,256 
Less:  
Unearned interest, insurance and fees(361,444,148)(326,746,136)
Allowance for credit losses(116,110,946)(102,962,811)
Loans receivable, net903,906,808 847,440,309 
Income taxes receivable7,188,053 3,091,229 
Operating lease right‐of‐use assets, net78,856,773 79,501,238 
Property and equipment, net20,551,225 22,897,197 
Deferred income taxes, net31,967,282 30,942,844 
Other assets, net36,775,212 42,198,242 
Goodwill7,370,791 7,370,791 
Intangible assets, net8,301,486 11,069,733 
Total assets$1,110,500,183 $1,056,351,043 
 
LIABILITIES & SHAREHOLDERS' EQUITY  
Liabilities:  
Senior notes payable$335,949,020 $223,419,132 
Senior unsecured notes payable, net223,910,142 272,609,632 
Operating lease liability81,207,297 81,920,865 
Accounts payable and accrued expenses41,263,775 53,974,198 
Total liabilities682,330,234 631,923,827 
Commitments and contingencies
Shareholders' equity:  
Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding
  
Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 5,787,976 and 5,938,665 shares at December 31, 2024 and March 31, 2024, respectively
  
Additional paid-in capital267,074,904 286,432,952 
Retained earnings161,095,045 137,994,264 
Total shareholders' equity428,169,949 424,427,216 
Total liabilities and shareholders' equity$1,110,500,183 $1,056,351,043 

See accompanying notes to consolidated financial statements.

5

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three months ended December 31,Nine months ended December 31,
2024202320242023
Revenues:  
Interest and fee income$122,390,403 $118,665,105 $347,456,761 $352,237,133 
Insurance and other income, net16,242,350 19,084,282 52,112,762 61,711,366 
Total revenues138,632,753 137,749,387 399,569,523 413,948,499 
Expenses:   
Provision for credit losses44,103,495 40,631,994 136,191,023 127,697,072 
General and administrative expenses:  
Personnel41,074,877 39,890,187 99,804,998 120,119,638 
Occupancy and equipment12,293,093 12,090,198 36,793,516 37,138,444 
Advertising4,448,074 3,721,155 8,925,597 8,712,406 
Amortization of intangible assets938,026 1,050,926 2,902,848 3,182,805 
Other8,468,838 9,156,841 26,563,688 27,828,730 
Total general and administrative expenses67,222,908 65,909,307 174,990,647 196,982,023 
Interest expense11,293,874 11,689,924 31,520,066 36,475,411 
Total expenses122,620,277 118,231,225 342,701,736 361,154,506 
Income before income taxes16,012,476 19,518,162 56,867,787 52,793,993 
Income tax expense2,624,180 2,853,344 11,403,906 10,508,008 
Net income$13,388,296 $16,664,818 $45,463,881 $42,285,985 
Net income per common share:   
Basic$2.46 $2.89 $8.32 $7.32 
Diluted$2.45 $2.84 $8.23 $7.17 
Weighted average common shares outstanding:  
Basic5,436,688 5,772,503 5,461,990 5,775,108 
Diluted5,464,217 5,860,117 5,526,784 5,896,716 

See accompanying notes to consolidated financial statements.

6

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(Unaudited)


Three months ended December 31, 2024
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at September 30, 20245,769,530 $268,746,030 $148,717,724 $417,463,754 
Proceeds from exercise of stock options5,324 424,420  424,420 
Common stock repurchases(9,465) (1,010,975)(1,010,975)
Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,544,812)
22,587 (2,181,186) (2,181,186)
Stock-based compensation related to stock options 85,640  85,640 
Net income  13,388,296 13,388,296 
Balances at December 31, 20245,787,976 $267,074,904 $161,095,045 $428,169,949 

Three months ended December 31, 2023
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at September 30, 20236,246,818 $287,246,730 $122,776,065 $410,022,795 
Proceeds from exercise of stock options11,104 948,441 — 948,441 
Common stock repurchases(148,765)— (17,291,997)(17,291,997)
Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,823,774)
(35,858)(3,514,473)— (3,514,473)
Stock-based compensation related to stock options— 189,582 — 189,582 
Net income— — 16,664,818 16,664,818 
Balances at December 31, 20236,073,299 $284,870,280 $122,148,886 $407,019,166 


7

Nine months ended December 31, 2024
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at March 31, 20245,938,665 $286,432,952 $137,994,264 $424,427,216 
Proceeds from exercise of stock options20,310 1,881,436  1,881,436 
Common stock repurchases(174,632) (22,363,100)(22,363,100)
Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,676,053)
3,633 (21,562,624) (21,562,624)
Stock-based compensation related to stock options 323,140  323,140 
Net income  45,463,881 45,463,881 
Balances at December 31, 20245,787,976 $267,074,904 $161,095,045 $428,169,949 
Nine months ended December 31, 2023
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at March 31, 20236,231,082 $288,071,839 $97,154,898 $385,226,737 
Proceeds from exercise of stock options22,847 2,018,412 — 2,018,412 
Common stock repurchases(148,765)(17,291,997)(17,291,997)
Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,823,774)
(31,865)(1,348,623)— (1,348,623)
Stock-based compensation (reversal) related to stock options— (3,871,348)— (3,871,348)
Net income— — 42,285,985 42,285,985 
Balances at December 31, 20236,073,299 $284,870,280 $122,148,886 $407,019,166 

See accompanying notes to consolidated financial statements.
8

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine months ended December 31,
 20242023
Cash flow from operating activities:  
Net income$45,463,881 $42,285,985 
Adjustments to reconcile net income to net cash provided by operating activities:  
Amortization of intangible assets2,902,848 3,182,805 
Accrued unearned interest(4,437,733)(4,225,244)
Amortization of deferred loan cost10,461,809 10,285,733 
Gain on extinguishment of senior unsecured notes payable(1,160,067)(1,162,581)
Amortization of debt issuance costs999,688 1,338,352 
Amortization of discount on loans acquired in an asset purchase(380,232) 
Provision for credit losses136,191,023 127,697,072 
Depreciation4,799,367 4,937,169 
Gain on sale of property and equipment(78,011)(95,621)
Deferred income tax expense (benefit)(1,024,438)4,674,792 
Stock-based compensation (reversal) related to equity classified awards(18,563,431)(2,396,197)
Change in accounts:  
Other assets, net5,007,294 5,213,994 
Income taxes receivable(4,096,824)(4,249,555)
Accounts payable and accrued expenses(12,878,833)(5,516,759)
Net cash provided by operating activities163,206,341 181,969,945 
Cash flows from investing activities:  
Increase in loans receivable, net(179,488,673)(153,198,324)
Cash paid for acquisitions, primarily loans(18,947,294) 
Purchases of property and equipment(2,814,437)(4,419,445)
Proceeds from the sale of property and equipment439,053 308,174 
Net cash used in investing activities(200,811,351)(157,309,595)
Cash flow from financing activities:  
Borrowings from senior notes payable297,385,341 215,066,622 
Payments on senior notes payable(184,855,453)(217,887,966)
Payments for extinguished senior unsecured notes payable(48,148,250)(6,978,717)
Payments for debt extinguishment costs(12,500)(20,625)
Debt issuance costs associated with senior notes payable(31,728)(475,716)
Proceeds from exercise of stock options1,881,436 2,018,412 
Payments for taxes related to net share settlement of equity awards(2,676,053)(2,823,774)
Repurchase of common stock(22,194,690)(17,291,997)
Net cash provided by (used in) financing activities
41,348,103 (28,393,761)
Net change in cash and cash equivalents3,743,093 (3,733,411)
Cash and cash equivalents at beginning of period11,839,460 16,508,935 
Cash and cash equivalents at end of period$15,582,553 $12,775,524 
Supplemental Disclosures:
Interest paid during the period$36,476,307 $41,233,947 
Income taxes paid during the period$3,204,509 $7,726,889 
Excise tax on stock repurchases not paid during the period
$168,410 $ 
9


See accompanying notes to consolidated financial statements.
10

WORLD ACCEPTANCE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 (Unaudited)

NOTE 1 – BASIS OF PRESENTATION

The consolidated financial statements of the Company at December 31, 2024 and 2023 and for the three and nine months then ended were prepared in accordance with the instructions for Form 10-Q and are unaudited; however, in the opinion of management, all adjustments (consisting only of items of a normal, recurring nature) necessary for a fair presentation of the financial position at December 31, 2024, and the results of operations and cash flows for the periods ended December 31, 2024 and 2023, have been included. The results for the interim periods are not necessarily indicative of the results that may be expected for the full year or any other interim period.

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. Actual results could differ from those estimates.

The consolidated financial statements do not include all disclosures required by GAAP and should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, as filed with the SEC (the "fiscal 2024 Annual Report"). The Company applies the accounting policies contained in Note 1 to the Consolidated Financial Statements included in fiscal 2024 Annual Report. The Company believes that the disclosures are adequate to make the information presented not misleading.

NOTE 2 – SUMMARY OF SIGNIFICANT POLICIES

Nature of Operations

The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.

Seasonality

The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters, and operating results for its fourth fiscal quarter are generally higher than in other quarters.

Loans receivable, net

Loans receivable are carried at amortized cost, which is the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination costs were $6.6 million and $5.0 million as of December 31, 2024 and March 31, 2024, respectively.

From time to time, the Company will sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing. See Note 4 to the Consolidated Financial Statements for further information.

Allowance for credit losses

Refer to Note 4 to the Consolidated Financial Statements for information regarding the Company's CECL allowance model and a description of the policies and methodology utilized.
11


Reclassification

From time to time, prior period amounts will be reclassified to conform to the current presentation. Such reclassifications have no impact on previously reported net income or shareholders' equity.

Recently Issued Accounting Standards Not Yet Adopted

Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to require entities to expand annual disclosures to 1) include specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold and 2) disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign taxes. ASU 2023-09 also requires entities to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal, state and foreign, among other changes. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires additional disclosure, in the notes to financial statements, about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, which was clarified by ASU 2025-01, Clarifying the Effective Date. Early adoption is permitted. ASU 2024-03 should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this update or (2) retrospectively to any or all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the consolidated financial statements and related disclosures as a result of future adoption.
12

NOTE 3 – FAIR VALUE

Fair Value Disclosures

The Company may carry certain financial instruments and derivative assets and liabilities at fair value measured on a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company measures the fair values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Fair value measurements are grouped in three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active.
Level 3 – Unobservable inputs for assets or liabilities reflecting the reporting entity’s own assumptions.

The Company’s financial instruments consist of cash and cash equivalents, loans receivable, net, the senior notes payable, and the senior unsecured notes payable. Loans receivable are originated at prevailing market rates and have an average life of up to twelve months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s senior notes payable, consisting of a senior revolving credit facility, has a variable rate based on a margin over SOFR and reprices with any changes in SOFR. The fair value of the senior unsecured notes payable is estimated based on quoted prices in markets that are not active. The Company also considers its creditworthiness in its estimation of fair value.

The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below.
December 31, 2024March 31, 2024
Input LevelCarrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
ASSETS
Cash and cash equivalents1$15,582,553 $15,582,553 $11,839,460 $11,839,460 
Loans receivable, net3903,906,808 903,906,808 847,440,309 847,440,309 
LIABILITIES
Senior unsecured notes payable, net
2223,910,142 222,969,719 272,609,632 254,208,482 
Senior notes payable3335,949,020 335,949,020 223,419,132 223,419,132 

There were no significant assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2024 or March 31, 2024.

NOTE 4 – LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES

The following is a summary of gross loans receivable by Customer Tenure as of:

13

Customer TenureDecember 31, 2024March 31, 2024
0 to 5 months$120,206,225 $73,699,568 
6 to 17 months83,792,574 69,616,739 
18 to 35 months119,019,301 140,340,728 
36 to 59 months152,290,291 181,399,293 
60+ months904,874,073 799,703,920 
TALs1,279,438 12,389,008 
Total gross loans$1,381,461,902 $1,277,149,256 

Current payment performance is used to assess the capability of the borrower to repay contractual obligations of the loan agreements as scheduled, which is monitored by management on a daily basis. The Company’s payment performance buckets are as follows: current, 30-60 days past due, 61-90 days past due, 91 days or more past due.

All loans, except for TALs, that are greater than 90 days past due on a recency basis and not written off as of the reporting date are reserved for at 100% of the outstanding balance, net of a calculated Rehab Rate. The weighted average Rehab Rate at December 31, 2024 and March 31, 2024 was 4.7% and 4.9%, respectively. A loan is charged off within the allowance for credit losses in the month following when an account reaches 120 days past due on a recency basis, subject to certain exceptions. Specifically, the Company’s customer accounts in a confirmed bankruptcy are generally charged off in the month after they reach 60 days past due on a recency basis. The accounts of deceased or incarcerated customers are also generally charged off in the month after they reach 60 days past due on a recency basis, with the exception of deceased customers with credit life insurance. Subsequent recoveries of amounts charged off, if any, are credited to the allowance for credit losses.

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,191,801,595 $53,796,457 $5,232,034 $246,907 $5,097 $4,612 $1,251,086,702 
30 - 60 days past due45,078,425 5,587,931 771,319 88,677 5,498 12,712 51,544,562 
61 - 90 days past due27,968,712 3,192,929 387,807 46,475 5,912 518 31,602,353 
91 or more days past due38,928,934 6,353,121 611,384 52,719 2,689  45,948,847 
Total$1,303,777,666 $68,930,438 $7,002,544 $434,778 $19,196 $17,842 $1,380,182,464 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$191,926 $ $ $ $ $ $191,926 
30 - 60 days past due71,880      71,880 
61 - 90 days past due56,193      56,193 
91 or more days past due959,439      959,439 
Total$1,279,438 $ $ $ $ $ $1,279,438 
Total gross loans$1,381,461,902 

14

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,094,896,350 $61,853,967 $4,807,924 $109,050 $25,850 $1,371 $1,161,694,512 
30 - 60 days past due34,034,537 4,600,615 610,649 10,856 14,076 5,429 39,276,162 
61 - 90 days past due21,874,701 2,154,561 200,117 17,493 204  24,247,076 
91 or more days past due34,560,868 4,600,040 364,386 6,151 5,617 5,436 39,542,498 
Total$1,185,366,456 $73,209,183 $5,983,076 $143,550 $45,747 $12,236 $1,264,760,248 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$7,441,660 $860 $ $ $ $ $7,442,520 
30 - 60 days past due4,942,757 788     4,943,545 
61 - 90 days past due 1,650     1,650 
91 or more days past due 1,293     1,293 
Total$12,384,417 $4,591 $ $ $ $ $12,389,008 
Total gross loans$1,277,149,256 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2024:

15

Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,179,892,149 $47,643,195 $4,032,753 $130,939 $ $ $1,231,699,036 
30 - 60 days past due46,938,294 4,289,434 347,554 10,189  4,836 51,590,307 
61 - 90 days past due30,851,070 3,357,138 300,261 20,307 205  34,528,981 
91 or more days past due46,096,156 13,640,670 2,321,974 273,343 18,991 13,006 62,364,140 
Total$1,303,777,669 $68,930,437 $7,002,542 $434,778 $19,196 $17,842 $1,380,182,464 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$158,737 $ $ $ $ $ $158,737 
30 - 60 days past due50,553      50,553 
61 - 90 days past due37,596      37,596 
91 or more days past due1,032,552      1,032,552 
Total$1,279,438 $ $ $ $ $ $1,279,438 
Total gross loans$1,381,461,902 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2024:
16

Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,079,720,968 $54,770,231 $3,681,104 $39,921 $10,484 $1,371 $1,138,224,079 
30 - 60 days past due37,475,784 3,388,380 288,576 1,064   41,153,804 
61 - 90 days past due26,191,269 2,903,253 208,172 3,430 204  29,306,328 
91 or more days past due41,978,436 12,147,320 1,805,223 99,134 35,059 10,865 56,076,037 
Total$1,185,366,457 $73,209,184 $5,983,075 $143,549 $45,747 $12,236 $1,264,760,248 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$7,441,661 $ $ $ $ $ $7,441,661 
30 - 60 days past due4,942,757      4,942,757 
61 - 90 days past due       
91 or more days past due 4,590     4,590 
Total$12,384,418 $4,590 $ $ $ $ $12,389,008 
Total gross loans$1,277,149,256 

The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2024:

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination YearLoansTALsTotalLoansTALsTotal
2020 and prior$ $ $ $24,919 $ $24,919 
20212,675  2,675 26,161  26,161 
2022148,994  148,994 708,565  708,565 
20231,463,591  1,463,591 8,571,378 175 8,571,553 
202423,325,438 651,498 23,976,936 103,377,399 2,814,391 106,191,790 
202523,230,774  23,230,774 23,867,489  23,867,489 
Total$48,171,472 $651,498 $48,822,970 $136,575,911 $2,814,566 $139,390,477 
The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2023:

17

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination YearLoansTALsTotalLoansTALsTotal
2019 and prior$1,958 $ $1,958 $11,385 $ $11,385 
20203,909  3,909 33,560  33,560 
202144,632  44,632 275,558  275,558 
20221,660,567 188 1,660,755 10,243,978 5,197 10,249,175 
202328,683,289 118,287 28,801,576 120,931,950 1,260,273 122,192,223 
202424,222,152  24,222,152 24,466,713  24,466,713 
Total$54,616,507 $118,475 $54,734,982 $155,963,144 $1,265,470 $157,228,614 
Credit risk is inherent in the business of extending loans to borrowers and is continuously monitored by management and reflected within the allowance for credit losses for loans. The allowance for credit losses is an estimate of expected losses inherent within the Company’s gross loans receivable portfolio. In estimating the allowance for credit losses, loans with similar risk characteristics are aggregated into pools and collectively assessed. The Company’s loan products have generally the same terms therefore the Company looks to borrower characteristics as a way to disaggregate loans into pools sharing similar risks.

In determining the allowance for credit losses, the Company examined four borrower risk metrics as noted below.

1.Borrower type
2.Active months
3.Prior loan performance
4.Customer Tenure

To determine how well each metric predicts default risk the Company used loss rate data over an observation period of twelve months at the loan level.

The information value was then calculated for each metric. From this analysis management determined the metric that had the strongest predictor of default risk was Customer Tenure. The Customer Tenure buckets used in the allowance for credit loss calculation are:

1.0 to 5 months
2.6 to 17 months
3.18 to 35     months
4.36 to 59 months
5.60+ months

Management will continue to monitor this credit metric on a quarterly basis.

Management estimates an allowance for each Customer Tenure bucket by performing a historical migration analysis of loans in that bucket for the twelve most recent historical twelve-month migration periods. Management considers whether current credit conditions might suggest a change is needed to the allowance for credit losses by monitoring trends in first pay success for new borrowers, 60-89 day delinquencies on a recency basis, percent of loan balances that are paying and percentage of gross loans that are acquired loans. If management determines that historical migration rates should be adjusted to reflect expected credit losses, a qualitative adjustment is made to reflect management's judgment regarding observable changes in recent or expected economic trends and conditions, portfolio composition, or other significant events or conditions that affect the current estimate. The increase in the allowance for credit losses from March 31, 2024 to December 31, 2024 was primarily due to loan growth during the period.

Due to the short term nature of the loan portfolio, forecasted changes in macroeconomic variables such as unemployment levels, general inflation and commodity prices, typically do not have a significant impact on loans outstanding at the end of a particular reporting period, unless those changes are particularly severe and sudden in nature. Therefore, management develops a reasonable and supportable forecast of losses by comparing the most recent six-month loss curves as compared to historical loss curves to see if there are significant changes in borrower behavior that may indicate the historical migration rates should be adjusted. If a change is determined necessary, then the Company has elected to immediately revert back to historical experience past the forecast period. As of December 31, 2024 and March 31, 2024, there were no conditions or other factors considered significant enough to warrant a forecast adjustment.
18


The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
2024202320242023
Beginning balance$114,455,495 $128,892,192 $102,962,811 $125,552,733 
Provision for credit losses44,103,495 40,631,994 136,191,023 127,697,072 
Charge-offs(48,822,970)(54,734,982)(139,390,477)(157,228,614)
Recoveries16,374,926 6,292,864 16,347,589 25,060,877 
Net charge-offs(42,448,044)(48,442,118)(123,042,888)(132,167,737)
Ending Balance$116,110,946 $121,082,068 $116,110,946 $121,082,068 

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$97,729,708 $8,178,732 $5,850,084 $8,447,701 $22,476,517 $120,206,225 
6 to 17 months71,894,285 4,123,710 2,957,998 4,816,581 11,898,289 83,792,574 
18 to 35 months104,818,028 5,232,991 3,486,649 5,481,633 14,201,273 119,019,301 
36 to 59 months135,845,513 6,391,258 3,906,289 6,147,231 16,444,778 152,290,291 
60+ months840,799,168 27,617,871 15,401,333 21,055,701 64,074,905 904,874,073 
TALs191,926 71,880 56,193 959,439 1,087,512 1,279,438 
Total gross loans1,251,278,628 51,616,442 31,658,546 46,908,286 130,183,274 1,381,461,902 
Unearned interest, insurance and fees(331,428,164)(9,525,813)(8,350,208)(12,139,963)(30,015,984)(361,444,148)
Total net loans$919,850,464 $42,090,629 $23,308,338 $34,768,323 $100,167,290 $1,020,017,754 
Percentage of period-end gross loans receivable3.7%2.3%3.4%9.4%

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:

1 Recoveries during the three months ended December 31, 2024 include $2.6 million and $1.5 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. Recoveries during the nine months ended December 31, 2024 include $7.6 million and $1.5 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. Recoveries during the three months ended December 31, 2023 include $2.9 million and $0.8 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. Recoveries during the nine months ended December 31, 2023 include $10.5 million and $5.7 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. These proceeds are included as a component of Provision for credit losses in the Consolidated Statements of Operations.
19

Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$56,802,704 $4,720,149 $4,496,518 $7,680,197 $16,896,864 $73,699,568 
6 to 17 months60,634,735 3,155,423 2,075,608 3,750,973 8,982,004 69,616,739 
18 to 35 months126,843,010 5,057,256 3,224,662 5,215,800 13,497,718 140,340,728 
36 to 59 months165,694,013 6,159,335 3,519,743 6,026,202 15,705,280 181,399,293 
60+ months751,720,050 20,183,999 10,930,545 16,869,326 47,983,870 799,703,920 
TALs7,442,520 4,943,545 1,650 1,293 4,946,488 12,389,008 
Total gross loans1,169,137,032 44,219,707 24,248,726 39,543,791 108,012,224 1,277,149,256 
Unearned interest, insurance and fees(301,616,958)(7,677,494)(6,674,554)(10,777,130)(25,129,178)(326,746,136)
Total net loans$867,520,074 $36,542,213 $17,574,172 $28,766,661 $82,883,046 $950,403,120 
Percentage of period-end gross loans receivable3.5 %1.9 %3.1 %8.5 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$97,003,231 $8,063,335 $5,874,364 $9,265,295 $23,202,994 $120,206,225 
6 to 17 months70,860,586 4,036,915 2,987,142 5,907,931 12,931,988 83,792,574 
18 to 35 months102,558,371 5,188,437 3,806,830 7,465,663 16,460,930 119,019,301 
36 to 59 months133,059,756 6,150,175 4,191,450 8,888,910 19,230,535 152,290,291 
60+ months828,217,092 28,151,445 17,669,195 30,836,341 76,656,981 904,874,073 
TALs158,737 50,553 37,596 1,032,552 1,120,701 1,279,438 
Total gross loans1,231,857,773 51,640,860 34,566,577 63,396,692 149,604,129 1,381,461,902 
Unearned interest, insurance and fees(327,330,320)(8,969,250)(9,101,669)(16,042,909)(34,113,828)(361,444,148)
Total net loans$904,527,453 $42,671,610 $25,464,908 $47,353,783 $115,490,301 $1,020,017,754 
Percentage of period-end gross loans receivable3.7%2.5%4.6%10.8 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:
20

Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$55,572,691 $4,645,860 $4,784,273 $8,696,744 $18,126,877 $73,699,568 
6 to 17 months58,920,283 2,990,455 2,364,202 5,341,799 10,696,456 69,616,739 
18 to 35 months123,878,546 5,246,778 3,813,284 7,402,120 16,462,182 140,340,728 
36 to 59 months161,614,270 6,388,791 4,435,367 8,960,865 19,785,023 181,399,293 
60+ months738,238,289 21,881,920 13,909,202 25,674,509 61,465,631 799,703,920 
TALs7,441,661 4,942,757  4,590 4,947,347 12,389,008 
Total gross loans1,145,665,740 46,096,561 29,306,328 56,080,627 131,483,516 1,277,149,256 
Unearned interest, insurance and fees(296,584,056)(7,544,366)(7,936,622)(14,681,092)(30,162,080)(326,746,136)
Total net loans$849,081,684 $38,552,195 $21,369,706 $41,399,535 $101,321,436 $950,403,120 
Percentage of period-end gross loans receivable3.6 %2.3 %4.4 %10.3 %

The Company elected not to record an allowance for credit losses for accrued interest as outlined in ASC 326-20-30-5A. Loans are placed on nonaccrual status when management determines that the full payment of principal and collection of interest according to contractual terms is no longer likely. The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest income is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced.

The following table presents unpaid accrued interest reversed against interest income by Customer Tenure for the three and nine months ended December 31, 2024 and 2023:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Customer Tenure
0 to 5 months$(1,513,556)$(1,364,409)$(3,943,143)$(3,910,003)
6 to 17 months(802,513)(779,642)(2,201,034)(2,653,697)
18 to 35 months(789,715)(949,250)(2,378,004)(2,612,375)
36 to 59 months(829,641)(1,068,613)(2,553,282)(3,214,245)
60+ months(3,227,592)(2,828,677)(8,869,807)(7,977,412)
Total$(7,163,017)$(6,990,591)$(19,945,270)$(20,367,732)

The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2024 and 2023:
21

Nonaccrual Loans Receivable
Customer TenureAs of December 31, 2024As of March 31, 2024
Interest Income
Recognized for the three months ended December 31, 2024
Interest Income
Recognized for the three months ended December 31, 2023
Interest Income
Recognized for the nine months ended December 31, 2024
Interest Income
Recognized for the nine months ended December 31, 2023
0 to 5 months$14,404,816 $13,971,062 $152,639 $197,470 $521,894 $769,418 
6 to 17 months9,047,425 8,507,503 217,517 319,474 661,265 1,168,253 
18 to 35 months11,964,366 12,569,729 346,761 396,720 1,057,869 1,249,102 
36 to 59 months13,915,169 15,250,596 402,275 547,608 1,315,569 1,728,965 
60+ months51,333,978 45,091,589 1,507,229 1,497,757 4,463,586 4,785,842 
Unearned interest, insurance and fees(26,362,491)(24,643,778) —  — 
Total$74,303,263 $70,746,701 $2,626,421 $2,959,029 $8,020,183 $9,701,580 

As of December 31, 2024 and March 31, 2024, there were no loans receivable 61 days or more past due, not on nonaccrual status, and no loans receivable on nonaccrual status with no related allowance for credit losses.
22


NOTE 5 – LEASES

Accounting Policies and Matters Requiring Management's Judgment

The Company uses its senior notes payable's effective annual interest rate to determine the discount rate when evaluating leases under Topic 842. Specifically, Management applies its senior notes payable's effective annual interest rate at the end of the prior fiscal year to leases entered into in the following year. For example, the senior notes payable's annual effective interest rate of 9.9% at March 31, 2024 was used as the discount rate when determining the lease type and the present value of lease payments for leases entered into in fiscal 2025.

Based on its historical practice, the Company believes it is reasonably certain to exercise a given option associated with a given office space lease. Therefore, the Company classifies all lease options for office space as “reasonably certain” unless it has specific knowledge to the contrary for a given lease. The Company does not believe it is reasonably certain to exercise any options associated with its office equipment leases.

Periodic Disclosures

The Company's operating leases consist of real estate leases for office space as well as office equipment. Both the branch real estate and office equipment lease terms generally range from three years to five years, and generally contain options to extend which mirror the original terms of the lease.

As of December 31, 2024 and 2023, the Company had no finance leases.

The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
 2024202320242023
Lease Cost
Operating lease cost$6,387,738 $6,163,762 $18,846,686 $19,000,163 
Variable lease cost940,465 888,119 2,949,878 2,808,845 
Total lease cost$7,328,203 $7,051,881 $21,796,564 $21,809,008 

The following table reports other information about the Company's leases for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
 2024202320242023
Other Lease Information
Operating cash flows for amounts included in the measurement of lease liabilities — operating leases$6,301,091 $6,265,527 $18,884,883 $18,965,468 
Right-of-use assets obtained in exchange for new operating lease liabilities$3,247,250 $4,568,169 $13,812,021 $13,560,648 
Weighted average remaining lease term — operating leases6.5 years6.9 years6.5 years6.9 years
Weighted-average discount rate — operating leases6.8 %6.3 %6.8 %6.3 %

23

The aggregate annual lease obligations as of December 31, 2024 are as follows:
Operating Leases
Remainder of 2025$6,160,520 
202622,367,057 
202717,961,935 
202814,520,255 
202910,573,915 
Thereafter29,343,439 
Total undiscounted lease liability$100,927,121 
Imputed interest19,719,824 
Total discounted lease liability$81,207,297 

The Company had no leases with related parties as of December 31, 2024 or March 31, 2024.

24

NOTE 6 – AVERAGE SHARE INFORMATION

The following is a summary of the basic and diluted average common shares outstanding:
Three months ended December 31,Nine months ended December 31,
2024202320242023
Basic:  
Weighted average common shares outstanding (denominator)5,436,688 5,772,503 5,461,990 5,775,108 
Diluted:  
Weighted average common shares outstanding5,436,688 5,772,503 5,461,990 5,775,108 
Dilutive potential common shares27,529 87,614 64,794 121,608 
Weighted average diluted shares outstanding (denominator)5,464,217 5,860,117 5,526,784 5,896,716 
 
Options to purchase 246,111 and 291,826 shares of common stock at various prices were outstanding during the three months ended December 31, 2024 and 2023, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.

Options to purchase 250,034 and 299,904 shares of common stock at various prices were outstanding during the nine months ended December 31, 2024 and 2023, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.
25

NOTE 7 – STOCK-BASED COMPENSATION

Stock Incentive Plans

The Company maintains the 2008 Plan, the 2011 Plan and the 2017 Plan for the benefit of certain non-employee directors, officers, and key employees. Under these plans, a total of 3,350,000 shares of authorized common stock have been reserved for issuance pursuant to grants approved by the Compensation Committee. Stock options granted under these plans have a maximum term of 10 years, may be subject to certain vesting requirements, which are generally three to six years for officers, non-employee directors, and key employees, and are priced at the market value of the Company's common stock on the option's grant date. At December 31, 2024, there were a total of 187,020 shares of common stock remaining available for grant under the 2017 Plan.

Stock-based compensation is recognized as provided under FASB ASC Topic 718-10 and FASB ASC Topic 505-50. FASB ASC Topic 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the consolidated financial statements based on their grant date fair values. Stock-based compensation related to restricted stock is based on the number of shares expected to vest and the fair market value of the common stock on the grant date. Stock-based compensation related to stock option awards is based on the number of shares expected to vest and the estimated fair value of the awards on the grant date using the Black-Scholes valuation model. Under the Black-Scholes valuation method, the assumptions used to determine the fair value are expected volatility, expected life, average risk-free rate, and dividend yield, if any. The expected stock price volatility is based on the historical volatility of the Company's common stock for a period approximating the expected life. The expected life represents the period of time that options are expected to be outstanding after the grant date. The risk-free rate reflects the interest rate at grant date on zero coupon U.S. governmental bonds having a remaining life similar to the expected option term.

2018 Long-term Incentive Program and Non-Employee Director Awards

On October 15, 2018, the Compensation Committee and Board of Directors approved and adopted a long-term incentive program that seeks to motivate and reward certain employees and to align management’s interest with shareholders’ interest by focusing executives on the achievement of long-term results. The program is comprised of four components: Service Options, Performance Options, Restricted Stock, and Performance Shares.

Pursuant to this program, in fiscal 2019, the Compensation Committee approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2011 Plan and the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Service Options and Restricted Stock to certain non-employee directors of the Company.

Under the long-term incentive program, up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of two trailing EPS performance targets established by the Compensation Committee that are based on EPS (measured at the end of each calendar quarter, commencing with the calendar quarter ending September 30, 2019) for the previous four calendar quarters. The Performance Shares are eligible to vest over the 2018 Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2018 Performance Share Measurement Period (or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement).

The Performance Share performance targets are set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%

During the second quarter of fiscal 2025, it was determined that the $20.45 Performance Share performance target was no longer probable of being achieved and that the $20.45 Performance Shares would likely be forfeited as of the last day of the performance period in accordance with their terms. As a result and in accordance with ASC 718, the Company reversed $18.5 million in previously recognized stock-based compensation related to the $20.45 Performance Shares during the second quarter of fiscal 2025.

26

The Restricted Stock awards typically vest in three to six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Service Options typically vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.

The Performance Options will fully vest if the Company attains the trailing EPS target over four consecutive calendar quarters occurring between September 30, 2018 and March 31, 2025 as described below. Such performance target was established by the Compensation Committee and will be measured at the end of each calendar quarter commencing on September 30, 2019. The Performance Options are eligible to vest over the 2018 Performance Option Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2018 Performance Option Measurement Period or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term. The Performance Option performance target is set forth below.

Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Options Eligible for Vesting
(Percentage of Award)
$25.30100%

During the second quarter of fiscal 2024, it was determined that the Performance Option performance target was no longer probable of being achieved and that the Performance Options would likely be forfeited as of the last day of the performance period in accordance with their terms. As a result and in accordance with ASC 718, the Company reversed $4.9 million in previously recognized stock-based compensation related to these Performance Options during the second quarter of fiscal 2024.

2024 Long-term Incentive Program and Non-Employee Director Awards

On December 18, 2024, the Compensation Committee and Board of Directors approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Restricted Stock to certain non-employee directors of the Company.

Up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of certain performance goals established by the Compensation Committee related to company operational performance metrics during the 2024 Performance Share Measurement Period, for which achievement must be certified by the Compensation Committee. The Performance Shares are eligible to vest over the 2024 Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2024 Performance Share Measurement Period or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Restricted Stock awards fully vest on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through the vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Service Options vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.

Up to 100% of the Performance Options will vest, if at all, based on the achievement of certain performance goals established by the Compensation Committee related to company operational performance metrics during the 2024 Performance Option Measurement Period, for which achievement must be certified by the Compensation Committee. The Performance Options typically vest in three equal annual installments, beginning on January 30, 2026, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the
27

applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term.

Stock Options

The weighted-average fair value at the grant date for options issued during the three months ended December 31, 2024 and 2023 was $58.29 and $68.52, respectively. The weighted-average fair value at the grant date for options issued during the nine months ended December 31, 2024 and 2023 was $58.29 and $69.00, respectively.

Fair value was estimated at grant date using the weighted-average assumptions listed below:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Dividend yield%%%%
Expected volatility59.53%62.54%59.53%62.55%
Average risk-free rate4.39%4.70%4.39%4.69%
Expected life4.5 years4.6 years4.5 years4.6 years

Option activity for the nine months ended December 31, 2024 was as follows:
 SharesWeighted Average Exercise
Price
Weighted Average
Remaining
Contractual Term
Aggregate Intrinsic Value
Options outstanding, beginning of period267,947 $105.77   
Granted during period38,661 111.68   
Exercised during period(20,310)92.64   
Forfeited during period(8,212)102.62   
Expired during period(1,549)206.52   
Options outstanding, end of period276,537  2$107.09 5.1 years$2,850,363 
Options exercisable, end of period131,659 $110.58 4.6 years$1,594,728 
 
The aggregate intrinsic value reflected in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on December 31, 2024 and the exercise price, multiplied by the number of in-the-money options that are currently exercisable) that would have been received by option holders had all option holders exercised their options as of December 31, 2024. This amount will change as the market price of the common stock changes. The total intrinsic value and tax benefit of options exercised during the three and nine month periods ended December 31, 2024 and 2023 were as follows:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Intrinsic value of options exercised$215,599 $369,543 $732,318 $810,853 
Tax benefit of options exercised52,822 90,538 179,418 198,659 
 
The total fair value of stock options vested during the nine months ended December 31, 2024 was $2,120,670. As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested stock options amounted to approximately $1.9 million, which is expected to be recognized over a weighted-average period of approximately 2.5 years.

2 Of the 276,537 options outstanding, 16,453 are not yet exercisable based solely on fulfilling a service condition and another 128,425 are not yet exercisable based solely on fulfilling performance conditions.
28

Restricted Stock

During the first nine months of fiscal 2025, the Company granted 71,186 shares of restricted stock (which are equity classified) to certain vice presidents, senior vice presidents, executive officers and non-employee directors with a grant date weighted average fair value of $111.64 per share.

During fiscal 2024, the Company granted 3,993 shares of restricted stock (which are equity classified) to certain vice presidents and senior vice presidents with a grant date weighted average fair value of $120.12 per share.

The total fair value of restricted stock vested during the nine months ended December 31, 2024 was $7,293,854. As of December 31, 2024, there was approximately $7.7 million of unrecognized compensation cost related to unvested restricted stock awards, which is expected to be recognized over the next 1.0 year based on current estimates.

A summary of the status of the Company’s restricted stock as of December 31, 2024, and changes during the nine months ended December 31, 2024, are presented below:
 SharesWeighted Average Fair Value at Grant Date
Outstanding at March 31, 2024388,577 $101.18 
Granted during the period71,186 111.64 
Vested during the period(62,577)104.08 
Forfeited during the period(44,566)100.37 
Outstanding at December 31, 2024352,620 $102.88 
 
Total Stock-Based Compensation

Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three and nine month periods ended December 31, 2024 and 2023 was as follows:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Stock-based compensation related to equity classified awards:
Stock-based compensation (reversal) related to stock options3$85,640 $189,582 $323,140 $(3,871,348)
Stock-based compensation (reversal) related to restricted stock4363,626 (690,699)(18,886,571)1,475,151 
Total stock-based compensation (reversal) related to equity classified awards$449,266 $(501,117)$(18,563,431)$(2,396,197)


NOTE 8 – ACQUISITIONS

The Company evaluates each set of assets and activities it acquires to determine if the set meets the definition of a business according to FASB ASC Topic 805-10-55. Acquisitions meeting the definition of a business are accounted for as business combinations while all other acquisitions are accounted for as asset purchases.

3 The $(3,871,348) for the nine months ended December 31, 2023 represents the reversal of $4.9 million in previously recognized stock-based compensation related to the Performance Options and $0.4 million in forfeiture credit, offset by $1.4 million in current period expense.
4 The $(18,886,570) for the nine months ended December 31, 2024 represents the reversal of $18.5 million in previously recognized stock-based compensation related to the $20.45 Performance Shares and $1.8 million in forfeiture credit, offset by $1.4 million in current period expense. The $(690,699) for the three months ended December 31, 2023 represents $1.4 million in forfeiture credit, offset by $0.7 million in current period expense.
29

The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2024 and 2023:
 Nine months ended December 31,
20242023
Acquisitions:
Number of loan portfolios acquired through asset purchases6  
Purchase price$18,947,294 $ 
Tangible assets: 
Loans receivable, net18,812,693  
Purchase price amount over carrying value of net tangible assets$134,601 $ 
Customer lists$127,995 $ 
Non-compete agreements$6,606 $ 

Acquisitions that are accounted for as business combinations typically result in one or more new branches. In such cases, the Company typically retains the existing employees and the branch location from the acquisition. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. The remainder is allocated to goodwill.

Acquisitions that are accounted for as asset purchases are typically limited to acquisitions of loan portfolios. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair values at the acquisition date. In an asset purchase, no goodwill is recorded. When the cost of an asset acquisition is less than the fair value of the net assets acquired, the benefit is allocated to nonmonetary long-lived assets acquired on a relative fair value basis. However, any assets for which the subsequent application of GAAP would result in an immediate gain (e.g., financial assets, assets held for sale) are not allocated a portion of the cost below fair value. Any remaining benefit is recorded as a discount on purchase, which is a component of Unearned interest, insurance and fees in the Company's Consolidated Balance Sheets, and is amortized over the life of loans receivable acquired. During the nine months ended December 31, 2024, the Company recorded a $1.0 million discount on loans acquired in asset purchases.

The Company’s acquisitions include tangible assets (generally loans and furniture and equipment) and intangible assets (generally non-compete agreements, customer lists, and goodwill), both of which are recorded at their fair values, which are estimated pursuant to the processes described below.

Acquired loans are valued at the net loan balance. Given the short-term nature of these loans, generally less than twelve months, and that these loans are priced at current rates, management believes the net loan balances approximate their fair value. Under CECL, acquired loans are included in the reserve calculations for all loan types (excluding TALs). Management includes recent acquisition activity compared to historical activity when considering reasonable and supportable forecasts as it relates to assessing the adequacy of the allowance for expected credit losses. The Company did not acquire any loans that would qualify as PCDs during the nine months ended December 31, 2024 and 2023.

Furniture and equipment are valued at the specific purchase price as agreed to by both parties at the time of acquisition, which management believes approximates their fair values.

Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates their fair values.

Customer lists are valued with a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists.

The results of all acquisitions are included in the Company’s consolidated financial statements since the respective acquisition date. The pro forma impact of these branches as though they had been acquired at the beginning of the periods presented would not have a material effect on the results of operations as reported.

NOTE 9 – INTANGIBLE ASSETS
30


The following table provides the gross carrying amount and related accumulated amortization of definite-lived intangible assets:
 December 31, 2024March 31, 2024
 Gross Carrying
Amount
Accumulated
Amortization
Net Intangible Asset Gross Carrying
Amount
Accumulated
Amortization
Net Intangible Asset
Customer lists$55,858,615 $(47,593,700)$8,264,915 $55,730,620 $(44,796,996)$10,933,624 
Non-compete agreements10,534,749 (10,498,178)36,571 10,528,143 (10,392,034)136,109 
Total$66,393,364 $(58,091,878)$8,301,486 $66,258,763 $(55,189,030)$11,069,733 

The estimated amortization expense for intangible assets for future fiscal years ended March 31 is as follows: $0.9 million for the remainder of 2025; $3.2 million for 2026; $2.7 million for 2027; $0.9 million for 2028; $0.4 million for 2029; and an aggregate of $0.2 million for the years thereafter.

NOTE 10 – DEBT

Senior Notes Payable; Revolving Credit Facility

At December 31, 2024, the Company's senior notes payable consisted of a $580.0 million senior revolving credit facility, which has an accordion feature permitting the maximum aggregate commitments to increase to $730.0 million provided that certain conditions are met.

At December 31, 2024, $335.9 million was outstanding under the Company's credit facility, not including $725.8 thousand in outstanding standby letters of credit, which include (i) $300.0 thousand related to worker's compensation expiring on December 31, 2025 and (ii) $425.8 thousand related to the Company's investment in captive insurance expiring on April 12, 2025. Both letters of credit automatically extend for one year on their expiration dates. To the extent that the letter of credit is drawn upon, the disbursement will be funded by the credit facility. There are no amounts due related to the letters of credit as of December 31, 2024. Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus 0.10% and an applicable margin of 3.5% with a minimum rate of 4.5%. The revolving credit facility has a commitment fee of 0.50% per annum on the unused portion of the commitment. Commitment fees on the unused portion of the borrowing totaled $1.2 million and $1.3 million for the nine months ended December 31, 2024 and 2023, respectively.

For the nine months ended December 31, 2024 and fiscal year ended March 31, 2024, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, was 9.7% annualized and 9.9%, respectively. At December 31, 2024, the unused amount available under the revolving credit facility was $243.3 million and borrowings under the revolving credit facility mature on June 7, 2026.

Substantially all of the Company’s assets are pledged as collateral for borrowings under the revolving credit agreement.

Senior Unsecured Notes Payable

On September 27, 2021, we issued $300 million in aggregate principal amount of 7.0% senior notes due November 2026. The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"). The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company could have redeemed the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company could have used the proceeds of certain equity offerings to redeem up to 40.0% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption.

We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes.

31

During the nine months ended December 31, 2024, the Company repurchased and extinguished $49.3 million of its Notes, net of $0.4 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $48.1 million.

During fiscal 2024, the Company repurchased and extinguished $15.7 million of its Notes, net of $0.2 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $14.1 million.

For the three months ended December 31, 2024 and 2023, the Company recognized a $50.0 thousand loss and a $0.6 million gain on extinguishment, respectively. For each of the the nine months ended December 31, 2024 and 2023, the Company recognized a $1.2 million gain on extinguishment. In accordance with ASC 470, the Company recognized the gain and loss on extinguishments as a component of interest expense in the Company's Consolidated Statements of Operations.

Debt Covenants

The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that generally restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement's financial covenants include (i) a minimum consolidated net worth of $325.0 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth of 2.25 to 1.0 for the fiscal quarter ended December 31, 2023 and each fiscal quarter thereafter; (iii) a maximum collateral performance indicator of 26.0% as of the end of each calendar month; and (iv) a minimum fixed charges coverage ratio of 2.0 to 1.0 for the fiscal quarters ending December 31, 2023 through December 31, 2024, and 2.25 to 1.0 for each fiscal quarter thereafter, where the ratio for the most recent four consecutive fiscal quarters (other than for the fiscal quarter ended September 30, 2023) must be at least 2.0 to 1.0 in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity.

The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate.

The Company was in compliance with these covenants at December 31, 2024 and does not believe that these covenants will materially limit its business and expansion strategy.

The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events, (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible loans receivable that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change.

The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions.

Debt Maturities

32

The aggregate annual maturities of the Company's debt arrangements for future fiscal years ended March 31 are as follows:

Amount
Remainder of 2025$ 
2026 
2027561,249,020 
2028 
2029 
Thereafter 
Total future debt payments$561,249,020 

NOTE 11 – INCOME TAXES

As of December 31, 2024 and March 31, 2024, the Company had $1.1 million of total gross unrecognized tax benefits including interest. Approximately $0.8 million represents the amount of net unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. At December 31, 2024, approximately $0.4 million of gross unrecognized tax benefits are expected to be resolved during the next twelve months through the expiration of the statute of limitations and settlement with taxing authorities. The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. The Company had approximately $327.9 thousand accrued for gross interest as of December 31, 2024, and accrued $10.9 thousand during the nine months ended December 31, 2024.

Investment in HTC was $18.7 million and $24.8 million as of December 31, 2024 and March 31, 2024, respectively, which is included as a component of Other assets, net in the Consolidated Balance Sheets. The Company recognized net amortization from these investments of $4.2 million and $1.2 million during the three months ended December 31, 2024 and 2023, respectively, and $12.4 million and $3.2 million during the nine months ended December 31, 2024 and 2023, respectively, in income tax expense. The Company recognized tax benefits from these investments of $4.3 million and $1.2 million for the three months ended December 31, 2024 and 2023, respectively, and $13.6 million and $3.6 million for the nine months ended December 31, 2024 and 2023, respectively, in income tax expense and in Income taxes payable in the Consolidated Statements of Cash Flows. The Company did not recognize any non-tax related activity or have any significant modifications in the investments during the current period.
 
The Company is subject to U.S. income taxes, as well as taxes in various other state and local jurisdictions. With the exception of a few states, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2021, although carryforward attributes that were generated prior to 2021 may still be adjusted upon examination by the taxing authorities if they either have been or will be used in a future period.

The Company’s effective income tax rate increased to 16.4% for the three months ended December 31, 2024 compared to 14.6% for the prior year quarter. The increase is primarily due to the effects of provision to return adjustments treated as discrete items in the prior year quarter, which were partially offset by pretax book earnings relative to the effects of various permanent items including a decrease in the disallowed executive compensation under Section 162(m) and the recognition of additional HTCs when compared to the prior year.

NOTE 12 – COMMITMENTS AND CONTINGENCIES

From time to time the Company is involved in litigation matters relating to claims arising out of its operations in the normal course of business.

Estimating an amount or range of possible losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve fines, penalties or damages that are discretionary in amount, involve a large number of claimants or significant discretion by regulatory authorities, represent a change in regulatory policy or interpretation, present novel legal theories, are in the early stages of the proceedings, are subject to appeal or could result in a change in business practices. In addition, because most legal proceedings are resolved over extended periods of time, potential losses are subject to change due to, among other things, new developments, changes in legal strategy, the outcome of intermediate procedural and substantive rulings and other parties’ settlement posture and their evaluation of the strength or weakness of their case against us. For these reasons, we are currently unable to predict the ultimate timing or outcome of, or reasonably estimate the possible
33

losses or a range of possible losses resulting from, any currently pending claims. Based on information currently available, the
Company does not believe that any reasonably possible losses arising from currently pending legal matters will be material to
the Company’s results of operations or financial conditions. However, in light of the inherent uncertainties involved in such matters, an adverse outcome in one or more of these matters could materially and adversely affect the Company’s financial condition, results of operations or cash flows in any particular reporting period.

NOTE 13 – SUBSEQUENT EVENTS

Management is not aware of any significant events occurring subsequent to the balance sheet date that would have a material effect on the financial statements thereby requiring adjustment or disclosure.
34

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward-Looking Information

This report on Form 10-Q, including "Management’s Discussion and Analysis of Financial Condition and Results of Operations," contains various "forward-looking statements," within the meaning of The Private Securities Litigation Reform Act of 1995, that are based on management’s beliefs and assumptions, as well as information currently available to management. Statements other than those of historical fact, including those identified by words such as “anticipate,” “estimate,” “intend,” “plan,” “expect,” "project," “believe,” “may,” “will,” “should,” "would," "could," "continue," "probable," "forecast," and any variation of the foregoing and similar expressions, are forward-looking statements. Although the Company believes that the expectations reflected in any such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Any such statements are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual financial results, performance or financial condition may vary materially from those anticipated, estimated or expected. Therefore, you should not rely on any of these forward-looking statements.

Among the key factors that could cause our actual financial results, performance or condition to differ from the expectations expressed or implied in such forward-looking statements are the following: recently enacted, proposed or future legislation and the manner in which it is implemented, including pursuant to policies of the new U.S. administration; changes in the U.S. tax code; the nature and scope of regulatory authority, particularly discretionary authority, that is or may be exercised by regulators, including, but not limited to, the U.S. Consumer Financial Protection Bureau, and individual state regulators having jurisdiction over the Company; the unpredictable nature of regulatory examinations, proceedings and litigation; employee misconduct or misconduct by third parties; uncertainties associated with management turnover and the effective succession of senior management; media and public characterization of consumer installment loans; labor unrest; the impact of changes in accounting rules and regulations, or their interpretation or application, which could materially and adversely affect the Company’s reported consolidated financial statements or necessitate material delays or changes in the issuance of the Company’s audited consolidated financial statements; the Company's assessment of its internal control over financial reporting; changes in interest rates; the impact of inflation; risks relating to the acquisition or sale of assets or businesses or other strategic initiatives, including increased loan delinquencies or net charge-offs, the loss of key personnel, integration or migration issues, the failure to achieve anticipated synergies, increased costs of servicing, incomplete records, and retention of customers; risks inherent in making loans, including repayment risks and value of collateral; cybersecurity threats or incidents, including the potential or actual misappropriation of assets or sensitive information, corruption of data or operational disruption and the costs of the associated response thereto; our dependence on debt and the potential impact of limitations in the Company’s amended revolving credit facility or other impacts on the Company's ability to borrow money on favorable terms, or at all; the timing and amount of revenues that may be recognized by the Company; changes in current revenue and expense trends (including trends affecting delinquency and charge-offs); the impact of extreme weather events and natural disasters; changes in the Company’s markets and general changes in the economy (particularly in the markets served by the Company).

These and other risks are discussed in more detail in Part I, Item 1A “Risk Factors” in the Company's fiscal 2024 Annual Report, and in the Company’s other reports filed with, or furnished to, the SEC from time to time. The Company does not undertake any obligation to update any forward-looking statements it may make, except to the extent required by law.

Results of Operations

The following table sets forth certain information derived from the Company's Consolidated Statements of Operations and Consolidated Balance Sheets (unaudited), as well as operating data and ratios, for the periods indicated:
35

Three months ended December 31,Nine months ended December 31,
 2024202320242023
 (Dollars in thousands)
Gross loans receivable$1,381,462 $1,400,622 $1,381,462 $1,400,622 
Average gross loans receivable (1)
1,336,375 1,383,194 1,299,519 1,388,752 
Net loans receivable (2)
1,020,018 1,028,311 1,020,018 1,028,311 
Average net loans receivable (3)
987,833 1,014,113 961,767 1,015,237 
Expenses as a percentage of total revenue:
Provision for credit losses31.8 %29.5 %34.1 %30.8 %
General and administrative48.5 %47.8 %43.8 %47.6 %
Interest expense8.1 %8.5 %7.9 %8.8 %
Operating income as a % of total revenue (4)
19.7 %22.7 %22.1 %21.6 %
Loan volume (5)
$777,197 $744,193 $2,161,632 $2,133,642 
Net charge-offs as percent of average net loans receivable on an annualized basis17.2 %19.1 %17.1 %17.4 %
Return on average assets (trailing 12 months)7.5 %6.0 %7.5 %6.0 %
Return on average equity (trailing 12 months)19.2 %17.3 %19.2 %17.3 %
Branches opened or acquired (merged or closed), net(10)(1)(13)(21)
Branches open (at period end)1,035 1,052 1,035 1,052 
_______________________________________________________
(1) Average gross loans receivable has been determined by averaging month-end gross loans receivable over the indicated period, excluding TALs.
(2) Net loans receivable is defined as gross loans receivable less unearned interest and deferred fees.
(3) Average net loans receivable has been determined by averaging month-end gross loans receivable less unearned interest and deferred fees over the indicated period, excluding TALs.
(4) Operating income is computed as total revenue less provision for credit losses and general and administrative expenses.
(5) Loan volume includes all loan balances originated by the Company. It does not include loans purchased through acquisitions.

Comparison of three months ended December 31, 2024 versus three months ended December 31, 2023

Gross loans outstanding decreased to $1.38 billion as of December 31, 2024, a 1.4% decrease from the $1.40 billion of gross loans outstanding as of December 31, 2023. During the most recent quarter, gross loans outstanding increased sequentially 6.6%, or $85.6 million, from $1.30 billion as of September 30, 2024, compared to an increase of 1.5%, or $21.1 million, in the comparable quarter of the prior year. During the most recent quarter, we saw improvement in borrowing from new, former and existing customers compared to the same quarter of fiscal year 2024. Specifically, new, former and refinance loan customer volume during the quarter increased 22.6%, 13.9% and 1.5%, respectively, compared to the same quarter of fiscal year 2024. Our customer base increased by 3.7% during the twelve-month period ended December 31, 2024, compared to a decrease of 2.4% for the comparable period ended December 31, 2023. During the three months ended December 31, 2024 our unique borrowers increased by 6.2% compared to an increase of 2.4% during the three months ended December 31, 2023. We continued to improve the gross yield to expected loss ratio for all new, former and refinance customer originations and will continue to monitor performance indicators and intend to adjust underwriting accordingly.

Net income for the three months ended December 31, 2024 decreased to $13.4 million, a 19.7% decrease from net income of $16.7 million for the same period of the prior year. Operating income, which is revenue less provision for credit losses and general and administrative expenses, decreased by $3.9 million, or 12.5%, compared to the same period of the prior year.
36


Revenues for the three months ended December 31, 2024 increased by $0.9 million, or 0.6%, to $138.6 million from $137.7 million for the same period of the prior year. Interest and fee income for the three months ended December 31, 2024 increased by $3.7 million, or 3.1%, from the same period of the prior year mostly due to an increase in interest yields.

Insurance and other income for the three months ended December 31, 2024 decreased by $2.8 million, or 14.9%, from the same period of the prior year. Insurance income decreased by approximately $2.0 million, or 14.1%, during the three months ended December 31, 2024 when compared to the three months ended December 31, 2023. Insurance commissions decreased primarily due to a decrease in loans where our insurance products are available to our customer. The large loan portfolio decreased from 55.2% of the overall portfolio as of December 31, 2023, to 48.2% as of December 31, 2024. Other income decreased by $0.8 million primarily due to lower motor club sales driven by fewer large loan customers.

The provision for credit losses increased $3.5 million, or 8.5%, to $44.1 million from $40.6 million when comparing the third quarter of fiscal 2025 to the third quarter of fiscal 2024. The table below itemizes the key components of the CECL allowance and provision impact during the quarter.

CECL Allowance and Provision (Dollars in millions)Q3 FY 2025Q3 FY 2024DifferenceReconciliation
Beginning Allowance - September 30$114.4$128.9$(14.5)
Change due to Growth$7.6$2.0$5.6$5.6
Change due to Expected Loss Rate on Performing Loans$(5.6)$(10.0)$4.4$4.4
Change due to 90 day past due$(0.3)$0.2$(0.5)$(0.5)
Ending Allowance - December 31$116.1$121.1$(5.0)$9.5
Net Charge-offs$42.4$48.4$(6.0)$(6.0)
Provision$44.1$40.6$3.5$3.5
Note: The change in allowance for the quarter plus net charge-offs for the quarter equals the provision for the quarter (see above reconciliation).

The provision was negatively impacted by loan growth and a smaller decrease in expected loss rates during the quarter. Specifically, expected loss rates were negatively impacted by an increase in our 0-5 month customers, our riskiest customers, as a percentage of the portfolio during the current quarter.

Net charge-offs for the quarter decreased $6.0 million, from $48.4 million in the third quarter of fiscal 2024 to $42.4 million in the third quarter of fiscal 2025. Net charge-offs as a percentage of average net loan receivables on an annualized basis decreased from 19.1% in the third quarter of fiscal 2024 to 17.2% in the third quarter of fiscal 2025.

The Company's allowance for credit losses as a percentage of net loans was 11.4% at December 31, 2024 compared to 11.8% at December 31, 2023. Accounts that were 61 days or more past due on a recency basis decreased to 5.7% at December 31, 2024 compared to 5.8% at December 31, 2023.

We experienced an improvement in recency delinquency on accounts at least 90 days past due, improving from 3.7% at December 31, 2023, to 3.4% at December 31, 2024.

G&A expenses for the three months ended December 31, 2024 increased by $1.3 million, or 2.0%, from the corresponding period of the previous year. As a percentage of revenues, G&A expenses increased from 47.8% during the three months ended December 31, 2023 to 48.5% during the three months ended December 31, 2024. G&A expenses per average open branch increased by 3.3% when comparing the two three-month periods. The change in G&A expense is explained in greater detail below.

Personnel expense totaled $41.1 million for the three months ended December 31, 2024, a $1.2 million, or 3.0%, increase over the three months ended December 31, 2023. Salary expense increased approximately $0.4 million, or 1.1%, during the quarter ended December 31, 2024, compared to the quarter ended December 31, 2023. Our headcount as of December 31, 2024, decreased 3.1% compared to December 31, 2023. Benefit expense decreased approximately $0.7 million, or 8.8%, when comparing the quarterly periods ended December 31, 2024 and 2023. Incentive expense increased $1.9 million in the third quarter of fiscal 2025 compared to the third quarter of fiscal 2024. The increase in incentive expense is mostly due to an increase in bonuses paid.

37

Occupancy and equipment expense totaled $12.3 million for the three months ended December 31, 2024, a $0.2 million, or 1.7%, increase over the three months ended December 31, 2023. Occupancy and equipment expense is generally a function of the number of branches the Company has open throughout the period.

Advertising expense increased $0.7 million, or 19.5%, in the third quarter of fiscal 2025 compared to the third quarter of fiscal 2024 due to increased spending on customer acquisition programs.

Amortization of intangible assets totaled $0.9 million for the three months ended December 31, 2024, a $0.1 million, or 10.7%, decrease over the three months ended December 31, 2023.

Other expense totaled $8.5 million for the three months ended December 31, 2024, a $0.7 million, or 7.5%, decrease over the three months ended December 31, 2023.
Interest expense for the three months ended December 31, 2024 decreased by $0.4 million, or 3.4%, from the corresponding three months of the previous year. The decrease in interest expense was due to a 5.8% decrease in the average debt outstanding from $567.1 million to $534.0 million and a 2.4% decrease in the effective interest rate from 8.6% to 8.4%. The Company’s debt-to-equity ratio decreased from 1.4:1 at December 31, 2023 to 1.3:1 at December 31, 2024. The Company repurchased and extinguished $15.6 million of its Notes, net of $0.1 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $15.6 million during the third quarter of fiscal 2025.

Other key return ratios for the three months ended December 31, 2024 included a 7.5% return on average assets and a return on average equity of 19.2% (both on a trailing 12-month basis), as compared to a 6.0% return on average assets and a return on average equity of 17.3% (both on a trailing 12-month basis) for the three months ended December 31, 2023.

The Company’s effective income tax rate increased to 16.4% for the three months ended December 31, 2024 compared to 14.6% for the corresponding period of the previous year. The increase is primarily due to the effects of provision to return adjustments treated as discrete items in the prior year quarter, which were partially offset by pretax book earnings relative to the effects of various permanent items including a decrease in the disallowed executive compensation under Section 162(m) and the recognition of additional HTCs when compared to the prior year.

Comparison of nine months ended December 31, 2024 versus nine months ended December 31, 2023

Gross loans outstanding decreased to $1.38 billion as of December 31, 2024, a 1.4% decrease from the $1.40 billion of gross loans outstanding as of December 31, 2023.

Net income for the nine months ended December 31, 2024 increased to $45.5 million from the $42.3 million net income reported for the same period of the prior year. Operating income, which is revenue less provision for credit losses and general and administrative expenses, decreased by $0.9 million, or 1.0%.

Revenues decreased by $14.4 million, or 3.5%, to $399.6 million during the nine months ended December 31, 2024 from $413.9 million for the same period of the prior year. The decrease was primarily due to a decrease in average net loans outstanding.

Interest and fee income for the nine months ended December 31, 2024 decreased by $4.8 million, or 1.4%, from the same period of the prior year. Net loans outstanding at December 31, 2024 decreased by 0.8% over the balance at December 31, 2023. Average net loans outstanding decreased by 5.3% for the nine months ended December 31, 2024 compared to the nine-month period ended December 31, 2023.

38

Insurance commissions and other income for the nine months ended December 31, 2024 decreased by $9.6 million, or 15.6%, from the same period of the prior year. Insurance commissions decreased by approximately $8.3 million, or 18.1%, during the nine months ended December 31, 2024 when compared to the nine months ended December 31, 2023. Insurance commissions decreased primarily due to a decrease in loans where our insurance products are available to our customer. Other income decreased by $1.3 million. Sales of our motor club product decreased by $2.0 million as sales opportunities decreased with lower originations. This decrease was offset by a $0.8 million increase in revenue from the Company's tax preparation.

The provision for credit losses increased $8.5 million, or 6.7%, to $136.2 million from $127.7 million when comparing the first three quarters of fiscal 2025 to the first three quarters of fiscal 2024. Net charge-offs as a percentage of average net loans receivable on an annualized basis decreased from 17.4% in the first three quarters of fiscal 2024 to 17.1% in the first three quarters of fiscal 2025.

G&A expenses for the nine months ended December 31, 2024 decreased by $22.0 million, or 11.2%, from the corresponding period of the previous year. As a percentage of revenues, G&A expenses decreased from 47.6% during the first nine months of fiscal 2024 to 43.8% during the first nine months of fiscal 2025. G&A expenses per average open branch decreased by 10.1% when comparing the two nine-month periods. The change in G&A expense is explained in greater detail below.

Personnel expense totaled $99.8 million for the nine months ended December 31, 2024, a $20.3 million, or 16.9%, decrease over the nine months ended December 31, 2023. Salary expense decreased approximately $0.4 million, or 0.5%, when comparing the nine month periods ended December 31, 2024 and 2023. Our headcount as of December 31, 2024, decreased 3.1% compared to December 31, 2023. Benefit expense decreased approximately $2.7 million, or 10.7%, when comparing the nine month periods ended December 31, 2024 and 2023. Incentive expense decreased $16.2 million, mostly due to the $18.5 million reversal of the expense associated with the $20.45 Performance Shares during the second quarter of fiscal 2025.

Occupancy and equipment expense totaled $36.8 million for the nine months ended December 31, 2024, a $0.3 million, or 0.9%, decrease over the nine months ended December 31, 2023. Occupancy and equipment expense is generally a function of the number of branches the Company has open throughout the period.

Advertising expense totaled $8.9 million for the nine months ended December 31, 2024, a $0.2 million, or 2.4%, increase over the nine months ended December 31, 2023 due to increased spending on customer acquisition programs.

Amortization of intangible assets totaled $2.9 million for the nine months ended December 31, 2024, a $0.3 million, or 8.8%, decrease over the nine months ended December 31, 2023.

Other expense totaled $26.6 million for the nine months ended December 31, 2024, a $1.3 million, or 4.5% decrease over the nine months ended December 31, 2023.

Interest expense for the nine months ended December 31, 2024 decreased by $5.0 million, or 13.6%, from the corresponding nine months of the previous year. The decrease in interest expense was due to a 12.6% decrease in the average debt outstanding, from $581.0 million to $507.5 million. The Company repurchased and extinguished $49.3 million of its Notes, net of $0.4 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $48.1 million, during the nine months ended December 31, 2024.

Other key return ratios for the first nine months of fiscal 2025 included a 7.5% return on average assets and a return on average equity of 19.2% (both on a trailing 12-month basis), as compared to a 6.0% return on average assets and a return on average equity of 17.3% (both on a trailing 12-month basis) for the first nine months of fiscal 2024.

The Company’s effective income tax rate increased to 20.1% for the nine months ended December 31, 2024 compared to 19.9% for the corresponding period of the previous year. The effective tax rate remained substantially unchanged from the prior year with the slight increase related to provision adjustments recorded as discrete items in the prior year.

Regulatory Matters

CFPB Rulemaking Initiatives

On October 5, 2017, the CFPB issued a final rule (the "Rule") imposing limitations on (i) short-term consumer loans, (ii) longer-term consumer installment loans with balloon payments, and (iii) higher-rate consumer installment loans repayable by a payment authorization. The Rule originally required lenders originating short-term loans and longer-term balloon payment
39

loans to evaluate whether each consumer has the ability to repay the loan along with current obligations and expenses (“ability to repay requirements”); however, the ability to repay requirements was rescinded in July 2020. The Rule also curtails repeated unsuccessful attempts to debit consumers’ accounts for short-term loans, balloon payment loans, and installment loans that involve a payment authorization and an annual percentage rate over 36% (“payment requirements”). Implementation of the Rule’s payment requirements may require changes to the Company’s practices and procedures for such loans, which could materially and adversely affect the Company’s ability to make such loans, the cost of making such loans, the Company’s ability to, or frequency with which it could, refinance any such loans, and the profitability of such loans.

In July 2020, the CFPB rescinded provisions of the Rule governing the ability to repay requirements. The payment requirements were scheduled to take effect in June 2022. However, on October 19, 2022, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit ruled, in Community Financial Services Association of America v. Consumer Financial Protection Bureau, that the funding mechanism for the CFPB violates the appropriations clause of the U.S. Constitution, and as a result, vacated the Rule. On October 3, 2023, the U.S. Supreme Court held oral argument to decide the constitutionality of the CFPB's funding mechanism. On May 16, 2024, the Supreme Court held that the funding mechanism for the CFPB complies with the appropriations clause of the U.S. Constitution, reversing the judgment of the Court of Appeals, and remanding the cause for further proceedings. In June 2024, the CFPB announced that the Rule would go into effect on March 30, 2025. Such regulatory changes could have effects beyond those currently contemplated that could further materially and adversely impact our business and operations. Unless rescinded or otherwise amended, the Company will have to comply with the Rule’s payment requirements if it continues to allow consumers to set up future recurring payments online for certain covered loans such that it meets the definition of having a “leveraged payment mechanism” under the Rule. If the payment provisions of the Rule apply, the Company will have to modify its loan payment procedures to comply with the required notices and mandated timeframes set forth in the final rule.

The CFPB also has stated that it expects to conduct separate rulemaking to identify larger participants in the installment lending market for purposes of its supervision program. This initiative was classified as “inactive” on the CFPB’s Spring 2018 rulemaking agenda and has remained inactive since, but the CFPB indicated that such action was not a decision on the merits. Though the likelihood and timing of any such rulemaking is uncertain, the Company believes that the implementation of such rules would likely bring the Company’s business under the CFPB’s supervisory authority which, among other things, would subject the Company to reporting obligations to, and on-site compliance examinations by, the CFPB. In addition, even in the absence of a “larger participant” rule, the CFPB has the power to order individual nonbank financial institutions to submit to supervision where the CFPB has reasonable cause to determine that the institution is engaged in “conduct that poses risks to consumers” under 12 USC 5514(a)(1)(C). In 2022, the CFPB announced that it had begun using this “dormant authority” to examine nonbank entities and the CFPB is attempting to expand the number of nonbank entities it currently supervises. Specifically, the CFPB previously notified the Company that it was seeking to establish such supervisory authority over the Company. Since then, the CFPB issued a public designation order setting forth its determination that the Company has met the legal requirements for supervision (the "Order"). Pursuant to the terms of the Order, the CFPB has supervisory authority over the Company pursuant to section 1024(a)(1)(C) of the Consumer Financial Protection Act of 2010 until such time as the Order is terminated consistent with 12 C.F.R. 1091.113. Importantly, while the Order establishes that the CFPB has supervisory authority over the Company, it does not constitute a finding that the Company has engaged in wrongdoing, nor does it require any immediate action on the part of the Company. However, the outcome of such supervision could result in operational changes which could reduce our ability to operate profitably or increase compliance costs. The supervision could also result in additional examinations, investigations, litigation, consent orders or administrative proceedings, which could require considerable resources, time, effort and attention from our management, and may result in operational changes, monetary penalties or declines in our stock price.

See Part I, Item 1, “Business Government Regulation Federal legislation,” for a further discussion of these matters and the federal regulations to which the Company’s operations are subject and Part I, Item 1A, “Risk Factors,” in each case, in the Company’s fiscal 2024 Annual Report for more information regarding these regulatory and related risks.

Liquidity and Capital Resources

The Company has historically financed and continues to finance its operations, acquisitions and branch expansion primarily through a combination of cash flows from operations and borrowings from its institutional lenders. As discussed below, the Company has also issued debt securities to finance its operations and repay a portion of its outstanding indebtedness. The Company has generally applied its cash flows from operations to fund its loan volume, fund acquisitions, repay long-term indebtedness, and repurchase its common stock. Net cash provided by operating activities for the nine months ended December 31, 2024 was $163.2 million.

The Company believes that attractive opportunities to acquire new branches or receivables from its competitors or to acquire branches in communities not currently served by the Company will continue to become available as conditions in local economies and the financial circumstances of owners change.
40


On September 27, 2021, we issued $300 million in aggregate principal amount of 7.0% senior notes due November 2026. The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act. The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company could have redeemed the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company could have used the proceeds of certain equity offerings to redeem up to 40% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption.

We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes.

During the nine months ended December 31, 2024, the Company repurchased and extinguished $49.3 million of its Notes, net of $0.4 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $48.1 million.

During fiscal 2024, the Company repurchased and extinguished $15.7 million of its Notes, net of $0.2 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $14.1 million.

The Company recognized a $50.0 thousand loss and a $0.5 million gain on extinguishment during the three months ended December 31, 2024 and 2023, respectively. For each of the nine months ended December 31, 2024 and 2023, the Company recognized a $1.2 million gain on extinguishment. In accordance with ASC 470, the Company recognized the gain and loss on extinguishments as a component of interest expense in the Company's Consolidated Statements of Operations.

The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions.

The Company continues to believe stock repurchases are a viable component of the Company’s long-term financial strategy and an excellent use of excess cash when the opportunity arises. However, our revolving credit facility and the Notes limit share repurchases to up to 50% of consolidated adjusted net income for the period commencing January 1, 2019. As of December 31, 2024, subject to further approval from our Board of Directors, we could repurchase approximately $32.2 million of shares under the terms of our debt facilities (subject to further board approval). Additional share repurchases can be made subject to compliance with, among other things, applicable restricted payment covenants under the revolving credit facility and the Notes.

The Company has a revolving credit facility with a syndicate of banks. The revolving credit facility provides for revolving borrowings of up to the lesser of (a) the aggregate commitments under the facility and (b) a borrowing base, and it includes $725.8 thousand in outstanding standby letters of credit.

Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus 0.10% and an applicable margin of 3.5% with a minimum rate of 4.5%. At December 31, 2024, the aggregate commitments under the revolving credit facility were $580.0 million. The Company had $725.8 thousand in outstanding standby letters of credit which include (i) $300.0 thousand related to worker's compensation expiring on December 31, 2025 and (ii) $425.8 thousand related to the Company's investment in captive insurance expiring on April 12, 2025. Both letters of credit automatically extend for one year on their expiration dates. The borrowing base limitation is equal to the product of (a) the Company’s eligible finance receivables, less unearned finance charges, insurance premiums and insurance commissions applicable to such eligible finance receivables, and (b) an advance rate percentage that ranges from 70% to 80% based on a collateral performance indicator, as more completely described below. Further, under the amended and restated revolving credit agreement, the administrative agent has the right to set aside reasonable reserves against the available borrowing base in such amounts as it may deem appropriate, including, without limitation, reserves with respect to certain regulatory events or any increased operational, legal, or regulatory risk of the Company and its subsidiaries.

41

For the nine months ended December 31, 2024 and fiscal year ended March 31, 2024, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, as it relates to the revolving credit facility was 9.7% annualized and 9.9%, respectively. At December 31, 2024, the unused amount available under the revolving credit facility was $243.3 million. Borrowings under the revolving credit facility mature on June 7, 2026.

The Company’s obligations under the revolving credit facility, together with treasury management and hedging obligations owing to any lender under the revolving credit facility or any affiliate of any such lender, are required to be guaranteed by each of the Company’s wholly-owned domestic subsidiaries. The obligations of the Company and the subsidiary guarantors under the revolving credit facility, together with such treasury management and hedging obligations, are secured by a first-priority security interest in substantially all assets of the Company and the subsidiary guarantors.

The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement's financial covenants include (i) a minimum consolidated net worth of $325 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth of 2.25 to 1.0 for the fiscal quarter ended December 31, 2023 and each fiscal quarter thereafter; (iii) a maximum collateral performance indicator of 26.0% as of the end of each calendar month; and (iv) a minimum fixed charges coverage ratio of 2.0 to 1.0 for the fiscal quarters ending December 31, 2023 through December 31, 2024, and 2.25 to 1.0 for each fiscal quarter thereafter, where the ratio for the most recent four consecutive fiscal quarters (other than for the fiscal quarter ended September 30, 2023) must be at least 2.0 to 1.0, in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity.

The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate.

The Company was in compliance with these covenants at December 31, 2024 and does not believe that these covenants will materially limit its business and expansion strategy.

The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events, (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible loans receivable that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change.

As of December 31, 2024, the Company's debt outstanding was $559.9 million, net of $1.4 million unamortized debt issuance costs related to the unsecured senior notes payable, and its shareholders' equity was $428.2 million resulting in a debt-to-equity ratio of 1.3:1.0. Management will continue to monitor the Company's debt-to-equity ratio and is committed to maintaining a debt level that will allow the Company to continue to execute its business objectives, while not putting undue stress on its consolidated balance sheet.

The Company believes that cash flow from operations and borrowings under its revolving credit facility or other sources will be adequate to fund the expected cost of opening or acquiring new branches, including funding initial operating losses of new branches and funding loans receivable originated by those branches and the Company's other branches (for the next 12 months and for the foreseeable future beyond that). Except as otherwise discussed in (i) this report including, but not limited to, any discussions in Part II, Item 1A, "Risk Factors" in this Quarterly Report on Form 10-Q and (ii) Part I, Item 1A, "Risk Factors" in the Company's fiscal 2024 Annual Report (as supplemented by any subsequent disclosures in information the Company files with or furnishes to the SEC from time to time), management is not currently aware of any trends, demands, commitments, events or uncertainties that it believes will or could result in, or are or could be reasonably likely to result in, any material adverse effect on the Company’s liquidity.

42

Share Repurchase Program

On May 15, 2024, the Board of Directors authorized the Company to repurchase up to $20.0 million of the Company’s outstanding common stock, inclusive of the amount that remained available for repurchase under prior repurchase authorizations. As of December 31, 2024, the Company had $9.0 million in aggregate remaining repurchase capacity under its current share repurchase program. The timing and actual number of shares repurchased will depend on a variety of factors, including the stock price, corporate and regulatory requirements, available funds, alternative uses of capital, restrictions under the revolving credit agreement, and other market and economic conditions. The Company’s stock repurchase program may be suspended or discontinued at any time.

The Company continues to believe stock repurchases are a viable component of the Company’s long-term financial strategy and an excellent use of excess cash when the opportunity arises. Additional share repurchases can be made subject to compliance with, among other things, applicable restricted payment covenants under the revolving credit facility and the Notes. Our first priority is to ensure we have enough capital to fund loan growth. As of December 31, 2024, subject to further approval from our Board of Directors, we could repurchase approximately $32.2 million of shares under the terms of our debt facilities (subject to further board approval). To the extent we have excess capital, we may repurchase stock, if appropriate and as authorized by our Board of Directors.

Inflation

The Company does not believe that inflation will have a materially adverse effect on its financial condition, unless changes in inflation are particularly severe and sudden in nature. Although inflation would increase the Company’s operating costs in absolute terms, the Company expects that the same decrease in the value of money would result in an increase in the size of loans demanded by its customer base. It is reasonable to anticipate that such a change in customer preference would result in an increase in total loans receivable and an increase in absolute revenue to be generated from that larger amount of loans receivable. The Company believes that this increase in absolute revenue should offset any increase in operating costs. In addition, because the Company’s loans have a relatively short contractual term and average life, it is unlikely that loans made at any given point in time will be repaid with significantly inflated dollars.

Quarterly Information and Seasonality

See Note 2 to the Consolidated Financial Statements.

Recently Adopted Accounting Pronouncements
 
There were no new accounting pronouncements recently adopted. See Note 2 to the Consolidated Financial Statements for information regarding recently issued accounting standards not yet adopted.

Critical Accounting Policies
 
The Company’s accounting and reporting policies are in accordance with GAAP and conform to general practices within the finance company industry. Certain accounting policies involve significant judgment by the Company’s management, including the use of estimates and assumptions which affect the reported amounts of assets, liabilities, revenue, and expenses. As a result, changes in these estimates and assumptions could significantly affect the Company’s financial position and results of operations. The Company considers its policies regarding the allowance for credit losses, share-based compensation and income taxes to be its most critical accounting policies due to the significant degree of management judgment involved.

Allowance for Credit Losses

Accounting policies related to the allowance for credit losses are considered to be critical as these policies involve considerable subjective judgement and estimation by management. In the case of loans, the allowance for credit losses is a contra-asset valuation account, calculated in accordance with ASC 326 that is deducted from the amortized cost basis of loans to present the net amount expected to be collected. The amount of the allowance account represents management’s best estimate of current expected credit losses on these financial instruments considering available information, from internal and external sources, relevant to assessing exposure to credit loss over the contractual term of the instrument. Relevant available information includes historical credit loss experience, current conditions, qualitative factors, and reasonable and supportable forecasts.
 
Share-Based Compensation

43

The Company measures compensation cost for share-based awards at fair value and recognizes compensation over the service period for awards expected to vest. The fair value of restricted stock is based on the number of shares granted and the quoted price of the Company’s common stock at the time of grant, and the fair value of stock options is determined using the Black-Scholes valuation model. The Black-Scholes model requires the input of assumptions, including expected volatility, risk-free interest rate and expected life.

Income Taxes
 
Management uses certain assumptions and estimates in determining income taxes payable or refundable, deferred income tax liabilities and assets for events recognized differently in its financial statements and income tax returns, and income tax expense. Determining these amounts requires analysis of certain transactions and interpretation of tax laws and regulations. Management exercises considerable judgment in evaluating the amount and timing of recognition of the resulting income tax liabilities and assets. These judgments and estimates are re-evaluated on a periodic basis as regulatory and business factors change.

No assurance can be given that either the tax returns submitted by management or the income tax reported on the consolidated financial statements will not be adjusted by either adverse rulings, changes in the tax code, or assessments made by the IRS, state, or foreign taxing authorities. The Company is subject to potential adverse adjustments, including but not limited to: an increase in the statutory federal or state income tax rates, the permanent non-deductibility of amounts currently considered deductible either now or in future periods, and the dependency on the generation of future taxable income in order to ultimately realize deferred income tax assets.
 
Under FASB ASC Topic 740, the Company will include the current and deferred tax impact of its tax positions in the financial statements when it is more likely than not (likelihood of greater than 50%) that such positions will be sustained by taxing authorities, with full knowledge of relevant information, based on the technical merits of the tax position. While the Company supports its tax positions by unambiguous tax law, prior experience with the taxing authority, and analysis of what it considers to be all relevant facts, circumstances and regulations, management must still rely on assumptions and estimates to determine the overall likelihood of success and proper quantification of a given tax position.

44

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

The Company’s outstanding debt under its revolving credit facility was $335.9 million at December 31, 2024. Interest on borrowings under this facility is based on the greater of 4.5% or one month SOFR plus 0.10% and an applicable margin of 3.5%. Based on the outstanding balance under the Company's revolving credit facility at December 31, 2024, a change of 1.0% in the interest rate would cause a change in interest expense of approximately $3.4 million on an annual basis.

Item 4. Controls and Procedures

Changes in Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Evaluation of Disclosure Controls and Procedures

Based on management’s evaluation, with the participation of our CEO and CFO, as of the end of the period covered by this report, our CEO and CFO have concluded that our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, are effective to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Our management is responsible for establishing and maintaining adequate “internal control over financial reporting,” as defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our management, including the CEO and CFO do not expect that our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

45

PART II.  OTHER INFORMATION

Item 1. Legal Proceedings

See Note 12 to the Consolidated Financial Statements included in this report for information regarding legal proceedings.

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed in Part I, Item 1A of the Company's fiscal 2024 Annual Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The Company's credit agreements contain certain limits on share repurchases. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources."

On May 15, 2024, the Board of Directors of the Company approved a share repurchase program authorizing the Company to repurchase up to $20.0 million of its outstanding common stock, inclusive of any amount that remains available for repurchase under prior repurchase authorizations. As of December 31, 2024 the Company had $9.0 million in aggregate remaining repurchase capacity under its current share repurchase program. The timing and actual number of shares repurchased will depend on a variety of factors, including the stock price, corporate and regulatory requirements, available funds, alternative uses of capital, restrictions under the revolving credit agreement, and other market and economic conditions. The Company’s stock repurchase program may be suspended or discontinued at any time.

The repurchase authorization does not have a stated expiration date. The following table details purchases of the Company's common stock, if any, made by the Company during the three months ended December 31, 2024:
(a)
Total number of
shares purchased
(b)
Average price paid
per share
(c)
Total number of shares purchased
as part of publicly announced
plans or programs
(d)
Approximate dollar value of shares
that may yet be purchased
under the plans or programs
October 1 through October 31, 2024— $— — $10,001,742 
November 1 through November 30, 2024— — — 10,001,742 
December 1 through December 31, 20249,465 110.5 9,465 8,955,896 
Total for the quarter9,465 $110.50 9,465 

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None of our officers or directors entered into, modified or terminated any “Rule 10b5-1 trading arrangements” or “non-Rule 10b5-1 trading arrangements” (each as defined in in Item 408(c) of Regulation S-K) during the quarter ended December 31, 2024.

Item 6. Exhibits

46


Exhibit
Number
Exhibit DescriptionFiled
Herewith
Incorporated by Reference
Form or
Registration
Number
ExhibitFiling
Date
3.01S-83.107-29-03
3.0210-Q3.0111-08-18
31.01*
31.02*
32.01*
32.02*
101.01The following materials from the Company's Quarterly Report for the fiscal quarter ended December 31, 2024, formatted in Inline XBRL:*
 (i)Consolidated Balance Sheets as of December 31, 2024 and March 31, 2024;  
 (ii)Consolidated Statements of Operations for the three and nine months ended December 31, 2024 and December 31, 2023;  
 (iii)Consolidated Statements of Shareholders' Equity for the three and nine months ended December 31, 2024 and December 31, 2023;  
 (iv)Consolidated Statements of Cash Flows for the nine months ended December 31, 2024 and December 31, 2023; and  
 (v)Notes to the Consolidated Financial Statements.  
104.01Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*
*Filed herewith.

47

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
WORLD ACCEPTANCE CORPORATION
 
By: /s/ Scott McIntyre
Scott McIntyre
Senior Vice President of Accounting
Signing on behalf of the registrant and as principal accounting officer
Date:February 6, 2025

48

EXHIBIT 31.01

CERTIFICATION

I, R. Chad Prashad, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of World Acceptance Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.




Dated: February 6, 2025/s/  R. Chad Prashad
 R. Chad Prashad
 President and Chief Executive Officer



EXHIBIT 31.02

CERTIFICATION

I, John L. Calmes, Jr., certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of World Acceptance Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.




Dated: February 6, 2025/s/  John L. Calmes, Jr.
 John L. Calmes, Jr.
 Executive Vice President and Chief Financial and Strategy Officer



EXHIBIT 32.01

CERTIFICATION OF PERIODIC REPORT

I, R. Chad Prashad, President and Chief Executive Officer of World Acceptance Corporation (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:
(1)the Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2024, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: February 6, 2025/s/  R. Chad Prashad
 R. Chad Prashad
 President and Chief Executive Officer





EXHIBIT 32.02

CERTIFICATION OF PERIODIC REPORT

I, John L. Calmes, Jr., Executive Vice President and Chief Financial and Strategy Officer of World Acceptance Corporation (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:
(1)the Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2024, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: February 6, 2025/s/  John L. Calmes, Jr.
 John L. Calmes, Jr.
 Executive Vice President and Chief Financial and Strategy Officer


v3.25.0.1
COVER - shares
9 Months Ended
Dec. 31, 2024
Jan. 31, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2024  
Document Transition Report false  
Entity File Number 000-19599  
Entity Registrant Name WORLD ACCEPTANCE CORP  
Entity Incorporation, State or Country Code SC  
Entity Tax Identification Number 57-0425114  
Entity Address, Address Line One 104 S Main Street  
Entity Address, City or Town Greenville,  
Entity Address, State or Province SC  
Entity Address, Postal Zip Code 29601  
City Area Code (864)  
Local Phone Number 298-9800  
Title of 12(b) Security Common Stock, no par value  
Trading Symbol WRLD  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   5,746,677
Entity Central Index Key 0000108385  
Current Fiscal Year End Date --03-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2024
Mar. 31, 2024
ASSETS    
Cash and cash equivalents $ 15,582,553 $ 11,839,460
Gross loans receivable 1,381,461,902 1,277,149,256
Less:    
Unearned interest, insurance and fees (361,444,148) (326,746,136)
Allowance for credit losses (116,110,946) (102,962,811)
Loans receivable, net 903,906,808 847,440,309
Income taxes receivable 7,188,053 3,091,229
Operating lease right‐of‐use assets, net 78,856,773 79,501,238
Property and equipment, net 20,551,225 22,897,197
Deferred income taxes, net 31,967,282 30,942,844
Other assets, net 36,775,212 42,198,242
Goodwill 7,370,791 7,370,791
Intangible assets, net 8,301,486 11,069,733
Total assets 1,110,500,183 1,056,351,043
Liabilities:    
Senior notes payable 335,949,020 223,419,132
Senior unsecured notes payable, net 223,910,142 272,609,632
Operating lease liability 81,207,297 81,920,865
Accounts payable and accrued expenses 41,263,775 53,974,198
Total liabilities 682,330,234 631,923,827
Commitments and contingencies
Shareholders' equity:    
Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding 0 0
Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 5,787,976 and 5,938,665 shares at December 31, 2024 and March 31, 2024, respectively 0 0
Additional paid-in capital 267,074,904 286,432,952
Retained earnings 161,095,045 137,994,264
Total shareholders' equity 428,169,949 424,427,216
Total liabilities and shareholders' equity $ 1,110,500,183 $ 1,056,351,043
v3.25.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2024
Mar. 31, 2024
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0 $ 0
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 95,000,000 95,000,000
Common stock, shares issued (in shares) 5,787,976 5,938,665
Common stock, shares outstanding (in shares) 5,787,976 5,938,665
v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Revenues:        
Interest and fee income $ 122,390,403 $ 118,665,105 $ 347,456,761 $ 352,237,133
Insurance and other income, net 16,242,350 19,084,282 52,112,762 61,711,366
Total revenues 138,632,753 137,749,387 399,569,523 413,948,499
Expenses:        
Provision for credit losses 44,103,495 40,631,994 136,191,023 127,697,072
General and administrative expenses:        
Personnel 41,074,877 39,890,187 99,804,998 120,119,638
Occupancy and equipment 12,293,093 12,090,198 36,793,516 37,138,444
Advertising 4,448,074 3,721,155 8,925,597 8,712,406
Amortization of intangible assets 938,026 1,050,926 2,902,848 3,182,805
Other 8,468,838 9,156,841 26,563,688 27,828,730
Total general and administrative expenses 67,222,908 65,909,307 174,990,647 196,982,023
Interest expense 11,293,874 11,689,924 31,520,066 36,475,411
Total expenses 122,620,277 118,231,225 342,701,736 361,154,506
Income before income taxes 16,012,476 19,518,162 56,867,787 52,793,993
Income tax expense 2,624,180 2,853,344 11,403,906 10,508,008
Net income $ 13,388,296 $ 16,664,818 $ 45,463,881 $ 42,285,985
Net income per common share:        
Basic (in dollars per share) $ 2.46 $ 2.89 $ 8.32 $ 7.32
Diluted (in dollars per share) $ 2.45 $ 2.84 $ 8.23 $ 7.17
Weighted average common shares outstanding:        
Basic (in shares) 5,436,688 5,772,503 5,461,990 5,775,108
Diluted (in shares) 5,464,217 5,860,117 5,526,784 5,896,716
v3.25.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Beginning balance (in shares) at Mar. 31, 2023   6,231,082    
Beginning balances at Mar. 31, 2023 $ 385,226,737   $ 288,071,839 $ 97,154,898
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Proceeds from exercise of stock options (in shares)   22,847    
Proceeds from exercise of stock options 2,018,412   2,018,412  
Common stock repurchases (in shares)   (148,765)    
Common stock repurchases (17,291,997)     (17,291,997)
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)   31,865    
Stock-based compensation (reversal) related to restricted stock, net of cancellations (1,348,623)   (1,348,623)  
Stock-based compensation related to stock options (3,871,348)   (3,871,348)  
Net income 42,285,985     42,285,985
Ending balance (in shares) at Dec. 31, 2023   6,073,299    
Ending balances at Dec. 31, 2023 407,019,166   284,870,280 122,148,886
Beginning balance (in shares) at Sep. 30, 2023   6,246,818    
Beginning balances at Sep. 30, 2023 410,022,795   287,246,730 122,776,065
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Proceeds from exercise of stock options (in shares)   11,104    
Proceeds from exercise of stock options 948,441   948,441  
Common stock repurchases (in shares)   (148,765)    
Common stock repurchases (17,291,997)     (17,291,997)
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)   35,858    
Stock-based compensation (reversal) related to restricted stock, net of cancellations (3,514,473)   (3,514,473)  
Stock-based compensation related to stock options 189,582   189,582  
Net income 16,664,818     16,664,818
Ending balance (in shares) at Dec. 31, 2023   6,073,299    
Ending balances at Dec. 31, 2023 $ 407,019,166   284,870,280 122,148,886
Beginning balance (in shares) at Mar. 31, 2024 5,938,665 5,938,665    
Beginning balances at Mar. 31, 2024 $ 424,427,216   286,432,952 137,994,264
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Proceeds from exercise of stock options (in shares)   20,310    
Proceeds from exercise of stock options 1,881,436   1,881,436  
Common stock repurchases (in shares)   (174,632)    
Common stock repurchases (22,363,100)     (22,363,100)
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)   3,633    
Stock-based compensation (reversal) related to restricted stock, net of cancellations (21,562,624)   (21,562,624)  
Stock-based compensation related to stock options 323,140   323,140  
Net income $ 45,463,881     45,463,881
Ending balance (in shares) at Dec. 31, 2024 5,787,976 5,787,976    
Ending balances at Dec. 31, 2024 $ 428,169,949   267,074,904 161,095,045
Beginning balance (in shares) at Sep. 30, 2024   5,769,530    
Beginning balances at Sep. 30, 2024 417,463,754   268,746,030 148,717,724
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Proceeds from exercise of stock options (in shares)   5,324    
Proceeds from exercise of stock options 424,420   424,420  
Common stock repurchases (in shares)   (9,465)    
Common stock repurchases (1,010,975)     (1,010,975)
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)   22,587    
Stock-based compensation (reversal) related to restricted stock, net of cancellations (2,181,186)   (2,181,186)  
Stock-based compensation related to stock options 85,640   85,640  
Net income $ 13,388,296     13,388,296
Ending balance (in shares) at Dec. 31, 2024 5,787,976 5,787,976    
Ending balances at Dec. 31, 2024 $ 428,169,949   $ 267,074,904 $ 161,095,045
v3.25.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]        
Issuance of restricted common stock under stock option plan $ 2,544,812 $ 2,823,774 $ 2,676,053 $ 2,823,774
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Cash flow from operating activities:          
Net income $ 13,388,296 $ 16,664,818 $ 45,463,881 $ 42,285,985  
Adjustments to reconcile net income to net cash provided by operating activities:          
Amortization of intangible assets 938,026 1,050,926 2,902,848 3,182,805  
Accrued unearned interest     (4,437,733) (4,225,244)  
Amortization of deferred loan cost     10,461,809 10,285,733  
Gain on extinguishment of senior unsecured notes payable     (1,160,067) (1,162,581)  
Amortization of debt issuance costs     999,688 1,338,352  
Amortization of discount on loans acquired in an asset purchase     (380,232) 0  
Provision for credit losses 44,103,495 40,631,994 136,191,023 127,697,072  
Depreciation     4,799,367 4,937,169  
Gain on sale of property and equipment     (78,011) (95,621)  
Deferred income tax expense (benefit)     (1,024,438) 4,674,792  
Stock-based compensation (reversal) related to equity classified awards     (18,563,431) (2,396,197)  
Change in accounts:          
Other assets, net     5,007,294 5,213,994  
Income taxes receivable     (4,096,824) (4,249,555)  
Accounts payable and accrued expenses     (12,878,833) (5,516,759)  
Net cash provided by operating activities     163,206,341 181,969,945  
Cash flows from investing activities:          
Increase in loans receivable, net     (179,488,673) (153,198,324)  
Cash paid for acquisitions, primarily loans     (18,947,294) 0  
Purchases of property and equipment     (2,814,437) (4,419,445)  
Proceeds from the sale of property and equipment     439,053 308,174  
Net cash used in investing activities     (200,811,351) (157,309,595)  
Cash flow from financing activities:          
Borrowings from senior notes payable     297,385,341 215,066,622  
Payments on senior notes payable     (184,855,453) (217,887,966)  
Payments for extinguished senior unsecured notes payable     (48,148,250) (6,978,717)  
Payments for debt extinguishment costs     (12,500) (20,625)  
Debt issuance costs associated with senior notes payable     (31,728) (475,716)  
Proceeds from exercise of stock options     1,881,436 2,018,412  
Payments for taxes related to net share settlement of equity awards     (2,676,053) (2,823,774)  
Repurchase of common stock     (22,194,690) (17,291,997)  
Net cash provided by (used in) financing activities     41,348,103 (28,393,761)  
Net change in cash and cash equivalents     3,743,093 (3,733,411)  
Cash and cash equivalents at beginning of period     11,839,460 16,508,935 $ 16,508,935
Cash and cash equivalents at end of period $ 15,582,553 $ 12,775,524 15,582,553 12,775,524 $ 11,839,460
Supplemental Disclosures:          
Interest paid during the period     36,476,307 41,233,947  
Income taxes paid during the period     3,204,509 7,726,889  
Excise tax on stock repurchases not paid during the period     $ 168,410 $ 0  
v3.25.0.1
BASIS OF PRESENTATION
9 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION BASIS OF PRESENTATION
The consolidated financial statements of the Company at December 31, 2024 and 2023 and for the three and nine months then ended were prepared in accordance with the instructions for Form 10-Q and are unaudited; however, in the opinion of management, all adjustments (consisting only of items of a normal, recurring nature) necessary for a fair presentation of the financial position at December 31, 2024, and the results of operations and cash flows for the periods ended December 31, 2024 and 2023, have been included. The results for the interim periods are not necessarily indicative of the results that may be expected for the full year or any other interim period.

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. Actual results could differ from those estimates.

The consolidated financial statements do not include all disclosures required by GAAP and should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, as filed with the SEC (the "fiscal 2024 Annual Report"). The Company applies the accounting policies contained in Note 1 to the Consolidated Financial Statements included in fiscal 2024 Annual Report. The Company believes that the disclosures are adequate to make the information presented not misleading.
v3.25.0.1
SUMMARY OF SIGNIFICANT POLICIES
9 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT POLICIES SUMMARY OF SIGNIFICANT POLICIES
Nature of Operations

The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.

Seasonality

The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters, and operating results for its fourth fiscal quarter are generally higher than in other quarters.

Loans receivable, net

Loans receivable are carried at amortized cost, which is the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination costs were $6.6 million and $5.0 million as of December 31, 2024 and March 31, 2024, respectively.

From time to time, the Company will sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing. See Note 4 to the Consolidated Financial Statements for further information.

Allowance for credit losses

Refer to Note 4 to the Consolidated Financial Statements for information regarding the Company's CECL allowance model and a description of the policies and methodology utilized.
Reclassification

From time to time, prior period amounts will be reclassified to conform to the current presentation. Such reclassifications have no impact on previously reported net income or shareholders' equity.

Recently Issued Accounting Standards Not Yet Adopted

Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to require entities to expand annual disclosures to 1) include specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold and 2) disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign taxes. ASU 2023-09 also requires entities to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal, state and foreign, among other changes. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires additional disclosure, in the notes to financial statements, about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, which was clarified by ASU 2025-01, Clarifying the Effective Date. Early adoption is permitted. ASU 2024-03 should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this update or (2) retrospectively to any or all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the consolidated financial statements and related disclosures as a result of future adoption.
v3.25.0.1
FAIR VALUE
9 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE FAIR VALUE
Fair Value Disclosures

The Company may carry certain financial instruments and derivative assets and liabilities at fair value measured on a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company measures the fair values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Fair value measurements are grouped in three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active.
Level 3 – Unobservable inputs for assets or liabilities reflecting the reporting entity’s own assumptions.

The Company’s financial instruments consist of cash and cash equivalents, loans receivable, net, the senior notes payable, and the senior unsecured notes payable. Loans receivable are originated at prevailing market rates and have an average life of up to twelve months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s senior notes payable, consisting of a senior revolving credit facility, has a variable rate based on a margin over SOFR and reprices with any changes in SOFR. The fair value of the senior unsecured notes payable is estimated based on quoted prices in markets that are not active. The Company also considers its creditworthiness in its estimation of fair value.

The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below.
December 31, 2024March 31, 2024
Input LevelCarrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
ASSETS
Cash and cash equivalents1$15,582,553 $15,582,553 $11,839,460 $11,839,460 
Loans receivable, net3903,906,808 903,906,808 847,440,309 847,440,309 
LIABILITIES
Senior unsecured notes payable, net
2223,910,142 222,969,719 272,609,632 254,208,482 
Senior notes payable3335,949,020 335,949,020 223,419,132 223,419,132 

There were no significant assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2024 or March 31, 2024.
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES
9 Months Ended
Dec. 31, 2024
Receivables [Abstract]  
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES
The following is a summary of gross loans receivable by Customer Tenure as of:
Customer TenureDecember 31, 2024March 31, 2024
0 to 5 months$120,206,225 $73,699,568 
6 to 17 months83,792,574 69,616,739 
18 to 35 months119,019,301 140,340,728 
36 to 59 months152,290,291 181,399,293 
60+ months904,874,073 799,703,920 
TALs1,279,438 12,389,008 
Total gross loans$1,381,461,902 $1,277,149,256 

Current payment performance is used to assess the capability of the borrower to repay contractual obligations of the loan agreements as scheduled, which is monitored by management on a daily basis. The Company’s payment performance buckets are as follows: current, 30-60 days past due, 61-90 days past due, 91 days or more past due.

All loans, except for TALs, that are greater than 90 days past due on a recency basis and not written off as of the reporting date are reserved for at 100% of the outstanding balance, net of a calculated Rehab Rate. The weighted average Rehab Rate at December 31, 2024 and March 31, 2024 was 4.7% and 4.9%, respectively. A loan is charged off within the allowance for credit losses in the month following when an account reaches 120 days past due on a recency basis, subject to certain exceptions. Specifically, the Company’s customer accounts in a confirmed bankruptcy are generally charged off in the month after they reach 60 days past due on a recency basis. The accounts of deceased or incarcerated customers are also generally charged off in the month after they reach 60 days past due on a recency basis, with the exception of deceased customers with credit life insurance. Subsequent recoveries of amounts charged off, if any, are credited to the allowance for credit losses.

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,191,801,595 $53,796,457 $5,232,034 $246,907 $5,097 $4,612 $1,251,086,702 
30 - 60 days past due45,078,425 5,587,931 771,319 88,677 5,498 12,712 51,544,562 
61 - 90 days past due27,968,712 3,192,929 387,807 46,475 5,912 518 31,602,353 
91 or more days past due38,928,934 6,353,121 611,384 52,719 2,689 — 45,948,847 
Total$1,303,777,666 $68,930,438 $7,002,544 $434,778 $19,196 $17,842 $1,380,182,464 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$191,926 $— $— $— $— $— $191,926 
30 - 60 days past due71,880 — — — — — 71,880 
61 - 90 days past due56,193 — — — — — 56,193 
91 or more days past due959,439 — — — — — 959,439 
Total$1,279,438 $— $— $— $— $— $1,279,438 
Total gross loans$1,381,461,902 
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,094,896,350 $61,853,967 $4,807,924 $109,050 $25,850 $1,371 $1,161,694,512 
30 - 60 days past due34,034,537 4,600,615 610,649 10,856 14,076 5,429 39,276,162 
61 - 90 days past due21,874,701 2,154,561 200,117 17,493 204 — 24,247,076 
91 or more days past due34,560,868 4,600,040 364,386 6,151 5,617 5,436 39,542,498 
Total$1,185,366,456 $73,209,183 $5,983,076 $143,550 $45,747 $12,236 $1,264,760,248 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$7,441,660 $860 $— $— $— $— $7,442,520 
30 - 60 days past due4,942,757 788 — — — — 4,943,545 
61 - 90 days past due— 1,650 — — — — 1,650 
91 or more days past due— 1,293 — — — — 1,293 
Total$12,384,417 $4,591 $— $— $— $— $12,389,008 
Total gross loans$1,277,149,256 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,179,892,149 $47,643,195 $4,032,753 $130,939 $— $— $1,231,699,036 
30 - 60 days past due46,938,294 4,289,434 347,554 10,189 — 4,836 51,590,307 
61 - 90 days past due30,851,070 3,357,138 300,261 20,307 205 — 34,528,981 
91 or more days past due46,096,156 13,640,670 2,321,974 273,343 18,991 13,006 62,364,140 
Total$1,303,777,669 $68,930,437 $7,002,542 $434,778 $19,196 $17,842 $1,380,182,464 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$158,737 $— $— $— $— $— $158,737 
30 - 60 days past due50,553 — — — — — 50,553 
61 - 90 days past due37,596 — — — — — 37,596 
91 or more days past due1,032,552 — — — — — 1,032,552 
Total$1,279,438 $— $— $— $— $— $1,279,438 
Total gross loans$1,381,461,902 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,079,720,968 $54,770,231 $3,681,104 $39,921 $10,484 $1,371 $1,138,224,079 
30 - 60 days past due37,475,784 3,388,380 288,576 1,064 — — 41,153,804 
61 - 90 days past due26,191,269 2,903,253 208,172 3,430 204 — 29,306,328 
91 or more days past due41,978,436 12,147,320 1,805,223 99,134 35,059 10,865 56,076,037 
Total$1,185,366,457 $73,209,184 $5,983,075 $143,549 $45,747 $12,236 $1,264,760,248 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$7,441,661 $— $— $— $— $— $7,441,661 
30 - 60 days past due4,942,757 — — — — — 4,942,757 
61 - 90 days past due— — — — — — — 
91 or more days past due— 4,590 — — — — 4,590 
Total$12,384,418 $4,590 $— $— $— $— $12,389,008 
Total gross loans$1,277,149,256 

The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2024:

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination YearLoansTALsTotalLoansTALsTotal
2020 and prior$— $— $— $24,919 $— $24,919 
20212,675 — 2,675 26,161 — 26,161 
2022148,994 — 148,994 708,565 — 708,565 
20231,463,591 — 1,463,591 8,571,378 175 8,571,553 
202423,325,438 651,498 23,976,936 103,377,399 2,814,391 106,191,790 
202523,230,774 — 23,230,774 23,867,489 — 23,867,489 
Total$48,171,472 $651,498 $48,822,970 $136,575,911 $2,814,566 $139,390,477 
The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2023:
Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination YearLoansTALsTotalLoansTALsTotal
2019 and prior$1,958 $— $1,958 $11,385 $— $11,385 
20203,909 — 3,909 33,560 — 33,560 
202144,632 — 44,632 275,558 — 275,558 
20221,660,567 188 1,660,755 10,243,978 5,197 10,249,175 
202328,683,289 118,287 28,801,576 120,931,950 1,260,273 122,192,223 
202424,222,152 — 24,222,152 24,466,713 — 24,466,713 
Total$54,616,507 $118,475 $54,734,982 $155,963,144 $1,265,470 $157,228,614 
Credit risk is inherent in the business of extending loans to borrowers and is continuously monitored by management and reflected within the allowance for credit losses for loans. The allowance for credit losses is an estimate of expected losses inherent within the Company’s gross loans receivable portfolio. In estimating the allowance for credit losses, loans with similar risk characteristics are aggregated into pools and collectively assessed. The Company’s loan products have generally the same terms therefore the Company looks to borrower characteristics as a way to disaggregate loans into pools sharing similar risks.

In determining the allowance for credit losses, the Company examined four borrower risk metrics as noted below.

1.Borrower type
2.Active months
3.Prior loan performance
4.Customer Tenure

To determine how well each metric predicts default risk the Company used loss rate data over an observation period of twelve months at the loan level.

The information value was then calculated for each metric. From this analysis management determined the metric that had the strongest predictor of default risk was Customer Tenure. The Customer Tenure buckets used in the allowance for credit loss calculation are:

1.0 to 5 months
2.6 to 17 months
3.18 to 35     months
4.36 to 59 months
5.60+ months

Management will continue to monitor this credit metric on a quarterly basis.

Management estimates an allowance for each Customer Tenure bucket by performing a historical migration analysis of loans in that bucket for the twelve most recent historical twelve-month migration periods. Management considers whether current credit conditions might suggest a change is needed to the allowance for credit losses by monitoring trends in first pay success for new borrowers, 60-89 day delinquencies on a recency basis, percent of loan balances that are paying and percentage of gross loans that are acquired loans. If management determines that historical migration rates should be adjusted to reflect expected credit losses, a qualitative adjustment is made to reflect management's judgment regarding observable changes in recent or expected economic trends and conditions, portfolio composition, or other significant events or conditions that affect the current estimate. The increase in the allowance for credit losses from March 31, 2024 to December 31, 2024 was primarily due to loan growth during the period.

Due to the short term nature of the loan portfolio, forecasted changes in macroeconomic variables such as unemployment levels, general inflation and commodity prices, typically do not have a significant impact on loans outstanding at the end of a particular reporting period, unless those changes are particularly severe and sudden in nature. Therefore, management develops a reasonable and supportable forecast of losses by comparing the most recent six-month loss curves as compared to historical loss curves to see if there are significant changes in borrower behavior that may indicate the historical migration rates should be adjusted. If a change is determined necessary, then the Company has elected to immediately revert back to historical experience past the forecast period. As of December 31, 2024 and March 31, 2024, there were no conditions or other factors considered significant enough to warrant a forecast adjustment.
The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
2024202320242023
Beginning balance$114,455,495 $128,892,192 $102,962,811 $125,552,733 
Provision for credit losses44,103,495 40,631,994 136,191,023 127,697,072 
Charge-offs(48,822,970)(54,734,982)(139,390,477)(157,228,614)
Recoveries16,374,926 6,292,864 16,347,589 25,060,877 
Net charge-offs(42,448,044)(48,442,118)(123,042,888)(132,167,737)
Ending Balance$116,110,946 $121,082,068 $116,110,946 $121,082,068 

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$97,729,708 $8,178,732 $5,850,084 $8,447,701 $22,476,517 $120,206,225 
6 to 17 months71,894,285 4,123,710 2,957,998 4,816,581 11,898,289 83,792,574 
18 to 35 months104,818,028 5,232,991 3,486,649 5,481,633 14,201,273 119,019,301 
36 to 59 months135,845,513 6,391,258 3,906,289 6,147,231 16,444,778 152,290,291 
60+ months840,799,168 27,617,871 15,401,333 21,055,701 64,074,905 904,874,073 
TALs191,926 71,880 56,193 959,439 1,087,512 1,279,438 
Total gross loans1,251,278,628 51,616,442 31,658,546 46,908,286 130,183,274 1,381,461,902 
Unearned interest, insurance and fees(331,428,164)(9,525,813)(8,350,208)(12,139,963)(30,015,984)(361,444,148)
Total net loans$919,850,464 $42,090,629 $23,308,338 $34,768,323 $100,167,290 $1,020,017,754 
Percentage of period-end gross loans receivable3.7%2.3%3.4%9.4%

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$56,802,704 $4,720,149 $4,496,518 $7,680,197 $16,896,864 $73,699,568 
6 to 17 months60,634,735 3,155,423 2,075,608 3,750,973 8,982,004 69,616,739 
18 to 35 months126,843,010 5,057,256 3,224,662 5,215,800 13,497,718 140,340,728 
36 to 59 months165,694,013 6,159,335 3,519,743 6,026,202 15,705,280 181,399,293 
60+ months751,720,050 20,183,999 10,930,545 16,869,326 47,983,870 799,703,920 
TALs7,442,520 4,943,545 1,650 1,293 4,946,488 12,389,008 
Total gross loans1,169,137,032 44,219,707 24,248,726 39,543,791 108,012,224 1,277,149,256 
Unearned interest, insurance and fees(301,616,958)(7,677,494)(6,674,554)(10,777,130)(25,129,178)(326,746,136)
Total net loans$867,520,074 $36,542,213 $17,574,172 $28,766,661 $82,883,046 $950,403,120 
Percentage of period-end gross loans receivable3.5 %1.9 %3.1 %8.5 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$97,003,231 $8,063,335 $5,874,364 $9,265,295 $23,202,994 $120,206,225 
6 to 17 months70,860,586 4,036,915 2,987,142 5,907,931 12,931,988 83,792,574 
18 to 35 months102,558,371 5,188,437 3,806,830 7,465,663 16,460,930 119,019,301 
36 to 59 months133,059,756 6,150,175 4,191,450 8,888,910 19,230,535 152,290,291 
60+ months828,217,092 28,151,445 17,669,195 30,836,341 76,656,981 904,874,073 
TALs158,737 50,553 37,596 1,032,552 1,120,701 1,279,438 
Total gross loans1,231,857,773 51,640,860 34,566,577 63,396,692 149,604,129 1,381,461,902 
Unearned interest, insurance and fees(327,330,320)(8,969,250)(9,101,669)(16,042,909)(34,113,828)(361,444,148)
Total net loans$904,527,453 $42,671,610 $25,464,908 $47,353,783 $115,490,301 $1,020,017,754 
Percentage of period-end gross loans receivable3.7%2.5%4.6%10.8 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$55,572,691 $4,645,860 $4,784,273 $8,696,744 $18,126,877 $73,699,568 
6 to 17 months58,920,283 2,990,455 2,364,202 5,341,799 10,696,456 69,616,739 
18 to 35 months123,878,546 5,246,778 3,813,284 7,402,120 16,462,182 140,340,728 
36 to 59 months161,614,270 6,388,791 4,435,367 8,960,865 19,785,023 181,399,293 
60+ months738,238,289 21,881,920 13,909,202 25,674,509 61,465,631 799,703,920 
TALs7,441,661 4,942,757 — 4,590 4,947,347 12,389,008 
Total gross loans1,145,665,740 46,096,561 29,306,328 56,080,627 131,483,516 1,277,149,256 
Unearned interest, insurance and fees(296,584,056)(7,544,366)(7,936,622)(14,681,092)(30,162,080)(326,746,136)
Total net loans$849,081,684 $38,552,195 $21,369,706 $41,399,535 $101,321,436 $950,403,120 
Percentage of period-end gross loans receivable3.6 %2.3 %4.4 %10.3 %

The Company elected not to record an allowance for credit losses for accrued interest as outlined in ASC 326-20-30-5A. Loans are placed on nonaccrual status when management determines that the full payment of principal and collection of interest according to contractual terms is no longer likely. The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest income is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced.

The following table presents unpaid accrued interest reversed against interest income by Customer Tenure for the three and nine months ended December 31, 2024 and 2023:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Customer Tenure
0 to 5 months$(1,513,556)$(1,364,409)$(3,943,143)$(3,910,003)
6 to 17 months(802,513)(779,642)(2,201,034)(2,653,697)
18 to 35 months(789,715)(949,250)(2,378,004)(2,612,375)
36 to 59 months(829,641)(1,068,613)(2,553,282)(3,214,245)
60+ months(3,227,592)(2,828,677)(8,869,807)(7,977,412)
Total$(7,163,017)$(6,990,591)$(19,945,270)$(20,367,732)

The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2024 and 2023:
Nonaccrual Loans Receivable
Customer TenureAs of December 31, 2024As of March 31, 2024
Interest Income
Recognized for the three months ended December 31, 2024
Interest Income
Recognized for the three months ended December 31, 2023
Interest Income
Recognized for the nine months ended December 31, 2024
Interest Income
Recognized for the nine months ended December 31, 2023
0 to 5 months$14,404,816 $13,971,062 $152,639 $197,470 $521,894 $769,418 
6 to 17 months9,047,425 8,507,503 217,517 319,474 661,265 1,168,253 
18 to 35 months11,964,366 12,569,729 346,761 396,720 1,057,869 1,249,102 
36 to 59 months13,915,169 15,250,596 402,275 547,608 1,315,569 1,728,965 
60+ months51,333,978 45,091,589 1,507,229 1,497,757 4,463,586 4,785,842 
Unearned interest, insurance and fees(26,362,491)(24,643,778) —  — 
Total$74,303,263 $70,746,701 $2,626,421 $2,959,029 $8,020,183 $9,701,580 

As of December 31, 2024 and March 31, 2024, there were no loans receivable 61 days or more past due, not on nonaccrual status, and no loans receivable on nonaccrual status with no related allowance for credit losses.
v3.25.0.1
LEASES
9 Months Ended
Dec. 31, 2024
Leases [Abstract]  
LEASES LEASES
Accounting Policies and Matters Requiring Management's Judgment

The Company uses its senior notes payable's effective annual interest rate to determine the discount rate when evaluating leases under Topic 842. Specifically, Management applies its senior notes payable's effective annual interest rate at the end of the prior fiscal year to leases entered into in the following year. For example, the senior notes payable's annual effective interest rate of 9.9% at March 31, 2024 was used as the discount rate when determining the lease type and the present value of lease payments for leases entered into in fiscal 2025.

Based on its historical practice, the Company believes it is reasonably certain to exercise a given option associated with a given office space lease. Therefore, the Company classifies all lease options for office space as “reasonably certain” unless it has specific knowledge to the contrary for a given lease. The Company does not believe it is reasonably certain to exercise any options associated with its office equipment leases.

Periodic Disclosures

The Company's operating leases consist of real estate leases for office space as well as office equipment. Both the branch real estate and office equipment lease terms generally range from three years to five years, and generally contain options to extend which mirror the original terms of the lease.

As of December 31, 2024 and 2023, the Company had no finance leases.

The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
 2024202320242023
Lease Cost
Operating lease cost$6,387,738 $6,163,762 $18,846,686 $19,000,163 
Variable lease cost940,465 888,119 2,949,878 2,808,845 
Total lease cost$7,328,203 $7,051,881 $21,796,564 $21,809,008 

The following table reports other information about the Company's leases for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
 2024202320242023
Other Lease Information
Operating cash flows for amounts included in the measurement of lease liabilities — operating leases$6,301,091 $6,265,527 $18,884,883 $18,965,468 
Right-of-use assets obtained in exchange for new operating lease liabilities$3,247,250 $4,568,169 $13,812,021 $13,560,648 
Weighted average remaining lease term — operating leases6.5 years6.9 years6.5 years6.9 years
Weighted-average discount rate — operating leases6.8 %6.3 %6.8 %6.3 %
The aggregate annual lease obligations as of December 31, 2024 are as follows:
Operating Leases
Remainder of 2025$6,160,520 
202622,367,057 
202717,961,935 
202814,520,255 
202910,573,915 
Thereafter29,343,439 
Total undiscounted lease liability$100,927,121 
Imputed interest19,719,824 
Total discounted lease liability$81,207,297 

The Company had no leases with related parties as of December 31, 2024 or March 31, 2024.
v3.25.0.1
AVERAGE SHARE INFORMATION
9 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
AVERAGE SHARE INFORMATION AVERAGE SHARE INFORMATION
The following is a summary of the basic and diluted average common shares outstanding:
Three months ended December 31,Nine months ended December 31,
2024202320242023
Basic:  
Weighted average common shares outstanding (denominator)5,436,688 5,772,503 5,461,990 5,775,108 
Diluted:  
Weighted average common shares outstanding5,436,688 5,772,503 5,461,990 5,775,108 
Dilutive potential common shares27,529 87,614 64,794 121,608 
Weighted average diluted shares outstanding (denominator)5,464,217 5,860,117 5,526,784 5,896,716 
 
Options to purchase 246,111 and 291,826 shares of common stock at various prices were outstanding during the three months ended December 31, 2024 and 2023, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.

Options to purchase 250,034 and 299,904 shares of common stock at various prices were outstanding during the nine months ended December 31, 2024 and 2023, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.
v3.25.0.1
STOCK-BASED COMPENSATION
9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Stock Incentive Plans

The Company maintains the 2008 Plan, the 2011 Plan and the 2017 Plan for the benefit of certain non-employee directors, officers, and key employees. Under these plans, a total of 3,350,000 shares of authorized common stock have been reserved for issuance pursuant to grants approved by the Compensation Committee. Stock options granted under these plans have a maximum term of 10 years, may be subject to certain vesting requirements, which are generally three to six years for officers, non-employee directors, and key employees, and are priced at the market value of the Company's common stock on the option's grant date. At December 31, 2024, there were a total of 187,020 shares of common stock remaining available for grant under the 2017 Plan.

Stock-based compensation is recognized as provided under FASB ASC Topic 718-10 and FASB ASC Topic 505-50. FASB ASC Topic 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the consolidated financial statements based on their grant date fair values. Stock-based compensation related to restricted stock is based on the number of shares expected to vest and the fair market value of the common stock on the grant date. Stock-based compensation related to stock option awards is based on the number of shares expected to vest and the estimated fair value of the awards on the grant date using the Black-Scholes valuation model. Under the Black-Scholes valuation method, the assumptions used to determine the fair value are expected volatility, expected life, average risk-free rate, and dividend yield, if any. The expected stock price volatility is based on the historical volatility of the Company's common stock for a period approximating the expected life. The expected life represents the period of time that options are expected to be outstanding after the grant date. The risk-free rate reflects the interest rate at grant date on zero coupon U.S. governmental bonds having a remaining life similar to the expected option term.

2018 Long-term Incentive Program and Non-Employee Director Awards

On October 15, 2018, the Compensation Committee and Board of Directors approved and adopted a long-term incentive program that seeks to motivate and reward certain employees and to align management’s interest with shareholders’ interest by focusing executives on the achievement of long-term results. The program is comprised of four components: Service Options, Performance Options, Restricted Stock, and Performance Shares.

Pursuant to this program, in fiscal 2019, the Compensation Committee approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2011 Plan and the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Service Options and Restricted Stock to certain non-employee directors of the Company.

Under the long-term incentive program, up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of two trailing EPS performance targets established by the Compensation Committee that are based on EPS (measured at the end of each calendar quarter, commencing with the calendar quarter ending September 30, 2019) for the previous four calendar quarters. The Performance Shares are eligible to vest over the 2018 Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2018 Performance Share Measurement Period (or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement).

The Performance Share performance targets are set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%

During the second quarter of fiscal 2025, it was determined that the $20.45 Performance Share performance target was no longer probable of being achieved and that the $20.45 Performance Shares would likely be forfeited as of the last day of the performance period in accordance with their terms. As a result and in accordance with ASC 718, the Company reversed $18.5 million in previously recognized stock-based compensation related to the $20.45 Performance Shares during the second quarter of fiscal 2025.
The Restricted Stock awards typically vest in three to six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Service Options typically vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.

The Performance Options will fully vest if the Company attains the trailing EPS target over four consecutive calendar quarters occurring between September 30, 2018 and March 31, 2025 as described below. Such performance target was established by the Compensation Committee and will be measured at the end of each calendar quarter commencing on September 30, 2019. The Performance Options are eligible to vest over the 2018 Performance Option Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2018 Performance Option Measurement Period or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term. The Performance Option performance target is set forth below.

Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Options Eligible for Vesting
(Percentage of Award)
$25.30100%

During the second quarter of fiscal 2024, it was determined that the Performance Option performance target was no longer probable of being achieved and that the Performance Options would likely be forfeited as of the last day of the performance period in accordance with their terms. As a result and in accordance with ASC 718, the Company reversed $4.9 million in previously recognized stock-based compensation related to these Performance Options during the second quarter of fiscal 2024.

2024 Long-term Incentive Program and Non-Employee Director Awards

On December 18, 2024, the Compensation Committee and Board of Directors approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Restricted Stock to certain non-employee directors of the Company.

Up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of certain performance goals established by the Compensation Committee related to company operational performance metrics during the 2024 Performance Share Measurement Period, for which achievement must be certified by the Compensation Committee. The Performance Shares are eligible to vest over the 2024 Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2024 Performance Share Measurement Period or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Restricted Stock awards fully vest on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through the vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Service Options vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.

Up to 100% of the Performance Options will vest, if at all, based on the achievement of certain performance goals established by the Compensation Committee related to company operational performance metrics during the 2024 Performance Option Measurement Period, for which achievement must be certified by the Compensation Committee. The Performance Options typically vest in three equal annual installments, beginning on January 30, 2026, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the
applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term.

Stock Options

The weighted-average fair value at the grant date for options issued during the three months ended December 31, 2024 and 2023 was $58.29 and $68.52, respectively. The weighted-average fair value at the grant date for options issued during the nine months ended December 31, 2024 and 2023 was $58.29 and $69.00, respectively.

Fair value was estimated at grant date using the weighted-average assumptions listed below:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Dividend yield—%—%—%—%
Expected volatility59.53%62.54%59.53%62.55%
Average risk-free rate4.39%4.70%4.39%4.69%
Expected life4.5 years4.6 years4.5 years4.6 years

Option activity for the nine months ended December 31, 2024 was as follows:
 SharesWeighted Average Exercise
Price
Weighted Average
Remaining
Contractual Term
Aggregate Intrinsic Value
Options outstanding, beginning of period267,947 $105.77   
Granted during period38,661 111.68   
Exercised during period(20,310)92.64   
Forfeited during period(8,212)102.62   
Expired during period(1,549)206.52   
Options outstanding, end of period276,537  2$107.09 5.1 years$2,850,363 
Options exercisable, end of period131,659 $110.58 4.6 years$1,594,728 
 
The aggregate intrinsic value reflected in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on December 31, 2024 and the exercise price, multiplied by the number of in-the-money options that are currently exercisable) that would have been received by option holders had all option holders exercised their options as of December 31, 2024. This amount will change as the market price of the common stock changes. The total intrinsic value and tax benefit of options exercised during the three and nine month periods ended December 31, 2024 and 2023 were as follows:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Intrinsic value of options exercised$215,599 $369,543 $732,318 $810,853 
Tax benefit of options exercised52,822 90,538 179,418 198,659 
 
The total fair value of stock options vested during the nine months ended December 31, 2024 was $2,120,670. As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested stock options amounted to approximately $1.9 million, which is expected to be recognized over a weighted-average period of approximately 2.5 years.
Restricted Stock

During the first nine months of fiscal 2025, the Company granted 71,186 shares of restricted stock (which are equity classified) to certain vice presidents, senior vice presidents, executive officers and non-employee directors with a grant date weighted average fair value of $111.64 per share.

During fiscal 2024, the Company granted 3,993 shares of restricted stock (which are equity classified) to certain vice presidents and senior vice presidents with a grant date weighted average fair value of $120.12 per share.

The total fair value of restricted stock vested during the nine months ended December 31, 2024 was $7,293,854. As of December 31, 2024, there was approximately $7.7 million of unrecognized compensation cost related to unvested restricted stock awards, which is expected to be recognized over the next 1.0 year based on current estimates.

A summary of the status of the Company’s restricted stock as of December 31, 2024, and changes during the nine months ended December 31, 2024, are presented below:
 SharesWeighted Average Fair Value at Grant Date
Outstanding at March 31, 2024388,577 $101.18 
Granted during the period71,186 111.64 
Vested during the period(62,577)104.08 
Forfeited during the period(44,566)100.37 
Outstanding at December 31, 2024352,620 $102.88 
 
Total Stock-Based Compensation

Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three and nine month periods ended December 31, 2024 and 2023 was as follows:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Stock-based compensation related to equity classified awards:
Stock-based compensation (reversal) related to stock options3$85,640 $189,582 $323,140 $(3,871,348)
Stock-based compensation (reversal) related to restricted stock4363,626 (690,699)(18,886,571)1,475,151 
Total stock-based compensation (reversal) related to equity classified awards$449,266 $(501,117)$(18,563,431)$(2,396,197)
v3.25.0.1
ACQUISITIONS
9 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
ACQUISITIONS ACQUISITIONS
The Company evaluates each set of assets and activities it acquires to determine if the set meets the definition of a business according to FASB ASC Topic 805-10-55. Acquisitions meeting the definition of a business are accounted for as business combinations while all other acquisitions are accounted for as asset purchases.
The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2024 and 2023:
 Nine months ended December 31,
20242023
Acquisitions:
Number of loan portfolios acquired through asset purchases6 — 
Purchase price$18,947,294 $— 
Tangible assets: 
Loans receivable, net18,812,693 — 
Purchase price amount over carrying value of net tangible assets$134,601 $— 
Customer lists$127,995 $— 
Non-compete agreements$6,606 $— 

Acquisitions that are accounted for as business combinations typically result in one or more new branches. In such cases, the Company typically retains the existing employees and the branch location from the acquisition. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. The remainder is allocated to goodwill.

Acquisitions that are accounted for as asset purchases are typically limited to acquisitions of loan portfolios. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair values at the acquisition date. In an asset purchase, no goodwill is recorded. When the cost of an asset acquisition is less than the fair value of the net assets acquired, the benefit is allocated to nonmonetary long-lived assets acquired on a relative fair value basis. However, any assets for which the subsequent application of GAAP would result in an immediate gain (e.g., financial assets, assets held for sale) are not allocated a portion of the cost below fair value. Any remaining benefit is recorded as a discount on purchase, which is a component of Unearned interest, insurance and fees in the Company's Consolidated Balance Sheets, and is amortized over the life of loans receivable acquired. During the nine months ended December 31, 2024, the Company recorded a $1.0 million discount on loans acquired in asset purchases.

The Company’s acquisitions include tangible assets (generally loans and furniture and equipment) and intangible assets (generally non-compete agreements, customer lists, and goodwill), both of which are recorded at their fair values, which are estimated pursuant to the processes described below.

Acquired loans are valued at the net loan balance. Given the short-term nature of these loans, generally less than twelve months, and that these loans are priced at current rates, management believes the net loan balances approximate their fair value. Under CECL, acquired loans are included in the reserve calculations for all loan types (excluding TALs). Management includes recent acquisition activity compared to historical activity when considering reasonable and supportable forecasts as it relates to assessing the adequacy of the allowance for expected credit losses. The Company did not acquire any loans that would qualify as PCDs during the nine months ended December 31, 2024 and 2023.

Furniture and equipment are valued at the specific purchase price as agreed to by both parties at the time of acquisition, which management believes approximates their fair values.

Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates their fair values.

Customer lists are valued with a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists.

The results of all acquisitions are included in the Company’s consolidated financial statements since the respective acquisition date. The pro forma impact of these branches as though they had been acquired at the beginning of the periods presented would not have a material effect on the results of operations as reported.
v3.25.0.1
INTANGIBLE ASSETS
9 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS INTANGIBLE ASSETS
The following table provides the gross carrying amount and related accumulated amortization of definite-lived intangible assets:
 December 31, 2024March 31, 2024
 Gross Carrying
Amount
Accumulated
Amortization
Net Intangible Asset Gross Carrying
Amount
Accumulated
Amortization
Net Intangible Asset
Customer lists$55,858,615 $(47,593,700)$8,264,915 $55,730,620 $(44,796,996)$10,933,624 
Non-compete agreements10,534,749 (10,498,178)36,571 10,528,143 (10,392,034)136,109 
Total$66,393,364 $(58,091,878)$8,301,486 $66,258,763 $(55,189,030)$11,069,733 

The estimated amortization expense for intangible assets for future fiscal years ended March 31 is as follows: $0.9 million for the remainder of 2025; $3.2 million for 2026; $2.7 million for 2027; $0.9 million for 2028; $0.4 million for 2029; and an aggregate of $0.2 million for the years thereafter.
v3.25.0.1
DEBT
9 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
DEBT DEBT
Senior Notes Payable; Revolving Credit Facility

At December 31, 2024, the Company's senior notes payable consisted of a $580.0 million senior revolving credit facility, which has an accordion feature permitting the maximum aggregate commitments to increase to $730.0 million provided that certain conditions are met.

At December 31, 2024, $335.9 million was outstanding under the Company's credit facility, not including $725.8 thousand in outstanding standby letters of credit, which include (i) $300.0 thousand related to worker's compensation expiring on December 31, 2025 and (ii) $425.8 thousand related to the Company's investment in captive insurance expiring on April 12, 2025. Both letters of credit automatically extend for one year on their expiration dates. To the extent that the letter of credit is drawn upon, the disbursement will be funded by the credit facility. There are no amounts due related to the letters of credit as of December 31, 2024. Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus 0.10% and an applicable margin of 3.5% with a minimum rate of 4.5%. The revolving credit facility has a commitment fee of 0.50% per annum on the unused portion of the commitment. Commitment fees on the unused portion of the borrowing totaled $1.2 million and $1.3 million for the nine months ended December 31, 2024 and 2023, respectively.

For the nine months ended December 31, 2024 and fiscal year ended March 31, 2024, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, was 9.7% annualized and 9.9%, respectively. At December 31, 2024, the unused amount available under the revolving credit facility was $243.3 million and borrowings under the revolving credit facility mature on June 7, 2026.

Substantially all of the Company’s assets are pledged as collateral for borrowings under the revolving credit agreement.

Senior Unsecured Notes Payable

On September 27, 2021, we issued $300 million in aggregate principal amount of 7.0% senior notes due November 2026. The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"). The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company could have redeemed the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company could have used the proceeds of certain equity offerings to redeem up to 40.0% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption.

We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes.
During the nine months ended December 31, 2024, the Company repurchased and extinguished $49.3 million of its Notes, net of $0.4 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $48.1 million.

During fiscal 2024, the Company repurchased and extinguished $15.7 million of its Notes, net of $0.2 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $14.1 million.

For the three months ended December 31, 2024 and 2023, the Company recognized a $50.0 thousand loss and a $0.6 million gain on extinguishment, respectively. For each of the the nine months ended December 31, 2024 and 2023, the Company recognized a $1.2 million gain on extinguishment. In accordance with ASC 470, the Company recognized the gain and loss on extinguishments as a component of interest expense in the Company's Consolidated Statements of Operations.

Debt Covenants

The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that generally restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement's financial covenants include (i) a minimum consolidated net worth of $325.0 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth of 2.25 to 1.0 for the fiscal quarter ended December 31, 2023 and each fiscal quarter thereafter; (iii) a maximum collateral performance indicator of 26.0% as of the end of each calendar month; and (iv) a minimum fixed charges coverage ratio of 2.0 to 1.0 for the fiscal quarters ending December 31, 2023 through December 31, 2024, and 2.25 to 1.0 for each fiscal quarter thereafter, where the ratio for the most recent four consecutive fiscal quarters (other than for the fiscal quarter ended September 30, 2023) must be at least 2.0 to 1.0 in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity.

The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate.

The Company was in compliance with these covenants at December 31, 2024 and does not believe that these covenants will materially limit its business and expansion strategy.

The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events, (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible loans receivable that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change.

The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions.

Debt Maturities
The aggregate annual maturities of the Company's debt arrangements for future fiscal years ended March 31 are as follows:

Amount
Remainder of 2025$— 
2026— 
2027561,249,020 
2028— 
2029— 
Thereafter— 
Total future debt payments$561,249,020 
v3.25.0.1
INCOME TAXES
9 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
As of December 31, 2024 and March 31, 2024, the Company had $1.1 million of total gross unrecognized tax benefits including interest. Approximately $0.8 million represents the amount of net unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. At December 31, 2024, approximately $0.4 million of gross unrecognized tax benefits are expected to be resolved during the next twelve months through the expiration of the statute of limitations and settlement with taxing authorities. The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. The Company had approximately $327.9 thousand accrued for gross interest as of December 31, 2024, and accrued $10.9 thousand during the nine months ended December 31, 2024.

Investment in HTC was $18.7 million and $24.8 million as of December 31, 2024 and March 31, 2024, respectively, which is included as a component of Other assets, net in the Consolidated Balance Sheets. The Company recognized net amortization from these investments of $4.2 million and $1.2 million during the three months ended December 31, 2024 and 2023, respectively, and $12.4 million and $3.2 million during the nine months ended December 31, 2024 and 2023, respectively, in income tax expense. The Company recognized tax benefits from these investments of $4.3 million and $1.2 million for the three months ended December 31, 2024 and 2023, respectively, and $13.6 million and $3.6 million for the nine months ended December 31, 2024 and 2023, respectively, in income tax expense and in Income taxes payable in the Consolidated Statements of Cash Flows. The Company did not recognize any non-tax related activity or have any significant modifications in the investments during the current period.
 
The Company is subject to U.S. income taxes, as well as taxes in various other state and local jurisdictions. With the exception of a few states, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2021, although carryforward attributes that were generated prior to 2021 may still be adjusted upon examination by the taxing authorities if they either have been or will be used in a future period.

The Company’s effective income tax rate increased to 16.4% for the three months ended December 31, 2024 compared to 14.6% for the prior year quarter. The increase is primarily due to the effects of provision to return adjustments treated as discrete items in the prior year quarter, which were partially offset by pretax book earnings relative to the effects of various permanent items including a decrease in the disallowed executive compensation under Section 162(m) and the recognition of additional HTCs when compared to the prior year.
v3.25.0.1
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
From time to time the Company is involved in litigation matters relating to claims arising out of its operations in the normal course of business.

Estimating an amount or range of possible losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve fines, penalties or damages that are discretionary in amount, involve a large number of claimants or significant discretion by regulatory authorities, represent a change in regulatory policy or interpretation, present novel legal theories, are in the early stages of the proceedings, are subject to appeal or could result in a change in business practices. In addition, because most legal proceedings are resolved over extended periods of time, potential losses are subject to change due to, among other things, new developments, changes in legal strategy, the outcome of intermediate procedural and substantive rulings and other parties’ settlement posture and their evaluation of the strength or weakness of their case against us. For these reasons, we are currently unable to predict the ultimate timing or outcome of, or reasonably estimate the possible
losses or a range of possible losses resulting from, any currently pending claims. Based on information currently available, the
Company does not believe that any reasonably possible losses arising from currently pending legal matters will be material to
the Company’s results of operations or financial conditions. However, in light of the inherent uncertainties involved in such matters, an adverse outcome in one or more of these matters could materially and adversely affect the Company’s financial condition, results of operations or cash flows in any particular reporting period.
v3.25.0.1
SUBSEQUENT EVENTS
9 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
Management is not aware of any significant events occurring subsequent to the balance sheet date that would have a material effect on the financial statements thereby requiring adjustment or disclosure.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure        
Net income $ 13,388,296 $ 16,664,818 $ 45,463,881 $ 42,285,985
v3.25.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
SUMMARY OF SIGNIFICANT POLICIES (Policies)
9 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Nature of Operations
Nature of Operations

The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.
Seasonality
Seasonality

The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters, and operating results for its fourth fiscal quarter are generally higher than in other quarters.
Loans receivable, net
Loans receivable, net

Loans receivable are carried at amortized cost, which is the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination costs were $6.6 million and $5.0 million as of December 31, 2024 and March 31, 2024, respectively.

From time to time, the Company will sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing. See Note 4 to the Consolidated Financial Statements for further information.
Allowance for credit losses
Allowance for credit losses

Refer to Note 4 to the Consolidated Financial Statements for information regarding the Company's CECL allowance model and a description of the policies and methodology utilized.
Reclassification
Reclassification
From time to time, prior period amounts will be reclassified to conform to the current presentation. Such reclassifications have no impact on previously reported net income or shareholders' equity
Recently Issued Accounting Standards Not Yet Adopted
Recently Issued Accounting Standards Not Yet Adopted

Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to require entities to expand annual disclosures to 1) include specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold and 2) disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign taxes. ASU 2023-09 also requires entities to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal, state and foreign, among other changes. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires additional disclosure, in the notes to financial statements, about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, which was clarified by ASU 2025-01, Clarifying the Effective Date. Early adoption is permitted. ASU 2024-03 should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this update or (2) retrospectively to any or all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.

We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the consolidated financial statements and related disclosures as a result of future adoption.
v3.25.0.1
FAIR VALUE (Tables)
9 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Values of Financial Assets and Liabilities
The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below.
December 31, 2024March 31, 2024
Input LevelCarrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
ASSETS
Cash and cash equivalents1$15,582,553 $15,582,553 $11,839,460 $11,839,460 
Loans receivable, net3903,906,808 903,906,808 847,440,309 847,440,309 
LIABILITIES
Senior unsecured notes payable, net
2223,910,142 222,969,719 272,609,632 254,208,482 
Senior notes payable3335,949,020 335,949,020 223,419,132 223,419,132 
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Tables)
9 Months Ended
Dec. 31, 2024
Receivables [Abstract]  
Schedule of Gross Loans Receivable by Customer Tenure
The following is a summary of gross loans receivable by Customer Tenure as of:
Customer TenureDecember 31, 2024March 31, 2024
0 to 5 months$120,206,225 $73,699,568 
6 to 17 months83,792,574 69,616,739 
18 to 35 months119,019,301 140,340,728 
36 to 59 months152,290,291 181,399,293 
60+ months904,874,073 799,703,920 
TALs1,279,438 12,389,008 
Total gross loans$1,381,461,902 $1,277,149,256 
The following table presents unpaid accrued interest reversed against interest income by Customer Tenure for the three and nine months ended December 31, 2024 and 2023:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Customer Tenure
0 to 5 months$(1,513,556)$(1,364,409)$(3,943,143)$(3,910,003)
6 to 17 months(802,513)(779,642)(2,201,034)(2,653,697)
18 to 35 months(789,715)(949,250)(2,378,004)(2,612,375)
36 to 59 months(829,641)(1,068,613)(2,553,282)(3,214,245)
60+ months(3,227,592)(2,828,677)(8,869,807)(7,977,412)
Total$(7,163,017)$(6,990,591)$(19,945,270)$(20,367,732)
Schedule of Payment Performance on a Recency Basis
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,191,801,595 $53,796,457 $5,232,034 $246,907 $5,097 $4,612 $1,251,086,702 
30 - 60 days past due45,078,425 5,587,931 771,319 88,677 5,498 12,712 51,544,562 
61 - 90 days past due27,968,712 3,192,929 387,807 46,475 5,912 518 31,602,353 
91 or more days past due38,928,934 6,353,121 611,384 52,719 2,689 — 45,948,847 
Total$1,303,777,666 $68,930,438 $7,002,544 $434,778 $19,196 $17,842 $1,380,182,464 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$191,926 $— $— $— $— $— $191,926 
30 - 60 days past due71,880 — — — — — 71,880 
61 - 90 days past due56,193 — — — — — 56,193 
91 or more days past due959,439 — — — — — 959,439 
Total$1,279,438 $— $— $— $— $— $1,279,438 
Total gross loans$1,381,461,902 
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,094,896,350 $61,853,967 $4,807,924 $109,050 $25,850 $1,371 $1,161,694,512 
30 - 60 days past due34,034,537 4,600,615 610,649 10,856 14,076 5,429 39,276,162 
61 - 90 days past due21,874,701 2,154,561 200,117 17,493 204 — 24,247,076 
91 or more days past due34,560,868 4,600,040 364,386 6,151 5,617 5,436 39,542,498 
Total$1,185,366,456 $73,209,183 $5,983,076 $143,550 $45,747 $12,236 $1,264,760,248 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$7,441,660 $860 $— $— $— $— $7,442,520 
30 - 60 days past due4,942,757 788 — — — — 4,943,545 
61 - 90 days past due— 1,650 — — — — 1,650 
91 or more days past due— 1,293 — — — — 1,293 
Total$12,384,417 $4,591 $— $— $— $— $12,389,008 
Total gross loans$1,277,149,256 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,179,892,149 $47,643,195 $4,032,753 $130,939 $— $— $1,231,699,036 
30 - 60 days past due46,938,294 4,289,434 347,554 10,189 — 4,836 51,590,307 
61 - 90 days past due30,851,070 3,357,138 300,261 20,307 205 — 34,528,981 
91 or more days past due46,096,156 13,640,670 2,321,974 273,343 18,991 13,006 62,364,140 
Total$1,303,777,669 $68,930,437 $7,002,542 $434,778 $19,196 $17,842 $1,380,182,464 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$158,737 $— $— $— $— $— $158,737 
30 - 60 days past due50,553 — — — — — 50,553 
61 - 90 days past due37,596 — — — — — 37,596 
91 or more days past due1,032,552 — — — — — 1,032,552 
Total$1,279,438 $— $— $— $— $— $1,279,438 
Total gross loans$1,381,461,902 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2024:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,079,720,968 $54,770,231 $3,681,104 $39,921 $10,484 $1,371 $1,138,224,079 
30 - 60 days past due37,475,784 3,388,380 288,576 1,064 — — 41,153,804 
61 - 90 days past due26,191,269 2,903,253 208,172 3,430 204 — 29,306,328 
91 or more days past due41,978,436 12,147,320 1,805,223 99,134 35,059 10,865 56,076,037 
Total$1,185,366,457 $73,209,184 $5,983,075 $143,549 $45,747 $12,236 $1,264,760,248 
Term Loans By Origination
TALsUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$7,441,661 $— $— $— $— $— $7,441,661 
30 - 60 days past due4,942,757 — — — — — 4,942,757 
61 - 90 days past due— — — — — — — 
91 or more days past due— 4,590 — — — — 4,590 
Total$12,384,418 $4,590 $— $— $— $— $12,389,008 
Total gross loans$1,277,149,256 

The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2024:

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination YearLoansTALsTotalLoansTALsTotal
2020 and prior$— $— $— $24,919 $— $24,919 
20212,675 — 2,675 26,161 — 26,161 
2022148,994 — 148,994 708,565 — 708,565 
20231,463,591 — 1,463,591 8,571,378 175 8,571,553 
202423,325,438 651,498 23,976,936 103,377,399 2,814,391 106,191,790 
202523,230,774 — 23,230,774 23,867,489 — 23,867,489 
Total$48,171,472 $651,498 $48,822,970 $136,575,911 $2,814,566 $139,390,477 
The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2023:
Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination YearLoansTALsTotalLoansTALsTotal
2019 and prior$1,958 $— $1,958 $11,385 $— $11,385 
20203,909 — 3,909 33,560 — 33,560 
202144,632 — 44,632 275,558 — 275,558 
20221,660,567 188 1,660,755 10,243,978 5,197 10,249,175 
202328,683,289 118,287 28,801,576 120,931,950 1,260,273 122,192,223 
202424,222,152 — 24,222,152 24,466,713 — 24,466,713 
Total$54,616,507 $118,475 $54,734,982 $155,963,144 $1,265,470 $157,228,614 
Summary of Changes in the Allowance for Loan Losses
The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
2024202320242023
Beginning balance$114,455,495 $128,892,192 $102,962,811 $125,552,733 
Provision for credit losses44,103,495 40,631,994 136,191,023 127,697,072 
Charge-offs(48,822,970)(54,734,982)(139,390,477)(157,228,614)
Recoveries16,374,926 6,292,864 16,347,589 25,060,877 
Net charge-offs(42,448,044)(48,442,118)(123,042,888)(132,167,737)
Ending Balance$116,110,946 $121,082,068 $116,110,946 $121,082,068 
Summary of the Past Due Receivables
The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$97,729,708 $8,178,732 $5,850,084 $8,447,701 $22,476,517 $120,206,225 
6 to 17 months71,894,285 4,123,710 2,957,998 4,816,581 11,898,289 83,792,574 
18 to 35 months104,818,028 5,232,991 3,486,649 5,481,633 14,201,273 119,019,301 
36 to 59 months135,845,513 6,391,258 3,906,289 6,147,231 16,444,778 152,290,291 
60+ months840,799,168 27,617,871 15,401,333 21,055,701 64,074,905 904,874,073 
TALs191,926 71,880 56,193 959,439 1,087,512 1,279,438 
Total gross loans1,251,278,628 51,616,442 31,658,546 46,908,286 130,183,274 1,381,461,902 
Unearned interest, insurance and fees(331,428,164)(9,525,813)(8,350,208)(12,139,963)(30,015,984)(361,444,148)
Total net loans$919,850,464 $42,090,629 $23,308,338 $34,768,323 $100,167,290 $1,020,017,754 
Percentage of period-end gross loans receivable3.7%2.3%3.4%9.4%

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$56,802,704 $4,720,149 $4,496,518 $7,680,197 $16,896,864 $73,699,568 
6 to 17 months60,634,735 3,155,423 2,075,608 3,750,973 8,982,004 69,616,739 
18 to 35 months126,843,010 5,057,256 3,224,662 5,215,800 13,497,718 140,340,728 
36 to 59 months165,694,013 6,159,335 3,519,743 6,026,202 15,705,280 181,399,293 
60+ months751,720,050 20,183,999 10,930,545 16,869,326 47,983,870 799,703,920 
TALs7,442,520 4,943,545 1,650 1,293 4,946,488 12,389,008 
Total gross loans1,169,137,032 44,219,707 24,248,726 39,543,791 108,012,224 1,277,149,256 
Unearned interest, insurance and fees(301,616,958)(7,677,494)(6,674,554)(10,777,130)(25,129,178)(326,746,136)
Total net loans$867,520,074 $36,542,213 $17,574,172 $28,766,661 $82,883,046 $950,403,120 
Percentage of period-end gross loans receivable3.5 %1.9 %3.1 %8.5 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$97,003,231 $8,063,335 $5,874,364 $9,265,295 $23,202,994 $120,206,225 
6 to 17 months70,860,586 4,036,915 2,987,142 5,907,931 12,931,988 83,792,574 
18 to 35 months102,558,371 5,188,437 3,806,830 7,465,663 16,460,930 119,019,301 
36 to 59 months133,059,756 6,150,175 4,191,450 8,888,910 19,230,535 152,290,291 
60+ months828,217,092 28,151,445 17,669,195 30,836,341 76,656,981 904,874,073 
TALs158,737 50,553 37,596 1,032,552 1,120,701 1,279,438 
Total gross loans1,231,857,773 51,640,860 34,566,577 63,396,692 149,604,129 1,381,461,902 
Unearned interest, insurance and fees(327,330,320)(8,969,250)(9,101,669)(16,042,909)(34,113,828)(361,444,148)
Total net loans$904,527,453 $42,671,610 $25,464,908 $47,353,783 $115,490,301 $1,020,017,754 
Percentage of period-end gross loans receivable3.7%2.5%4.6%10.8 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$55,572,691 $4,645,860 $4,784,273 $8,696,744 $18,126,877 $73,699,568 
6 to 17 months58,920,283 2,990,455 2,364,202 5,341,799 10,696,456 69,616,739 
18 to 35 months123,878,546 5,246,778 3,813,284 7,402,120 16,462,182 140,340,728 
36 to 59 months161,614,270 6,388,791 4,435,367 8,960,865 19,785,023 181,399,293 
60+ months738,238,289 21,881,920 13,909,202 25,674,509 61,465,631 799,703,920 
TALs7,441,661 4,942,757 — 4,590 4,947,347 12,389,008 
Total gross loans1,145,665,740 46,096,561 29,306,328 56,080,627 131,483,516 1,277,149,256 
Unearned interest, insurance and fees(296,584,056)(7,544,366)(7,936,622)(14,681,092)(30,162,080)(326,746,136)
Total net loans$849,081,684 $38,552,195 $21,369,706 $41,399,535 $101,321,436 $950,403,120 
Percentage of period-end gross loans receivable3.6 %2.3 %4.4 %10.3 %
Schedule of Amortized Cost Basis of Loans on Nonaccrual
The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2024 and 2023:
Nonaccrual Loans Receivable
Customer TenureAs of December 31, 2024As of March 31, 2024
Interest Income
Recognized for the three months ended December 31, 2024
Interest Income
Recognized for the three months ended December 31, 2023
Interest Income
Recognized for the nine months ended December 31, 2024
Interest Income
Recognized for the nine months ended December 31, 2023
0 to 5 months$14,404,816 $13,971,062 $152,639 $197,470 $521,894 $769,418 
6 to 17 months9,047,425 8,507,503 217,517 319,474 661,265 1,168,253 
18 to 35 months11,964,366 12,569,729 346,761 396,720 1,057,869 1,249,102 
36 to 59 months13,915,169 15,250,596 402,275 547,608 1,315,569 1,728,965 
60+ months51,333,978 45,091,589 1,507,229 1,497,757 4,463,586 4,785,842 
Unearned interest, insurance and fees(26,362,491)(24,643,778) —  — 
Total$74,303,263 $70,746,701 $2,626,421 $2,959,029 $8,020,183 $9,701,580 
v3.25.0.1
LEASES (Tables)
9 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Lease Cost
The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
 2024202320242023
Lease Cost
Operating lease cost$6,387,738 $6,163,762 $18,846,686 $19,000,163 
Variable lease cost940,465 888,119 2,949,878 2,808,845 
Total lease cost$7,328,203 $7,051,881 $21,796,564 $21,809,008 

The following table reports other information about the Company's leases for the three and nine months ended December 31, 2024 and 2023:
Three months ended December 31,Nine months ended December 31,
 2024202320242023
Other Lease Information
Operating cash flows for amounts included in the measurement of lease liabilities — operating leases$6,301,091 $6,265,527 $18,884,883 $18,965,468 
Right-of-use assets obtained in exchange for new operating lease liabilities$3,247,250 $4,568,169 $13,812,021 $13,560,648 
Weighted average remaining lease term — operating leases6.5 years6.9 years6.5 years6.9 years
Weighted-average discount rate — operating leases6.8 %6.3 %6.8 %6.3 %
Schedule of Operating Lease Maturity
The aggregate annual lease obligations as of December 31, 2024 are as follows:
Operating Leases
Remainder of 2025$6,160,520 
202622,367,057 
202717,961,935 
202814,520,255 
202910,573,915 
Thereafter29,343,439 
Total undiscounted lease liability$100,927,121 
Imputed interest19,719,824 
Total discounted lease liability$81,207,297 
Schedule of Finance Lease Maturity
The aggregate annual lease obligations as of December 31, 2024 are as follows:
Operating Leases
Remainder of 2025$6,160,520 
202622,367,057 
202717,961,935 
202814,520,255 
202910,573,915 
Thereafter29,343,439 
Total undiscounted lease liability$100,927,121 
Imputed interest19,719,824 
Total discounted lease liability$81,207,297 
v3.25.0.1
AVERAGE SHARE INFORMATION (Tables)
9 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Average Common Shares Outstanding
The following is a summary of the basic and diluted average common shares outstanding:
Three months ended December 31,Nine months ended December 31,
2024202320242023
Basic:  
Weighted average common shares outstanding (denominator)5,436,688 5,772,503 5,461,990 5,775,108 
Diluted:  
Weighted average common shares outstanding5,436,688 5,772,503 5,461,990 5,775,108 
Dilutive potential common shares27,529 87,614 64,794 121,608 
Weighted average diluted shares outstanding (denominator)5,464,217 5,860,117 5,526,784 5,896,716 
v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Performance Shares Vesting Based on EPS Targets
The Performance Share performance targets are set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%
The Performance Option performance target is set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Options Eligible for Vesting
(Percentage of Award)
$25.30100%
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
Fair value was estimated at grant date using the weighted-average assumptions listed below:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Dividend yield—%—%—%—%
Expected volatility59.53%62.54%59.53%62.55%
Average risk-free rate4.39%4.70%4.39%4.69%
Expected life4.5 years4.6 years4.5 years4.6 years
Schedule of Stock Option Activity
Option activity for the nine months ended December 31, 2024 was as follows:
 SharesWeighted Average Exercise
Price
Weighted Average
Remaining
Contractual Term
Aggregate Intrinsic Value
Options outstanding, beginning of period267,947 $105.77   
Granted during period38,661 111.68   
Exercised during period(20,310)92.64   
Forfeited during period(8,212)102.62   
Expired during period(1,549)206.52   
Options outstanding, end of period276,537  2$107.09 5.1 years$2,850,363 
Options exercisable, end of period131,659 $110.58 4.6 years$1,594,728 
Schedule of Intrinsic Value of Options Exercised The total intrinsic value and tax benefit of options exercised during the three and nine month periods ended December 31, 2024 and 2023 were as follows:
Three months ended December 31,Nine months ended December 31,
2024202320242023
Intrinsic value of options exercised$215,599 $369,543 $732,318 $810,853 
Tax benefit of options exercised52,822 90,538 179,418 198,659 
Summary of the Status and Changes Restricted Stock
A summary of the status of the Company’s restricted stock as of December 31, 2024, and changes during the nine months ended December 31, 2024, are presented below:
 SharesWeighted Average Fair Value at Grant Date
Outstanding at March 31, 2024388,577 $101.18 
Granted during the period71,186 111.64 
Vested during the period(62,577)104.08 
Forfeited during the period(44,566)100.37 
Outstanding at December 31, 2024352,620 $102.88 
Schedule of Share-Based Compensation Included as a Component of Net Income (Loss)
Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three and nine month periods ended December 31, 2024 and 2023 was as follows:

Three months ended December 31,Nine months ended December 31,
2024202320242023
Stock-based compensation related to equity classified awards:
Stock-based compensation (reversal) related to stock options3$85,640 $189,582 $323,140 $(3,871,348)
Stock-based compensation (reversal) related to restricted stock4363,626 (690,699)(18,886,571)1,475,151 
Total stock-based compensation (reversal) related to equity classified awards$449,266 $(501,117)$(18,563,431)$(2,396,197)
v3.25.0.1
ACQUISITIONS (Tables)
9 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Business Acquisition, Pro Forma Information
The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2024 and 2023:
 Nine months ended December 31,
20242023
Acquisitions:
Number of loan portfolios acquired through asset purchases6 — 
Purchase price$18,947,294 $— 
Tangible assets: 
Loans receivable, net18,812,693 — 
Purchase price amount over carrying value of net tangible assets$134,601 $— 
Customer lists$127,995 $— 
Non-compete agreements$6,606 $— 
v3.25.0.1
INTANGIBLE ASSETS (Tables)
9 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
The following table provides the gross carrying amount and related accumulated amortization of definite-lived intangible assets:
 December 31, 2024March 31, 2024
 Gross Carrying
Amount
Accumulated
Amortization
Net Intangible Asset Gross Carrying
Amount
Accumulated
Amortization
Net Intangible Asset
Customer lists$55,858,615 $(47,593,700)$8,264,915 $55,730,620 $(44,796,996)$10,933,624 
Non-compete agreements10,534,749 (10,498,178)36,571 10,528,143 (10,392,034)136,109 
Total$66,393,364 $(58,091,878)$8,301,486 $66,258,763 $(55,189,030)$11,069,733 
v3.25.0.1
DEBT (Tables)
9 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Aggregate Annual Maturities of the Notes Payable
The aggregate annual maturities of the Company's debt arrangements for future fiscal years ended March 31 are as follows:

Amount
Remainder of 2025$— 
2026— 
2027561,249,020 
2028— 
2029— 
Thereafter— 
Total future debt payments$561,249,020 
v3.25.0.1
SUMMARY OF SIGNIFICANT POLICIES (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Mar. 31, 2024
Accounting Policies [Abstract]    
Unamortized deferred origination fees and costs $ 6.6 $ 5.0
v3.25.0.1
FAIR VALUE (Details) - USD ($)
Dec. 31, 2024
Mar. 31, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior unsecured notes payable, net $ 223,910,142 $ 272,609,632
Senior notes payable 335,949,020 223,419,132
Fair Value, Inputs, Level 1 | Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 15,582,553 11,839,460
Fair Value, Inputs, Level 1 | Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 15,582,553 11,839,460
Fair Value, Inputs, Level 3 | Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loans receivable, net 903,906,808 847,440,309
Fair Value, Inputs, Level 3 | Carrying Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior notes payable 335,949,020 223,419,132
Fair Value, Inputs, Level 3 | Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loans receivable, net 903,906,808 847,440,309
Fair Value, Inputs, Level 3 | Estimated Fair Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior notes payable 335,949,020 223,419,132
Fair Value, Inputs, Level 2 | Carrying Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior unsecured notes payable, net 223,910,142 272,609,632
Fair Value, Inputs, Level 2 | Estimated Fair Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior unsecured notes payable, net $ 222,969,719 $ 254,208,482
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Gross Loans Receivable By Customer Tenure) (Details) - USD ($)
Dec. 31, 2024
Mar. 31, 2024
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 1,381,461,902 $ 1,277,149,256
TALs    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,279,438 12,389,008
0 to 5 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 120,206,225 73,699,568
6 to 17 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 83,792,574 69,616,739
18 to 35 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 119,019,301 140,340,728
36 to 59 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 152,290,291 181,399,293
60+ months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 904,874,073 $ 799,703,920
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Receivables [Abstract]          
Weighted average rehab rate 4.70%   4.70%   4.90%
Proceeds from prior write offs, current period $ 2.6 $ 2.9 $ 7.6 $ 10.5  
Proceeds from prior write offs, prior periods $ 1.5 $ 0.8 $ 1.5 $ 5.7  
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Payment Performance On A Recency Basis) (Details) - USD ($)
Dec. 31, 2024
Mar. 31, 2024
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 1,381,461,902 $ 1,277,149,256
Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,303,777,666 1,185,366,456
Financing receivable, between 1 and 2 years ago 68,930,438 73,209,183
Financing receivable, between 2 and 3 years ago 7,002,544 5,983,076
Financing receivable, between 3 and 4 years ago 434,778 143,550
Financing receivable, between 4 and 5 years ago 19,196 45,747
Financing receivable, more than 5 years ago 17,842 12,236
Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,380,182,464 1,264,760,248
Loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 45,078,425 34,034,537
Financing receivable, between 1 and 2 years ago 5,587,931 4,600,615
Financing receivable, between 2 and 3 years ago 771,319 610,649
Financing receivable, between 3 and 4 years ago 88,677 10,856
Financing receivable, between 4 and 5 years ago 5,498 14,076
Financing receivable, more than 5 years ago 12,712 5,429
Gross loans receivable 51,544,562 39,276,162
Loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 27,968,712 21,874,701
Financing receivable, between 1 and 2 years ago 3,192,929 2,154,561
Financing receivable, between 2 and 3 years ago 387,807 200,117
Financing receivable, between 3 and 4 years ago 46,475 17,493
Financing receivable, between 4 and 5 years ago 5,912 204
Financing receivable, more than 5 years ago 518 0
Gross loans receivable 31,602,353 24,247,076
Loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 38,928,934 34,560,868
Financing receivable, between 1 and 2 years ago 6,353,121 4,600,040
Financing receivable, between 2 and 3 years ago 611,384 364,386
Financing receivable, between 3 and 4 years ago 52,719 6,151
Financing receivable, between 4 and 5 years ago 2,689 5,617
Financing receivable, more than 5 years ago 0 5,436
Gross loans receivable 45,948,847 39,542,498
TALs    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,279,438 12,384,417
Financing receivable, between 1 and 2 years ago 0 4,591
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 1,279,438 12,389,008
TALs | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 71,880 4,942,757
Financing receivable, between 1 and 2 years ago 0 788
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 71,880 4,943,545
TALs | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 56,193 0
Financing receivable, between 1 and 2 years ago 0 1,650
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 56,193 1,650
TALs | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 959,439 0
Financing receivable, between 1 and 2 years ago 0 1,293
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 959,439 1,293
Performing Financing Receivable | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,191,801,595 1,094,896,350
Financing receivable, between 1 and 2 years ago 53,796,457 61,853,967
Financing receivable, between 2 and 3 years ago 5,232,034 4,807,924
Financing receivable, between 3 and 4 years ago 246,907 109,050
Financing receivable, between 4 and 5 years ago 5,097 25,850
Financing receivable, more than 5 years ago 4,612 1,371
Performing Financing Receivable | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,251,086,702 1,161,694,512
Performing Financing Receivable | TALs    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 191,926 7,441,660
Financing receivable, between 1 and 2 years ago 0 860
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable $ 191,926 $ 7,442,520
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Payment Performance On A Contractual Basis) (Details) - USD ($)
Dec. 31, 2024
Mar. 31, 2024
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 1,381,461,902 $ 1,277,149,256
Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,303,777,666 1,185,366,456
Financing receivable, between 1 and 2 years ago 68,930,438 73,209,183
Financing receivable, between 2 and 3 years ago 7,002,544 5,983,076
Financing receivable, between 3 and 4 years ago 434,778 143,550
Financing receivable, between 4 and 5 years ago 19,196 45,747
Financing receivable, more than 5 years ago 17,842 12,236
Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,380,182,464 1,264,760,248
Loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 45,078,425 34,034,537
Financing receivable, between 1 and 2 years ago 5,587,931 4,600,615
Financing receivable, between 2 and 3 years ago 771,319 610,649
Financing receivable, between 3 and 4 years ago 88,677 10,856
Financing receivable, between 4 and 5 years ago 5,498 14,076
Financing receivable, more than 5 years ago 12,712 5,429
Gross loans receivable 51,544,562 39,276,162
Loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 27,968,712 21,874,701
Financing receivable, between 1 and 2 years ago 3,192,929 2,154,561
Financing receivable, between 2 and 3 years ago 387,807 200,117
Financing receivable, between 3 and 4 years ago 46,475 17,493
Financing receivable, between 4 and 5 years ago 5,912 204
Financing receivable, more than 5 years ago 518 0
Gross loans receivable 31,602,353 24,247,076
Loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 38,928,934 34,560,868
Financing receivable, between 1 and 2 years ago 6,353,121 4,600,040
Financing receivable, between 2 and 3 years ago 611,384 364,386
Financing receivable, between 3 and 4 years ago 52,719 6,151
Financing receivable, between 4 and 5 years ago 2,689 5,617
Financing receivable, more than 5 years ago 0 5,436
Gross loans receivable 45,948,847 39,542,498
TALs    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,279,438 12,384,417
Financing receivable, between 1 and 2 years ago 0 4,591
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 1,279,438 12,389,008
TALs | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 71,880 4,942,757
Financing receivable, between 1 and 2 years ago 0 788
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 71,880 4,943,545
TALs | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 56,193 0
Financing receivable, between 1 and 2 years ago 0 1,650
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 56,193 1,650
TALs | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 959,439 0
Financing receivable, between 1 and 2 years ago 0 1,293
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 959,439 1,293
Performing Financing Receivable | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,191,801,595 1,094,896,350
Financing receivable, between 1 and 2 years ago 53,796,457 61,853,967
Financing receivable, between 2 and 3 years ago 5,232,034 4,807,924
Financing receivable, between 3 and 4 years ago 246,907 109,050
Financing receivable, between 4 and 5 years ago 5,097 25,850
Financing receivable, more than 5 years ago 4,612 1,371
Performing Financing Receivable | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,251,086,702 1,161,694,512
Performing Financing Receivable | TALs    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 191,926 7,441,660
Financing receivable, between 1 and 2 years ago 0 860
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 191,926 7,442,520
Contractual basis    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,381,461,902 1,277,149,256
Contractual basis | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 51,640,860 46,096,561
Contractual basis | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 34,566,577 29,306,328
Contractual basis | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 63,396,692 56,080,627
Contractual basis | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,303,777,669 1,185,366,457
Financing receivable, between 1 and 2 years ago 68,930,437 73,209,184
Financing receivable, between 2 and 3 years ago 7,002,542 5,983,075
Financing receivable, between 3 and 4 years ago 434,778 143,549
Financing receivable, between 4 and 5 years ago 19,196 45,747
Financing receivable, more than 5 years ago 17,842 12,236
Contractual basis | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,380,182,464 1,264,760,248
Contractual basis | Loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 46,938,294 37,475,784
Financing receivable, between 1 and 2 years ago 4,289,434 3,388,380
Financing receivable, between 2 and 3 years ago 347,554 288,576
Financing receivable, between 3 and 4 years ago 10,189 1,064
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 4,836 0
Gross loans receivable 51,590,307 41,153,804
Contractual basis | Loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 30,851,070 26,191,269
Financing receivable, between 1 and 2 years ago 3,357,138 2,903,253
Financing receivable, between 2 and 3 years ago 300,261 208,172
Financing receivable, between 3 and 4 years ago 20,307 3,430
Financing receivable, between 4 and 5 years ago 205 204
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 34,528,981 29,306,328
Contractual basis | Loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 46,096,156 41,978,436
Financing receivable, between 1 and 2 years ago 13,640,670 12,147,320
Financing receivable, between 2 and 3 years ago 2,321,974 1,805,223
Financing receivable, between 3 and 4 years ago 273,343 99,134
Financing receivable, between 4 and 5 years ago 18,991 35,059
Financing receivable, more than 5 years ago 13,006 10,865
Gross loans receivable 62,364,140 56,076,037
Contractual basis | TALs    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,279,438 12,384,418
Financing receivable, between 1 and 2 years ago 0 4,590
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 1,279,438 12,389,008
Contractual basis | TALs | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 50,553 4,942,757
Financing receivable, between 1 and 2 years ago 0 0
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 50,553 4,942,757
Contractual basis | TALs | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 37,596 0
Financing receivable, between 1 and 2 years ago 0 0
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 37,596 0
Contractual basis | TALs | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,032,552 0
Financing receivable, between 1 and 2 years ago 0 4,590
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 1,032,552 4,590
Contractual basis | Performing Financing Receivable | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,179,892,149 1,079,720,968
Financing receivable, between 1 and 2 years ago 47,643,195 54,770,231
Financing receivable, between 2 and 3 years ago 4,032,753 3,681,104
Financing receivable, between 3 and 4 years ago 130,939 39,921
Financing receivable, between 4 and 5 years ago 0 10,484
Financing receivable, more than 5 years ago 0 1,371
Contractual basis | Performing Financing Receivable | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,231,699,036 1,138,224,079
Contractual basis | Performing Financing Receivable | TALs    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 158,737 7,441,661
Financing receivable, between 1 and 2 years ago 0 0
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable $ 158,737 $ 7,441,661
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Company’s Gross Charge-Offs By Year of Origination) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Financing Receivable, Recorded Investment [Line Items]        
2020 and prior $ 0 $ 1,958 $ 24,919 $ 11,385
2021 2,675 3,909 26,161 33,560
2022 148,994 44,632 708,565 275,558
2023 1,463,591 1,660,755 8,571,553 10,249,175
2024 23,976,936 28,801,576 106,191,790 122,192,223
2025 23,230,774 24,222,152 23,867,489 24,466,713
Total 48,822,970 54,734,982 139,390,477 157,228,614
Loans        
Financing Receivable, Recorded Investment [Line Items]        
2020 and prior 0 1,958 24,919 11,385
2021 2,675 3,909 26,161 33,560
2022 148,994 44,632 708,565 275,558
2023 1,463,591 1,660,567 8,571,378 10,243,978
2024 23,325,438 28,683,289 103,377,399 120,931,950
2025 23,230,774 24,222,152 23,867,489 24,466,713
Total 48,171,472 54,616,507 136,575,911 155,963,144
TALs        
Financing Receivable, Recorded Investment [Line Items]        
2020 and prior 0 0 0 0
2021 0 0 0 0
2022 0 0 0 0
2023 0 188 175 5,197
2024 651,498 118,287 2,814,391 1,260,273
2025 0 0 0 0
Total $ 651,498 $ 118,475 $ 2,814,566 $ 1,265,470
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Roll Forward of the Allowance for Credit Losses on Our Gross Loans Receivable) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]        
Beginning balance $ 114,455,495 $ 128,892,192 $ 102,962,811 $ 125,552,733
Provision for credit losses 44,103,495 40,631,994 136,191,023 127,697,072
Charge-offs (48,822,970) (54,734,982) (139,390,477) (157,228,614)
Recoveries 6,374,926 6,292,864 16,347,589 25,060,877
Net charge-offs (42,448,044) (48,442,118) (123,042,888) (132,167,737)
Ending Balance $ 116,110,946 $ 121,082,068 $ 116,110,946 $ 121,082,068
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Summary of Past Due Receivables) (Details) - USD ($)
Dec. 31, 2024
Mar. 31, 2024
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 1,381,461,902 $ 1,277,149,256
Unearned interest, insurance and fees (6,600,000) (5,000,000)
TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,279,438 12,389,008
30 - 60 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 120,206,225 73,699,568
30 - 60 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 83,792,574 69,616,739
30 - 60 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 119,019,301 140,340,728
30 - 60 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 152,290,291 181,399,293
30 - 60 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 904,874,073 799,703,920
Recency Basis    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,381,461,902 1,277,149,256
Unearned interest, insurance and fees (361,444,148) (326,746,136)
Total net loans $ 1,020,017,754 $ 950,403,120
Financing receivable, percent past due 9.40% 8.50%
Recency Basis | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 1,279,438 $ 12,389,008
Recency Basis | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 120,206,225 73,699,568
Recency Basis | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 83,792,574 69,616,739
Recency Basis | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 119,019,301 140,340,728
Recency Basis | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 152,290,291 181,399,293
Recency Basis | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 904,874,073 799,703,920
Recency Basis | Current    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,251,278,628 1,169,137,032
Unearned interest, insurance and fees (331,428,164) (301,616,958)
Total net loans 919,850,464 867,520,074
Recency Basis | Current | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 191,926 7,442,520
Recency Basis | Current | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 97,729,708 56,802,704
Recency Basis | Current | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 71,894,285 60,634,735
Recency Basis | Current | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 104,818,028 126,843,010
Recency Basis | Current | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 135,845,513 165,694,013
Recency Basis | Current | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 840,799,168 751,720,050
Recency Basis | 30 - 60 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 51,616,442 44,219,707
Unearned interest, insurance and fees (9,525,813) (7,677,494)
Total net loans $ 42,090,629 $ 36,542,213
Financing receivable, percent past due 3.70% 3.50%
Recency Basis | 30 - 60 days past due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 71,880 $ 4,943,545
Recency Basis | 30 - 60 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 8,178,732 4,720,149
Recency Basis | 30 - 60 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,123,710 3,155,423
Recency Basis | 30 - 60 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,232,991 5,057,256
Recency Basis | 30 - 60 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 6,391,258 6,159,335
Recency Basis | 30 - 60 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 27,617,871 20,183,999
Recency Basis | 61 - 90 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 31,658,546 24,248,726
Unearned interest, insurance and fees (8,350,208) (6,674,554)
Total net loans $ 23,308,338 $ 17,574,172
Financing receivable, percent past due 2.30% 1.90%
Recency Basis | 61 - 90 days past due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 56,193 $ 1,650
Recency Basis | 61 - 90 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,850,084 4,496,518
Recency Basis | 61 - 90 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 2,957,998 2,075,608
Recency Basis | 61 - 90 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 3,486,649 3,224,662
Recency Basis | 61 - 90 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 3,906,289 3,519,743
Recency Basis | 61 - 90 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 15,401,333 10,930,545
Recency Basis | 91 or more days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 46,908,286 39,543,791
Unearned interest, insurance and fees (12,139,963) (10,777,130)
Total net loans $ 34,768,323 $ 28,766,661
Financing receivable, percent past due 3.40% 3.10%
Recency Basis | 91 or more days past due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 959,439 $ 1,293
Recency Basis | 91 or more days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 8,447,701 7,680,197
Recency Basis | 91 or more days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,816,581 3,750,973
Recency Basis | 91 or more days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,481,633 5,215,800
Recency Basis | 91 or more days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 6,147,231 6,026,202
Recency Basis | 91 or more days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 21,055,701 16,869,326
Recency Basis | Total Past Due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 130,183,274 108,012,224
Unearned interest, insurance and fees (30,015,984) (25,129,178)
Total net loans 100,167,290 82,883,046
Recency Basis | Total Past Due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,087,512 4,946,488
Recency Basis | Total Past Due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 22,476,517 16,896,864
Recency Basis | Total Past Due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 11,898,289 8,982,004
Recency Basis | Total Past Due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 14,201,273 13,497,718
Recency Basis | Total Past Due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 16,444,778 15,705,280
Recency Basis | Total Past Due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 64,074,905 47,983,870
Contractual basis    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,381,461,902 1,277,149,256
Unearned interest, insurance and fees (361,444,148) (326,746,136)
Total net loans $ 1,020,017,754 $ 950,403,120
Financing receivable, percent past due 10.80% 10.30%
Contractual basis | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 1,279,438 $ 12,389,008
Contractual basis | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 120,206,225 73,699,568
Contractual basis | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 83,792,574 69,616,739
Contractual basis | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 119,019,301 140,340,728
Contractual basis | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 152,290,291 181,399,293
Contractual basis | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 904,874,073 799,703,920
Contractual basis | Current    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,231,857,773 1,145,665,740
Unearned interest, insurance and fees (327,330,320) (296,584,056)
Total net loans 904,527,453 849,081,684
Contractual basis | Current | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 158,737 7,441,661
Contractual basis | Current | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 97,003,231 55,572,691
Contractual basis | Current | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 70,860,586 58,920,283
Contractual basis | Current | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 102,558,371 123,878,546
Contractual basis | Current | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 133,059,756 161,614,270
Contractual basis | Current | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 828,217,092 738,238,289
Contractual basis | 30 - 60 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 51,640,860 46,096,561
Unearned interest, insurance and fees (8,969,250) (7,544,366)
Total net loans $ 42,671,610 $ 38,552,195
Financing receivable, percent past due 3.70% 3.60%
Contractual basis | 30 - 60 days past due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 50,553 $ 4,942,757
Contractual basis | 30 - 60 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 8,063,335 4,645,860
Contractual basis | 30 - 60 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,036,915 2,990,455
Contractual basis | 30 - 60 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,188,437 5,246,778
Contractual basis | 30 - 60 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 6,150,175 6,388,791
Contractual basis | 30 - 60 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 28,151,445 21,881,920
Contractual basis | 61 - 90 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 34,566,577 29,306,328
Unearned interest, insurance and fees (9,101,669) (7,936,622)
Total net loans $ 25,464,908 $ 21,369,706
Financing receivable, percent past due 2.50% 2.30%
Contractual basis | 61 - 90 days past due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 37,596 $ 0
Contractual basis | 61 - 90 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,874,364 4,784,273
Contractual basis | 61 - 90 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 2,987,142 2,364,202
Contractual basis | 61 - 90 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 3,806,830 3,813,284
Contractual basis | 61 - 90 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,191,450 4,435,367
Contractual basis | 61 - 90 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 17,669,195 13,909,202
Contractual basis | 91 or more days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 63,396,692 56,080,627
Unearned interest, insurance and fees (16,042,909) (14,681,092)
Total net loans $ 47,353,783 $ 41,399,535
Financing receivable, percent past due 4.60% 4.40%
Contractual basis | 91 or more days past due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 1,032,552 $ 4,590
Contractual basis | 91 or more days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 9,265,295 8,696,744
Contractual basis | 91 or more days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,907,931 5,341,799
Contractual basis | 91 or more days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 7,465,663 7,402,120
Contractual basis | 91 or more days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 8,888,910 8,960,865
Contractual basis | 91 or more days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 30,836,341 25,674,509
Contractual basis | Total Past Due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 149,604,129 131,483,516
Unearned interest, insurance and fees (34,113,828) (30,162,080)
Total net loans 115,490,301 101,321,436
Contractual basis | Total Past Due | TALs    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,120,701 4,947,347
Contractual basis | Total Past Due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 23,202,994 18,126,877
Contractual basis | Total Past Due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 12,931,988 10,696,456
Contractual basis | Total Past Due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 16,460,930 16,462,182
Contractual basis | Total Past Due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 19,230,535 19,785,023
Contractual basis | Total Past Due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 76,656,981 $ 61,465,631
v3.25.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Nonaccrual) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed $ (7,163,017) $ (6,990,591) $ (19,945,270) $ (20,367,732)  
Financing receivable, nonaccrual 74,303,263   74,303,263   $ 70,746,701
Interest Income Recognized 2,626,421 2,959,029 8,020,183 9,701,580  
Nonaccrual status          
Financing Receivable, Nonaccrual [Line Items]          
Unearned interest, insurance and fees (26,362,491)   (26,362,491)   (24,643,778)
0 to 5 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (1,513,556) (1,364,409) (3,943,143) (3,910,003)  
Financing receivable, nonaccrual 14,404,816   14,404,816   13,971,062
Interest Income Recognized 152,639 197,470 521,894 769,418  
6 to 17 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (802,513) (779,642) (2,201,034) (2,653,697)  
Financing receivable, nonaccrual 9,047,425   9,047,425   8,507,503
Interest Income Recognized 217,517 319,474 661,265 1,168,253  
18 to 35 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (789,715) (949,250) (2,378,004) (2,612,375)  
Financing receivable, nonaccrual 11,964,366   11,964,366   12,569,729
Interest Income Recognized 346,761 396,720 1,057,869 1,249,102  
36 to 59 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (829,641) (1,068,613) (2,553,282) (3,214,245)  
Financing receivable, nonaccrual 13,915,169   13,915,169   15,250,596
Interest Income Recognized 402,275 547,608 1,315,569 1,728,965  
60+ months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (3,227,592) (2,828,677) (8,869,807) (7,977,412)  
Financing receivable, nonaccrual 51,333,978   51,333,978   $ 45,091,589
Interest Income Recognized $ 1,507,229 $ 1,497,757 $ 4,463,586 $ 4,785,842  
v3.25.0.1
LEASES (Narrative) (Details)
Dec. 31, 2024
Mar. 31, 2024
Lessee, Lease, Description [Line Items]    
Effective interest rate   9.90%
Minimum    
Lessee, Lease, Description [Line Items]    
Operating lease, term of contract 3 years  
Maximum    
Lessee, Lease, Description [Line Items]    
Operating lease, term of contract 5 years  
v3.25.0.1
LEASES (Lease Cost) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]        
Operating lease cost $ 6,387,738 $ 6,163,762 $ 18,846,686 $ 19,000,163
Variable lease cost 940,465 888,119 2,949,878 2,808,845
Total lease cost 7,328,203 7,051,881 21,796,564 21,809,008
Operating cash flows for amounts included in the measurement of lease liabilities — operating leases 6,301,091 6,265,527 18,884,883 18,965,468
Right-of-use assets obtained in exchange for new operating lease liabilities $ 3,247,250 $ 4,568,169 $ 13,812,021 $ 13,560,648
Weighted average remaining lease term — operating leases 6 years 6 months 6 years 10 months 24 days 6 years 6 months 6 years 10 months 24 days
Weighted-average discount rate — operating leases 6.80% 6.30% 6.80% 6.30%
v3.25.0.1
LEASES (Aggregate Annual Lease Obligations) (Details) - USD ($)
Dec. 31, 2024
Mar. 31, 2024
Operating Leases    
Remainder of 2025 $ 6,160,520  
2026 22,367,057  
2027 17,961,935  
2028 14,520,255  
2029 10,573,915  
Thereafter 29,343,439  
Total undiscounted lease liability 100,927,121  
Imputed interest 19,719,824  
Total discounted lease liability $ 81,207,297 $ 81,920,865
v3.25.0.1
AVERAGE SHARE INFORMATION (Details) - shares
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Basic:        
Weighted average common shares outstanding (in shares) 5,436,688 5,772,503 5,461,990 5,775,108
Diluted:        
Weighted average common shares outstanding (in shares) 5,436,688 5,772,503 5,461,990 5,775,108
Dilutive potential common shares (in shares) 27,529 87,614 64,794 121,608
Weighted average diluted shares outstanding (in shares) 5,464,217 5,860,117 5,526,784 5,896,716
Anti-dilutive shares (in shares) 246,111 291,826 250,034 299,904
v3.25.0.1
STOCK-BASED COMPENSATION (Narrative) (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 18, 2024
Dec. 31, 2024
USD ($)
installment
$ / shares
shares
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
Dec. 31, 2024
USD ($)
installment
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
Mar. 31, 2024
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares available for grant (in shares) | shares   187,020       187,020    
Vesting percentage           100.00%    
Stock based compensation expense (reversal)       $ 700,000   $ 1,400,000 $ 1,400,000  
Weighted-average fair value at the grant date (in dollars per share) | $ / shares   $ 58.29   $ 68.52   $ 58.29 $ 69.00  
Fair value of stock options vested           $ 2,120,670    
Stock-based compensation (reversal) related to equity classified awards       $ (690,699)   (18,886,570) $ (3,871,348)  
Forfeiture credit       1,400,000   $ 1,800,000 400,000  
Employee Stock Option                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares of authorized common stock reserved for issuance (in shares) | shares   3,350,000       3,350,000    
Options outstanding (in shares) | shares   276,537       276,537   267,947
Total unrecognized stock-based compensation expense related to non-vested stock options   $ 1,900,000       $ 1,900,000    
Weighted average period for recognition           2 years 6 months    
Stock-based compensation (reversal) related to equity classified awards   $ 85,640   189,582   $ 323,140 (3,871,348)  
Employee Stock Option | Scenario 1                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Options outstanding (in shares) | shares   16,453       16,453    
Employee Stock Option | Scenario 2                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Options outstanding (in shares) | shares   128,425       128,425    
Employee Stock Option | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period           3 years    
Employee Stock Option | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock option, expiration period           10 years    
Vesting period           6 years    
Restricted Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average period for recognition           1 year    
Awards granted (in shares) | shares           71,186   3,993
Grant date fair value (in dollars per share) | $ / shares           $ 111.64   $ 120.12
Fair value of restricted stock vested           $ 7,293,854    
Unvested restricted stock awards   $ 7,700,000       7,700,000    
Stock-based compensation (reversal) related to equity classified awards   $ 363,626   $ (690,699)   $ (18,886,571) $ 1,475,151  
Restricted Stock | 2024 Long-term Incentive Program and Non-Employee Director Awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period 10 years              
Vesting percentage 100.00%              
Restricted Stock | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of installments | installment   3       3    
Restricted Stock | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of installments | installment   6       6    
Service Option                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period           10 years    
Performance Shares                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period           10 years    
Stock based compensation expense (reversal)     $ (18,500,000)   $ (4,900,000) $ (18,500,000)    
Performance Shares | 2024 Long-term Incentive Program and Non-Employee Director Awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period 10 years              
Vesting percentage 100.00%              
v3.25.0.1
STOCK-BASED COMPENSATION (Share and Options Performance Targets) (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2024
Dec. 31, 2024
Target 1    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
EPS target (in dollars per share)   $ 16.35
Vesting percentage   40.00%
Target 2    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
EPS target (in dollars per share) $ 20.45 $ 20.45
Vesting percentage   60.00%
Target 3    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
EPS target (in dollars per share)   $ 25.30
Vesting percentage   100.00%
v3.25.0.1
STOCK-BASED COMPENSATION (Grants Date Using The Weighted-Average Assumptions) (Details)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]        
Dividend yield 0.00% 0.00% 0.00% 0.00%
Expected volatility 59.53% 62.54% 59.53% 62.55%
Average risk-free rate 4.39% 4.70% 4.39% 4.69%
Expected life 4 years 6 months 4 years 7 months 6 days 4 years 6 months 4 years 7 months 6 days
v3.25.0.1
STOCK-BASED COMPENSATION (Stock Option Activity and Intrinsic Value) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted-average fair value at the grant date (in dollars per share) $ 58.29 $ 68.52 $ 58.29 $ 69.00
Stock Options Plans        
Options Activity [Roll Forward]        
Options outstanding, beginning of year (in shares)     267,947  
Granted (in shares)     38,661  
Exercised (in shares)     (20,310)  
Forfeited (in shares)     (8,212)  
Expired (in shares)     (1,549)  
Options outstanding, end of period (in shares) 276,537   276,537  
Options exercisable, end of period (in shares) 131,659   131,659  
Weighted Average Exercise Price        
Options outstanding, beginning of year (in dollars per share)     $ 105.77  
Granted (in dollars per share)     111.68  
Exercised (in dollars per share)     92.64  
Forfeited (in dollars per share)     102.62  
Expired (in dollars per share)     206.52  
Options outstanding, end of period (in dollars per share) $ 107.09   107.09  
Options exercisable, end of period (in dollars per share) $ 110.58   $ 110.58  
Stock Option Activity Additional Disclosures [Abstract]        
Weighted-average remaining contractual term, options outstanding, end of period     5 years 1 month 6 days  
Weighted-average remaining contractual terms, options exercisable, end of period     4 years 7 months 6 days  
Aggregate intrinsic value, options outstanding, end of period $ 2,850,363   $ 2,850,363  
Aggregate intrinsic value, options exercisable, end of period 1,594,728   1,594,728  
Intrinsic value of options exercised 215,599 $ 369,543 732,318 $ 810,853
Tax benefit of options exercised $ 52,822 $ 90,538 $ 179,418 $ 198,659
v3.25.0.1
STOCK-BASED COMPENSATION (Company Restricted Stock and Total Stock-Based Compensation) (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Weighted Average Fair Value at Grant Date          
Stock-based compensation (reversal) related to equity classified awards   $ (690,699) $ (18,886,570) $ (3,871,348)  
Restricted Stock          
Shares          
Outstanding at beginning of year (in shares)     388,577    
Granted during the period (in shares)     71,186   3,993
Vested during the period (in shares)     (62,577)    
Forfeited during the period (in shares)     (44,566)    
Outstanding at end of period (in shares) 352,620   352,620   388,577
Weighted Average Fair Value at Grant Date          
Outstanding at beginning period (in dollars per share)     $ 101.18    
Granted during the period (in shares)     111.64   $ 120.12
Vested during the period (in dollars per share)     104.08    
Forfeited during the period (in dollars per share)     100.37    
Outstanding at ending period (in dollars per share) $ 102.88   $ 102.88   $ 101.18
Stock-based compensation (reversal) related to equity classified awards $ 363,626 (690,699) $ (18,886,571) 1,475,151  
Stock Options Plans          
Weighted Average Fair Value at Grant Date          
Stock-based compensation (reversal) related to equity classified awards 85,640 189,582 323,140 (3,871,348)  
Equity Securities          
Weighted Average Fair Value at Grant Date          
Stock-based compensation (reversal) related to equity classified awards $ 449,266 $ (501,117) $ (18,563,431) $ (2,396,197)  
v3.25.0.1
ACQUISITIONS (Details)
9 Months Ended
Dec. 31, 2024
USD ($)
acquisition
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
acquisition
Business Acquisition [Line Items]      
Purchase price amount over carrying value of net tangible assets $ 7,370,791 $ 7,370,791  
Loans purchased $ 1,000,000    
Series of Business Acquisitions      
Business Acquisition [Line Items]      
Number of loan portfolios acquired through asset purchases | acquisition 6   0
Purchase price $ 18,947,294   $ 0
Loans receivable, net 18,812,693   0
Purchase price amount over carrying value of net tangible assets 134,601   0
Customer lists 127,995   0
Non-compete agreements $ 6,606   $ 0
v3.25.0.1
INTANGIBLE ASSETS (Schedule of Assets) (Details) - USD ($)
Dec. 31, 2024
Mar. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 66,393,364 $ 66,258,763
Accumulated Amortization (58,091,878) (55,189,030)
Net Intangible Asset 8,301,486 11,069,733
Customer lists    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 55,858,615 55,730,620
Accumulated Amortization (47,593,700) (44,796,996)
Net Intangible Asset 8,264,915 10,933,624
Non-compete agreements    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 10,534,749 10,528,143
Accumulated Amortization (10,498,178) (10,392,034)
Net Intangible Asset $ 36,571 $ 136,109
v3.25.0.1
INTANGIBLE ASSETS (Maturity Schedule) (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Remainder of 2025 $ 0.9
2026 3.2
2027 2.7
2028 0.9
2029 0.4
Thereafter $ 0.2
v3.25.0.1
DEBT (Narrative) (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 27, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Line of Credit Facility [Line Items]            
Letters of credit outstanding, amount   $ 725,800   $ 725,800    
Payments for debt extinguishment costs       12,500 $ 20,625  
Gain (loss) on extinguishment of senior unsecured notes payable       1,160,067 1,162,581  
Letter Of Credit, Worker's Compensation            
Line of Credit Facility [Line Items]            
Letters of credit outstanding, amount   300,000   300,000    
Letters of Credit, Investment In Captive Insurance            
Line of Credit Facility [Line Items]            
Letters of credit outstanding, amount   425,800   425,800    
Senior Notes Due 2026 | Senior notes            
Line of Credit Facility [Line Items]            
Interest rate, percentage 7.00%          
Aggregate principal amount $ 300,000,000          
Redemption price, percentage of equity offerings 40.00%          
Repurchased and extinguished amount of debt       49,300,000   $ 15,700,000
Debt issuance costs   400,000   400,000   200,000
Payments for debt extinguishment costs       48,100,000   $ 14,100,000
Gain (loss) on extinguishment of senior unsecured notes payable   (50,000) $ 600,000 1,200,000 1,200,000  
Senior Notes Due 2026 | Senior notes | Period One            
Line of Credit Facility [Line Items]            
Redemption price percent 100.00%          
Senior Notes Due 2026 | Senior notes | Period Two            
Line of Credit Facility [Line Items]            
Redemption price percent 107.00%          
Revolving Credit Facility            
Line of Credit Facility [Line Items]            
Maximum borrowing capacity   580,000,000.0   580,000,000.0    
Accordion feature   730,000,000.0   730,000,000.0    
Amount outstanding   $ 335,900,000   $ 335,900,000    
Basis spread on variable rate (in hundredths)       0.10%    
Interest rate, percentage   3.50%   3.50%    
Commitment fee percentage       0.50%    
Unused borrowing capacity, fee       $ 1,200,000 $ 1,300,000  
Interest rate, effective percentage   9.70%   9.70%   9.90%
Unused amount available   $ 243,300,000   $ 243,300,000    
Debt covenants minimum net worth       $ 325,000,000    
Fixed conversion ratio       2.0    
Expiration period       60 days    
Revolving Credit Facility | Scenario 1            
Line of Credit Facility [Line Items]            
Debt covenant, maximum ratio of total debt       2.25    
Debt covenant, maximum collateral performance indicator percentage       26.00%    
Fixed conversion ratio       2.0    
Revolving Credit Facility | Scenario 2            
Line of Credit Facility [Line Items]            
Fixed conversion ratio       2.25    
Revolving Credit Facility | Minimum            
Line of Credit Facility [Line Items]            
Interest rate, percentage   4.50%   4.50%    
v3.25.0.1
DEBT (Debt Maturities) (Details)
Dec. 31, 2024
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2025 $ 0
2026 0
2027 561,249,020
2028 0
2029 0
Thereafter 0
Total future debt payments $ 561,249,020
v3.25.0.1
INCOME TAXES (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Income Tax Contingency [Line Items]          
Total gross unrecognized tax benefits including interest $ 1,100,000   $ 1,100,000   $ 1,100,000
Unrecognized tax benefits 800,000   800,000   800,000
Gross unrecognized tax benefits, limitations and settlement with taxing authorities 400,000   400,000    
Accrued gross interest $ 327,900   327,900    
Gross interest expense     10,900    
Effective income tax rate reconciliation, percent 16.40% 14.60%      
Historic Tax Credit Investment          
Income Tax Contingency [Line Items]          
Equity method investment $ 18,700,000   18,700,000   $ 24,800,000
Historic tax credit investments amortization 4,200,000 $ 1,200,000 12,400,000 $ 3,200,000  
Tax benefits from these investments $ 4,300,000 $ 1,200,000 $ 13,600,000 $ 3,600,000  

World Acceptance (NASDAQ:WRLD)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse World Acceptance
World Acceptance (NASDAQ:WRLD)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse World Acceptance